MDR_REPORT_KEY|MDR_TEXT_KEY|TEXT_TYPE_CODE|PATIENT_SEQUENCE_NUMBER|DATE_REPORT|FOI_TEXT|BRAND_NAME|CATALOG_NUMBER|DATE_RECEIVED|DATE_REMOVED_FLAG|DATE_RETURNED_TO_MANUFACTURER|DEVICE_AGE_TEXT|DEVICE_AVAILABILITY|DEVICE_EVALUATED_BY_MANUFACTUR|DEVICE_EVENT_KEY|DEVICE_OPERATOR|DEVICE_REPORT_PRODUCT_CODE|DEVICE_SEQUENCE_NO|EXPIRATION_DATE_OF_DEVICE|GENERIC_NAME|IMPLANT_FLAG|LOT_NUMBER|MANUFACTURER_D_ADDRESS_1|MANUFACTURER_D_ADDRESS_2|MANUFACTURER_D_CITY|MANUFACTURER_D_COUNTRY_CODE|MANUFACTURER_D_NAME|MANUFACTURER_D_POSTAL_CODE|MANUFACTURER_D_STATE_CODE|MANUFACTURER_D_ZIP_CODE|MANUFACTURER_D_ZIP_CODE_EXT|MODEL_NUMBER|OTHER_ID_NUMBER|filter
6315557|66927053|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6540530|74301792|N|1||EVENTS LYMPHOMA ALCL SEROMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY RECORD DHR PROVIDES REVIEW DHR B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MAY ASSOCIATED REPORTED DEVICE EVENT GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY |STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-401|05/03/2017||||N|R||0HP|FTR|1.0|07/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2010555|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247187|66742201|N|1||EVENTS LYMPHOMA-ALCL LATE SEROMA INFLAMMATION PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY RECORD DHR SUMMARY REVIEW DHR WORK ORDER 1321464 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER 1321464 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS REPORTED EVENTS ADDRESSED DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6247187|66742202|D|1||ADDITIONAL INFORMATION RECEIVED HEALTH PROFESSIONAL REGARDING EVENT MRI REPORT DATED B6 2016 ADDITIONAL REPORTED EVENT IMPLANT SURROUNDED LARGE COLLECTION FLUID PATHOLOGY RESULTS B6 2016 REVEALED LEFT PERIPROSTHETIC CAPSULE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT PATHOLOGY SHOWS ALCL MARKERS CD30+ ALK- PHYSICIAN ADDITIONALLY REPORTED EVENTS PAIN FEELING LOCALIZED INFLAMMATION AROUND IMPLANT EVENT PAIN DEVICE RELATED SECONDARY SYMPTOM REPORTED EVENTS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6751756|81359983|N|1||FOLLOW-UP COMPLETE REPORTING COMPETENT AUTHORITY PROVIDE INFORMATION SAFEGUARD PRIVACY INVOLVED PATIENTSÂ¿ EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FX-410495|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6751766|81359644|N|1||FOLLOW-UP COMPLETE REPORTING COMPETENT AUTHORITY PROVIDE INFORMATION SAFEGUARD PRIVACY INVOLVED PATIENTSÂ¿ EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410FX|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6378780|69092151|N|1||RESPONSE FDA REPORT NUMBER MW5067421 EVENTS LYMPHOMA ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY RECORD DHR REPORTS BASED RISK ANALYSIS PERFORMED AE TERM CODE LYMPHOMA-ALCL SELECTED ANALYSIS REPRESENTS HIGHEST RISK FALLING MONITOR RISK REGION APPLICABLE INVESTIGATION LEVEL 3 REVIEW DHR WORK ORDER 1157904 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MAY ASSOCIATED REPORTED DEVICE EVENT SALINE BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT ORACLE VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS QMS LISTING REPORT INDICATES NCMRS ERS UNITS MANUFACTURED WORK ORDER 1157904 ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER 1157904 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-300|03/04/2017||||Y|*||0HP|FWM|1.0|09/24/2009|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1157904|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6257136|64954240|D|1||PHYSICIAN REPORTED RIGHT SIDE LATE SEROMA POSITIVE CYTOLOGY ANAPLASTIC LARGE CELL LYMPHOMA CYTOLOGICAL MARKERS NECESSARY DIAGNOSIS CONFIRMED EVENT ALCL CAPTURED LYMPHOMA TIME MENTION EXPLANT|STYLE 150 EXPANDABLE BREAST IMPLANT|N-27-150386|01/17/2017||||N|R||0HP|FTR|1.0|03/26/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2262674|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6559362|74887820|N|1||B4 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY RECORD REVIEW REVIEW DHR WORK ORDER 2183997 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER 2183997 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS REPORTED EVENTS ADDRESSED LABELING PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENT CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT RUPTURE ONE COMMON REASONS REOPERATION ALLERGAN TESTED EFFECTS RADIATION THERAPY PATIENTS BREAST IMPLANTS LITERATURE SUGGESTS RADIATION THERAPY MAY INCREASE LIKELIHOOD CAPSULAR CONTRACTURE NECROSIS IMPLANT EXTRUSION POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT PERFORM SELF-EXAMINATION BREASTS EVERY MONTH CANCER SCREENING HOWEVER MAY DIFFICULT IMPLANTS ASK SURGEON HELP DISTINGUISH IMPLANT BREAST TISSUE PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGES IMPLANT SHAPE MAY SIGNS RUPTURE IMPLANT SIGNS REPORTED SURGEON POSSIBLY EVALUATED MRI BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM445|05/10/2017||||N|R||0HP|FTR|1.0|10/11/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2183997|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6576687|75473262|N|1||EVENTS LYMPHOMA ALCL CAPSULAR CONTRACTURE EDEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES NATRELLEÂ® SILICONE-FILLED BREAST IMPLANTS NATRELLE INSPIRAÂ¿ BREAST IMPLANTS INDICATED WOMEN FOLLOWING BREAST AUGMENTATION WOMEN LEAST 22 YEARS OLD BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT RUPTURE ONE COMMON REASONS REOPERATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/18/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6567317|75169544|D|1||REPORTED EVENT PATIENT LEFT SIDE Â¿INAMED BIOCELL TEXTURED SALINE IMPLANTÂ¿ EXPERIENCING Â¿DEFLATIONÂ¿ NOTED ARTICLE Â¿CD30+ CELLS LATE SEROMA MAY DIAGNOSTIC BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ PUBLISHED AESTHETIC SURGERY JOURNAL 11APR2017 PP 1-5 DEVICE EXPLANTED REPLACED Â¿NATRELLE STYLE 410 HIGHLY COHESIVE TEXTURED SILICONE GEL IMPLANTÂ¿|UNK SALINE IMPLANT|UNK SALINE IMPLANT|05/15/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6567317|75169503|N|1||ARTICLE CITATION Â¿CD30+ CELLS LATE SEROMA MAY DIAGNOSTIC BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ MARSHALL E KADIN MD JOHN MORGAN PHD HAIYING XU BS CAROLINE GLICKSMAN MD PUBLISHED AESTHETIC SURGERY JOURNAL 11APR2017 PP 1-5 REQUEST INFORMATION MADE REPORTING PHYSICIAN ADDITIONAL INFORMATION PROVIDED FOLLOW POSSIBLE DOCTOR AVAILABLE ADDITIONAL QUESTIONING DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY DEFLATION Â¿ BREAST IMPLANTS LIFETIME DEVICES SALINE BREAST IMPLANTS DEFLATE SHELL DEVELOPS TEAR HOLE DEFLATION OCCUR TIME IMPLANTATION LIKELY OCCUR LONGER IMPLANT IMPLANTED FOLLOWING THINGS MAY CAUSE IMPLANTS DEFLATE DAMAGE SURGICAL INSTRUMENTS FOLDING WRINKLING IMPLANT SHELL EXCESSIVE FORCE CHEST EG CLOSED CAPSULOTOMY CONTRAINDICATED TRAUMA COMPRESSION MAMMOGRAPHIC IMAGING SEVERE CAPSULAR CONTRACTURE BREAST IMPLANTS MAY ALSO SIMPLY WEAR TIME LABORATORY STUDIES IDENTIFIED CAUSES DEFLATION ALLERGANÂ¿S PRODUCT HOWEVER CONCLUSIVELY KNOWN WHETHER TESTS IDENTIFIED CAUSES DEFLATION -|UNK SALINE IMPLANT|UNK SALINE IMPLANT|05/15/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6730693|80619152|D|1||EVENT LITERATURE SOURCE REPORTED PATIENT UNDERWENT AXILLARY LYMPH NODE DISSECTION ALND IMMEDIATE BREAST RECONSTRUCTION IBR LATISSIMUS DORSI LD FLAP RECONSTRUCTION 2005 MENTOR MEMORY SHAPE BREAST IMPLANT MEDIUM HEIGHT MODERATE PROFILE 355CC  CATALOG  354-1308 IMPLANTED PROCEDURE PATIENT RECEIVED ADJUVANT CHEMOTHERAPY CHEST WALL RADIOTHERAPY ENDOCRINE THERAPY TAMOXIFEN MCGHAN 150 TISSUE EXPANDER USED 2006 PATIENT DEVICE REPLACEMENT ALLERGAN N27-FX155-775 UNKNOWN REASON 2013 PATIENT PRESENTED SEROMA DIAGNOSED STAGE DISEASE 2016 PATIENT TREATED SUCCESSFULLY IMPLANT REMOVAL COMPLETE UNILATERAL CAPSULECTOMY FOLLOW 8 MONTHS TITLE BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA UK EXPERIENCE RECOMMENDATIONS MANAGEMENT IMPLICATIONS INFORMED CONSENT|nan|354-1308|07/20/2017||||N|R||0HP|FTR|1.0||BREAST IMPLANT||UNK|3041 SKYWAY CIRCLE||NORTH IRVING|US|MENTOR|750383540|TX|75038|3540||354-1308|True
6460137|71714491|N|1||ARTICLE CITATION Â¿A CASE SUSPECTED LATE-STAGE RECURRENCE ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANT INSERTION SITEÂ¿ FUKUSHIMA ISHII INOUE SAKURAI PUBLISHED JOURNAL JAPANESE PATHOLOGY ASSOCIATION VOL 102 NUMBER 1 PG 137 APR 2013 EVENTS LYMPHOMA LUMPNODULE PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/05/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6460137|71714494|D|1||REPORTED EVENT PATIENT DIAGNOSED Â¿ALCLÂ¿ Â¿SUBCUTANEOUS TUMORÂ¿ FOUND Â¿A CASE SUSPECTED LATE-STAGE RECURRENCE ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANT INSERTION SITE PUBLISHED JOURNAL JAPANESE PATHOLOGY ASSOCIATION VOL 102 NUMBER 1 PG 137 APR 2013 TREATMENT Â¿ANTIBIOTICSÂ¿ PROVIDED DEVICE LATER EXPLANTED MANUFACTURER DEVICE UNKNOWN MEDWATCH REPRESENTS LEFT SIDE SEE MFR 9617229-2017-00129 RIGHT SIDE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/05/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6654587|78019287|N|1||B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY REVIEW DHR REPORTS REVIEW DHR B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-300|06/20/2017||||N|R||0HP|FTR|1.0|12/27/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2232205|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6323445|67166355|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6744780|81082639|N|1||EVENTS LYMPHOMA LATE SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSM520|07/26/2017||||N|R||0HP|FTR|1.0|10/04/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180982|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6745299|81111775|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|07/26/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6331755|67482135|N|1||CLARIFICATION REGARDING EVENT EVENT CASE CONSIDERED LYMPHOMA EVENT STATED RECEIVED PROFILE REGISTRY DATABASE DEDICATED CAPTURING REPORTS ALCL EVENT LYMPHOMA PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED UPON ADDITIONAL FOLLOW PHYSICIAN DETERMINED ADDITIONAL INFORMATION AVAILABLE DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/15/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6331760|67507919|N|1||CLARIFICATION REGARDING EVENT EVENT CASE CONSIDERED LYMPHOMA EVENT STATED RECEIVED PROFILE REGISTRY DATABASE DEDICATED CAPTURING REPORTS ALCL EVENT LYMPHOMA PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED UPON ADDITIONAL FOLLOW PHYSICIAN DETERMINED ADDITIONAL INFORMATION AVAILABLE DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/15/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6497135|72921040|D|1||PATIENT REPORTED LEFT SIDE MASSIVE SWELLING LEFT BREAST DOUBLED SIZE PATIENT ADDITIONALLY REPORTED GETTING REALLY SICK DIAGNOSED BREAST IMPLANT ANAPLASTIC LARGE CELL LYMPHOMA B6 2016 PATIENT ADDITIONALLY REPORTED PATHOLOGY SHOWED LEFT SIDE MASS SPREAD OUTSIDE CAPSULE HEALTHCARE PROFESSIONAL CONFIRMED REPORTED EVENTS HEALTHCARE PROFESSIONAL ADDITIONALLY REPORTED LEFT SIDE Â¿PERIPROSTHETIC FLUID TIME DIAGNOSISÂ¿ SPONTANEOUS LARGE LEFT SIDED SEROMA TOTAL CAPSULECTOMY EXPLANTATION PERFORMED PATHOLOGY RESULTS SHOWED ALCL WITHIN LEFT CAPSULE SMALL LEFT BREAST MASS|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRF415|04/17/2017||||N|R||0HP|FTR|1.0|04/29/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2109766|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6497135|72921039|N|1||B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY RECORD DHR REPORTS BASED RISK ANALYSIS PERFORMED AE TERM CODE LYMPHOMA ALCL SELECTED ANALYSIS REPRESENTS HIGHEST RISK FALLING MONITOR RISK REGION APPLICABLE INVESTIGATION LEVEL THREE REVIEW DHR WORK ORDER B4 IDENTIFY ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS QUERY PERFORMED QMS SYSTEM DEVIATIONS NON-CONFORMANCES FOUND RELATED WORK ORDER B4  ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRF415|04/17/2017||||N|R||0HP|FTR|1.0|04/29/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2109766|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6634993|77375388|N|1||B4 CLARIFICATION PATIENTS EXACT DATE DEATH PROVIDED KNOWN INFORMATION YEAR 2012 ARTICLE CITATION SHOCKING DIAGNOSIS BREAST IMPLANTS GAVE CANCER DENISE GRADY NEW YORK TIMES MAY 14 2017 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT DETAILS CANNOT OBTAINED PATIENT EXPLANTING PHYSICIAN CONTACT INFORMATION PROVIDED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT MISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/12/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6498449|72963713|N|1||REPORT SUBMITTED RESPONSE FDA NOTICE TITLED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCL PROVIDED 21MAR2017 TOTAL NUMBER CASES REFERENCED NOTICE 359 INCLUDING 9 DEATHS INFORMATION PROVIDED NOTICE CLASSIFIES ALCL EVENTS DIFFERENT CATEGORIES INCLUDING TYPES DEVICE ASSOCIATED ADVERSE EVENTS PRESENTATION DIAGNOSIS DETAILS IDENTIFY SPECIFIC DEVICES PATIENTS POSSIBLE INDIVIDUALIZE INFORMATION SPECIFIC REPORTS DEFINITION ALREADY INCLUDES EVENTS REPORTED ALLERGAN PAST THEREFORE ACCORDANCE 21 CFR 803 REPORT REPRESENT ACKNOWLEDGEMENT RECEIPT NOTICE DOCUMENTATION ALLERGANS ATTEMPT INVESTIGATE ADVERSE EVENTS IDENTIFIED NOTICE REPORT SUBSTITUTE INVESTIGATION COMPLAINTS RECEIVED INDIVIDUAL PATIENTS ALLERGAN DEVICES IDENTIFIED INCLUSIVE EXCLUSIVE 359 CASES MENTIONED NOTICE B4 EVENTS DEATH LYMPHOMA-ALCL LYMPHOMA SEROMA CAPSULAR CONTRACTURE BREAST LUMPS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS SALINE DEVICE LABELING RADIATION BREAST Â¿ ALLERGAN TESTED VIVO EFFECTS RADIATION THERAPY PATIENTS BREAST IMPLANTS LITERATURE SUGGESTS RADIATION THERAPY MAY INCREASE LIKELIHOOD CAPSULAR CONTRACTURE NECROSIS IMPLANT EXTRUSION POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY CAPSULAR CONTRACTURE Â¿ PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT DEFLATION ONE COMMON REASONS REOPERATION PATIENTS ALSO ADVISED ADDITIONAL SURGERY MAY NEEDED CASES PAIN ANDOR FIRMNESS SEVERE SURGERY RANGES REMOVAL IMPLANT CAPSULE TISSUE REMOVAL POSSIBLE REPLACEMENT IMPLANT SURGERY MAY RESULT LOSS BREAST TISSUE CAPSULAR CONTRACTURE MAY HAPPEN ADDITIONAL SURGERIES CAPSULAR CONTRACTURE MAY INCREASE RISK DEFLATION ADDITIONAL COMPLICATIONS Â¿ BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS PASS STUDY LEAST 1 REOPERATION PERFORMED 315 PATIENTS 365 10 YEARS TOTAL 424 REOPERATIONS PERFORMED PRIMARY REASON REOPERATION 10 YEARS AUGMENTATION PATIENTS IMPLANT DEFLATION 217 PERCENTAGE REOPERATIONS DUE LUMPMASSCYST INCREASED 85 293 REOPERATIONS 5 YEARS 139 424 REOPERATIONS 10 YEARS OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PATIENTS AGE COULD EXPLANATION INCREASE BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFORMATION FDAÂ¿S ANALYSIS REVIEW ALCL PATIENTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM ALSO REQUIRED REPORT PRODUCT PROBLEM SERIOUS ADVERSE EVENT ALLERGAN DEATHS MUST REPORTED ALLERGAN FDA SILICONE DEVICE LABELING ONE KEY COMPLICATIONS REPORTED CALLED Â¿CAPSULAR CONTRACTUREÂ¿ CAPSULAR CONTRACTURE TIGHTENING SCAR TISSUE ALSO CALLED CAPSULE NORMALLY FORMS AROUND BREAST IMPLANT HEALING PROCESS SURGERY WOMEN SCAR TISSUE CAPSULE SQUEEZES IMPLANT RESULTS FIRMNESS HARDENING BREAST RISK IMPLANT RUPTURE DEGREES CAPSULAR CONTRACTURE CLASSIFIED BAKER GRADING SCALE1 CAPSULAR CONTRACTURE BAKER GRADES III IV SEVERE BAKER GRADE III OFTEN RESULTS NEED ADDITIONAL SURGERY REOPERATION PAIN POSSIBLY ABNORMAL APPEARANCE BAKER GRADE IV USUALLY RESULTS NEED REOPERATION PAIN UNACCEPTABLE APPEARANCE TREAT CAPSULAR CONTRACTURE CLOSED CAPSULOTOMY FORCEFUL EXTERNAL COMPRESSION LIKELY RESULT IMPLANT DAMAGE RUPTURE FOLDS ANDOR HEMATOMA ALLERGAN TESTED EFFECTS RADIATION THERAPY PATIENTS BREAST IMPLANTS LITERATURE SUGGESTS RADIATION THERAPY MAY INCREASE LIKELIHOOD CAPSULAR CONTRACTURE NECROSIS IMPLANT EXTRUSION POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT PERFORM SELF-EXAMINATION BREASTS EVERY MONTH CANCER SCREENING HOWEVER MAY DIFFICULT IMPLANTS ASK SURGEON HELP DISTINGUISH IMPLANT BREAST TISSUE PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGES IMPLANT SHAPE MAY SIGNS RUPTURE IMPLANT SIGNS REPORTED SURGEON POSSIBLY EVALUATED MRI BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFORMATION FDAÂ¿S ANALYSIS REVIEW ALCL PATIENTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6571801|75326410|N|1||CONCOMITANT MEDICAL PRODUCTS NITROGLYCERIN VALIUM 2 ZOLOFT B4 INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY RECORD DHR REPORTS REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MAY ASSOCIATED REPORTED DEVICE EVENT GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANTS LIFETIME DEVICES BREAST IMPLANTS RUPTURE SHELL DEVELOPS TEAR HOLE RUPTURES OCCUR TIME IMPLANTATION LIKELY OCCUR LONGER IMPLANT IMPLANTED FOLLOWING THINGS MAY CAUSE IMPLANTS RUPTURE DAMAGE SURGICAL INSTRUMENTS STRESSING IMPLANT IMPLANTATION WEAKENING FOLDING WRINKLING IMPLANT SHELL EXCESSIVE FORCE CHEST EG CLOSED CAPSULOTOMY CONTRAINDICATED TRAUMA COMPRESSION MAMMOGRAPHIC IMAGING SEVERE CAPSULAR CONTRACTURE BREAST IMPLANTS MAY ALSO SIMPLY WEAR TIME LABORATORY STUDIES IDENTIFIED CAUSES RUPTURE ALLERGANÂ¿S PRODUCT CONCLUSIVELY KNOWN WHETHER TESTS IDENTIFIED CAUSES RUPTURE LABORATORY STUDIES IDENTIFY ADDITIONAL CAUSES RUPTURE ONGOING SILICONE GEL-FILLED IMPLANT RUPTURES OFTEN SILENT MEANS TIME NEITHER PATIENT KNOW IMPLANT TEAR HOLE SHELL MRI EXAMINATION CURRENTLY BEST METHOD SCREEN RUPTURE SOMETIMES SYMPTOMS ASSOCIATED GEL IMPLANT RUPTURE SYMPTOMS INCLUDE HARD KNOTS LUMPS SURROUNDING IMPLANT ARMPIT CHANGE LOSS SIZE SHAPE BREAST IMPLANT PAIN TINGLING SWELLING NUMBNESS BURNING HARDENING BREAST MRI SIGNS RUPTURE FOUND SUBCAPSULAR LINES CHARACTERISTIC FOLDED WAVY LINES TEARDROP SIGN KEYHOLE SIGN NOOSE SIGN SIGNS SYMPTOMS RUPTURE REMOVE IMPLANT GEL DETERMINE PATIENT WITHOUT REPLACEMENT IMPLANT ALSO MAY NECESSARY REMOVE TISSUE CAPSULE ALSO CONSEQUENCES RUPTURE RUPTURE OCCURS SILICONE GEL MAY EITHER REMAIN WITHIN SCAR TISSUE CAPSULE SURROUNDING IMPLANT INTRACAPSULAR RUPTURE MOVE OUTSIDE CAPSULE EXTRACAPSULAR RUPTURE MOVE OUTSIDE BREAST GEL MIGRATION ALSO POSSIBILITY RUPTURE MAY PROGRESS INTRACAPSULAR EXTRACAPSULAR BEYOND|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-420|05/17/2017||||N|R||0HP|FTR|1.0|04/15/2004|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||49463|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6670624|78496499|N|1||INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ADDRESSES REPORTED EVENT FOLLOWS BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/27/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6460158|71723777|D|1||REPORTED EVENT PATIENT DIAGNOSED Â¿ALCLÂ¿ Â¿SUBCUTANEOUS TUMORÂ¿ FOUND Â¿A CASE SUSPECTED LATE-STAGE RECURRENCE ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANT INSERTION SITE PUBLISHED JOURNAL JAPANESE PATHOLOGY ASSOCIATION VOL 102 NUMBER 1 PG 137 APR 2013 TREATMENT Â¿ANTIBIOTICSÂ¿ PROVIDED DEVICE LATER EXPLANTED MANUFACTURER DEVICE UNKNOWN MEDWATCH REPRESENTS RIGHT SIDE SEE MFR 9617229-2017-00128 LEFT SIDE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/05/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6460158|71723776|N|1||ARTICLE CITATION Â¿A CASE SUSPECTED LATE-STAGE RECURRENCE ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANT INSERTION SITEÂ¿ FUKUSHIMA ISHII INOUE SAKURAI PUBLISHED JOURNAL JAPANESE PATHOLOGY ASSOCIATION VOL 102 NUMBER 1 PG 137 APR 2013 EVENTS LYMPHOMA LUMPNODULE PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/05/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6734621|80749897|N|1||DEVICE REMAINS IMPLANTED EVENT BREAST CANCER PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REVIEW DEVICE HISTORY RECORD INITIATED NEW CHANGED CORRECTED INFORMATION NOTED SUPPLEMENTAL MEDWATCH SUBMITTED INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY CANCER PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFORMATION FDAÂ¿S ANALYSIS REVIEW ALCL PATIENTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM|STYLE 68 SALINE FILLED BREAST IMPLANT|68-240|07/21/2017||||N|R||0HP|FWM|1.0|04/05/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1257756|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6323429|67161071|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6638620|77500427|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/13/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6730694|80619208|D|1||COMPLAINT LITERATURE SOURCE REPORTED 23 CASES BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED 15 REGIONAL CENTERS THROUGHOUT B6 2012 2016 AMONG ONE PATIENT STAGE DISEASE PRESENTED RECURRENT LARGE VOLUME EFFUSION PATIENT IMPLANTED MENTOR BECKER IMPLANT 2005 INAMED ST410 2006 INAMED 2007 INDICATIONS IMPLANT INSERTION BILATERAL MX CONTRALATERAL RADIOTHERAPY PATIENT PRESENTED MISSHAPEN BREAST SWELLING 2016 PATIENT BILATERAL CAPSULECTOMY BILATERAL IMPLANT REMOVAL TITLE Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 EXPERIENCE RECOMMENDATIONS MANAGEMENT IMPLICATIONS INFORMED CONSENTÂ¿|nan|UNKNOWN GEL IMPLANT|07/20/2017||||N|R||0HP|FTR|1.0||BREAST IMPLANT||UNK|3041 SKYWAY CIRCLE||NORTH IRVING|US|MENTOR|750383540|TX|75038|3540||UNKNOWN GEL IMPLANT|True
6315868|67108883|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6752720|81359775|N|1||FOLLOW-UP COMPLETE REPORTING COMPETENT AUTHORITY PROVIDE INFORMATION SAFEGUARD PRIVACY INVOLVED PATIENTSÂ¿ EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410MF|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6567310|75169069|N|1||ARTICLE CITATION Â¿CD30+ CELLS LATE SEROMA MAY DIAGNOSTIC BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ MARSHALL E KADIN MD JOHN MORGAN PHD HAIYING XU BS CAROLINE GLICKSMAN MD PUBLISHED AESTHETIC SURGERY JOURNAL 11APR2017 PP 1-5 EVENT SEROMA PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REQUEST INFORMATION MADE REPORTING PHYSICIAN ADDITIONAL INFORMATION PROVIDED FOLLOW POSSIBLE DOCTOR AVAILABLE ADDITIONAL QUESTIONING DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/15/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6567310|75169070|D|1||REPORTED EVENT PATIENT LEFT SIDE Â¿NATRELLE STYLE 410 HIGHLY COHESIVE TEXTURED SILICONE GEL IMPLANTÂ¿ EXPERIENCED Â¿LARGE SEROMA DISCOMFORTÂ¿ FOUND ARTICLE Â¿CD30+ CELLS LATE SEROMA MAY DIAGNOSTIC BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA PUBLISHED AESTHETIC SURGERY JOURNAL 11APR2017 PP 1-5 DEVICE EXPLANTED REPLACED ALLERGAN Â¿NATRELLE INSPIRA SMOOTH ROUND SILICONE GEL IMPLANTÂ¿|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/15/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6460781|71746777|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|04/05/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6677037|78706810|N|1||INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENT PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTED EVENT ADDRESSED LABELING ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/29/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6341238|67800491|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6498277|72952111|N|1||EVENTS LYMPHOMA EDEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6572184|75359098|D|1||RIGHT OPEN CAPSULECTOMY IMPLANT REMOVAL DIAGNOSIS ANAPLASTIC LARGE CELL LYMPHOMA B6 2012 REQUIRED RADIATION THERAPY B6 2012 IMPLANT EXCHANGE 2007 TEXTURED SILICONE STYLE 120 600CC VOLUME DR B6 B6 2010 RIGHT BREAST PERIPROSTHETIC FLUID CAPSULAR CONTRACTURE TREATED LEVAQUIN DR B6 IMPLANT EXCHANGE B6 2010 BILATERAL STRATTICE CAPSULAR CONTRACTURE - PATHOLOGY SENT - PLASCMEEN TOF MENTOR SMOOTH ROUND MODERATE PLUS STYLE 1000 700CC DR B6 PROGRESSIVE CAPSULAR CONTRACTURE RIGHT 1210 OPEN CAPSULOTOMY USING IMPLANT DR B6 RESOLUTION SYMPTOMS MOTOR VEHICLE COLLISION B6 HEMATOMA RIGHT BREAST UNTREATED PROGRESSIVE CAPSULAR CONTRACTURE RETURNED B6 2011 UNDERWENT RIGHT CAPSULOTOMYPARTIAL CAPSULECTOMY IMPLANT DIAGNOSIS REASON USE BREAST AUGMENTATION|BREAST IMPLANT SILICONE STYLE 120 600CC||05/15/2017||||N|I||0HP|FTR|1.0||BREAST IMPLANT|||||||ALLERGAN|||||||True
6572184|75359098|D|1||RIGHT OPEN CAPSULECTOMY IMPLANT REMOVAL DIAGNOSIS ANAPLASTIC LARGE CELL LYMPHOMA B6 2012 REQUIRED RADIATION THERAPY B6 2012 IMPLANT EXCHANGE 2007 TEXTURED SILICONE STYLE 120 600CC VOLUME DR B6 B6 2010 RIGHT BREAST PERIPROSTHETIC FLUID CAPSULAR CONTRACTURE TREATED LEVAQUIN DR B6 IMPLANT EXCHANGE B6 2010 BILATERAL STRATTICE CAPSULAR CONTRACTURE - PATHOLOGY SENT - PLASCMEEN TOF MENTOR SMOOTH ROUND MODERATE PLUS STYLE 1000 700CC DR B6 PROGRESSIVE CAPSULAR CONTRACTURE RIGHT 1210 OPEN CAPSULOTOMY USING IMPLANT DR B6 RESOLUTION SYMPTOMS MOTOR VEHICLE COLLISION B6 HEMATOMA RIGHT BREAST UNTREATED PROGRESSIVE CAPSULAR CONTRACTURE RETURNED B6 2011 UNDERWENT RIGHT CAPSULOTOMYPARTIAL CAPSULECTOMY IMPLANT DIAGNOSIS REASON USE BREAST AUGMENTATION|MENTOR SMOOTH ROUND PLUS STYLE, 1000 700CC||05/15/2017||||N|I||0HP|FTR|2.0||BREAST IMPLANT|||||||ALLERGAN|||||||True
6725178|80442607|D|1||EVENT REPORTED VIA  MW5023558 PATIENT REPORTED UNDERWENT COSMETIC BREAST SURGERY USING MENTOR SALINE IMPLANTS PRIMARY AUGMENTATION 1986 2008 DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT TREATED CHEMOTHERAPY RADIATION THERAPY RIGHT IMPLANT STILL RED SWOLLEN TREATMENT IMPLANTS EXPLANTED CONTACT INFORMATION PROVIDED MW REPORT THEREFORE INFORMATION MADE AVAILABLE|nan|UNKNOWN SALINE IMPLANT|07/19/2017||||N|R||0HP|FWM|1.0||BREAST IMPLANT||UNK|3041 SKYWAY CIRCLE||NORTH IRVING|US|MENTOR|750383540|TX|75038|3540||UNKNOWN SALINE IMPLANT|True
6395062|69619795|N|1||EVENTS LYMPHOMA SEROMA LUMPNODULE PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/10/2017|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6309206|66741539|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/07/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6595799|76126750|N|1||FOLLOW-UP PERFORMED INFORMATION REGARDING REPORT NEW INFORMATION RECEIVED REPORTED SUPPLEMENTAL REPORT REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/26/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6595799|76126750|N|1||FOLLOW-UP PERFORMED INFORMATION REGARDING REPORT NEW INFORMATION RECEIVED REPORTED SUPPLEMENTAL REPORT REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410LX|05/26/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6617685|76841698|N|1||ALLERGAN UNABLE CONFIRM HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL EVENT PRODUCT PATIENT DETAILS ATTAINABLE REPORTED EVENTS LYMPHOMA SEROMA EDEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING PATIENT TOLD PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGE IMPLANT SHAPE MAY SIGNS SYMPTOMATIC RUPTURE IMPLANT PATIENT SIGNS TOLD REPORT POSSIBLY MRI EVALUATION SCREEN RUPTURE POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|06/07/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6309203|66741187|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/07/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6663360|78278939|N|1||FOLLOW-UP PERFORMED INFORMATION REGARDING EVENT NEW INFORMATION RECEIVED REPORTED SUPPLEMENTAL REPORT REPORTED EVENT PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTED EVENTS ADDRESSED LABELING ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|TSF385|06/23/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6574813|75416230|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PATIENTS AGE COULD EXPLANATION INCREASE ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL REPORTS MEDICAL LITERATURE INDICATE PATIENTS BREAST IMPLANTS GREATER RISK WITHOUT BREAST IMPLANTS DEVELOPING BREAST CANCER REPORTS SUGGESTED BREAST IMPLANTS MAY INTERFERE DELAY BREAST CANCER DETECTION MAMMOGRAPHY ANDOR BIOPSY HOWEVER REPORTS PUBLISHED MEDICAL LITERATURE INDICATE BREAST IMPLANTS NEITHER SIGNIFICANTLY DELAY BREAST CANCER DETECTION ADVERSELY AFFECT CANCER SURVIVAL WOMEN BREAST IMPLANTS LARGE FOLLOW-UP STUDY REPORTED EVIDENCE ASSOCIATION BREAST IMPLANTS CANCER EVEN SHOWED DECREASED INCIDENCE BREAST CANCER COMPARED GENERAL POPULATION ONE STUDY REPORTED INCREASED INCIDENCE BRAIN CANCER WOMEN BREAST IMPLANTS COMPARED GENERAL POPULATION INCIDENCE BRAIN CANCER HOWEVER SIGNIFICANTLY INCREASED WOMEN BREAST IMPLANTS COMPARED WOMEN PLASTIC SURGERIES PUBLISHED REVIEW 4 LARGE STUDIES WOMEN COSMETIC IMPLANTS ADDITIONAL LONG-TERM FOLLOW-UP STUDY CONCLUDED EVIDENCE SUPPORT ASSOCIATION BRAIN CANCER BREAST IMPLANTS EPIDEMIOLOGICAL REVIEW ALSO LENT SUPPORT LACK CAUSATION IMPLANTS TYPE CANCER STUDIES REPORTED INCREASED INCIDENCE RESPIRATORYLUNG CANCER WOMEN BREAST IMPLANTS STUDIES WOMEN SWEDEN DENMARK FOUND WOMEN GET BREAST IMPLANTS LIKELY CURRENT SMOKERS WOMEN GET BREAST REDUCTION SURGERY TYPES COSMETIC SURGERY SEVERAL LARGE STUDIES FOUND ASSOCIATION BREAST IMPLANTS RESPIRATORYLUNG CANCER TWO STUDIES REPORTED INCREASED INCIDENCE CERVICALVULVAR CANCER WOMEN BREAST IMPLANTS ANOTHER LONG-TERM FOLLOW-UP STUDY SHOWED EQUIVALENT INCIDENCES CERVICAL CANCER WOMEN BREAST IMPLANTS COMPARED GENERAL POPULATION RECENT LARGE STUDIES CONCLUDED EVIDENCE SUPPORT ASSOCIATION REPRODUCTIVE SYSTEM CANCERS BREAST IMPLANTS SEVERAL STUDIES PUBLISHED EXAMINED RISK TYPES CANCERS EG THYROID CANCERS URINARY SYSTEM CANCERS SARCOMA ENDOCRINE CANCER CONNECTIVE TISSUE CANCER CANCER EYE UNSPECIFIED CANCERS WOMEN BREAST IMPLANTS STUDIES FOUND INCREASED RISK WOMEN BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574813|75416231|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS Â¿PATIENTS PRESENTED STAGE IIA DISEASE ONE PATIENTS BBA PRESENTED MASS ADJACENT IMPLANT PROGRESSED RAPIDLY NEOADJUVANT CHOP DEVELOP LIFE THREATENING CHEST WALLTHORACIC CAVITY INVOLVEMENT PATIENT ACHIEVED COMPLETE PATHOLOGICAL RESPONSE SIX CYCLES BRENTUXIMAB FOLLOWED BILATERAL TOTAL CAPSULECTOMY IMPLANT REMOVAL FIRST REPORTED CASE NEO-ADJUVANT ANTIBODY THERAPY BIA-ALCLÂ¿ EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574824|75417105|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS Â¿PATIENTS PRESENTED STAGE IIA DISEASE ONE PREVIOUS RRM IMPLANT RECONSTRUCTION PRESENTED MASS TREATMENT CHOP+ ECHELON2 TRIAL RADIOTHERAPY IMPLANT REMOVALREMAINS WELL TWO YEARSÂ¿ EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574824|75417104|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PATIENTS AGE COULD EXPLANATION INCREASE ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6597657|76167628|D|1||DEVELOPED ALCL ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS TEXTURED SILICONE DEVICES PREVIOUS RIGHT BREAST IMPLANT ALSO NATRELLE 120-300 SERIAL NUMBER B4 IMPLANTED B6 2008 IMPLANT REMOVED SEROMA FLUID EXAMINED FOUND NORMAL|NATRELLE||05/26/2017||||*|I||I|FTR|2.0||SILICONE-FILLED TEXTURED BREAST|||||GOLETA|US|ALLERGAN|93117|CA|93117||||True
6597657|76167628|D|1||DEVELOPED ALCL ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS TEXTURED SILICONE DEVICES PREVIOUS RIGHT BREAST IMPLANT ALSO NATRELLE 120-300 SERIAL NUMBER B4 IMPLANTED B6 2008 IMPLANT REMOVED SEROMA FLUID EXAMINED FOUND NORMAL|NATRELLE|120-300|05/26/2017||||Y|I||0HP|FTR|1.0||SILICONE-FILLED TEXTURED BREAST|||||GOLETA|US|ALLERGAN|93117|CA|93117||120-300||True
6315886|67108821|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6323469|67162000|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/10/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6584653|75765031|N|1||B4 EVENTS LYMPHOMA LUMPNODULE SKIN RASHDERMATITIS CAPSULAR CONTRACTURE BAKER GRADE III PHYSIOLOGICAL COMPLAINT ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT ANDOR PATIENT DETAILS REQUESTED DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFORMATION FDAÂ¿S ANALYSIS REVIEW ALCL PATIENTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM LITERATURE REPORTS ALSO MADE ASSOCIATING SILICONE BREAST IMPLANTS VARIOUS RHEUMATOLOGICAL SIGNS SYMPTOMS SKIN RASHES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE CAPSULAR CONTRACTURE PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT RUPTURE ONE COMMON REASONS REOPERATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/23/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6613947|76724095|N|1||B4 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX140-520|06/06/2017|||DA|N|R||0HP|FTR|1.0|10/31/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1777073|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6551502|74631918|N|1||B4 INFORMATION REPORTER REGARDING EVENT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME EVENTS LYMPHOMA LATE SEROMA LYMPHADENOPATHY BREAST LUMPS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY ADDITIONAL COMPLICATIONS Â¿ BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PATIENTS AGE COULD EXPLANATION INCREASE BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/08/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6551502|74631919|D|1||PHYSICIAN REPORTED COMPLETE RIGHT CAPSULECTOMY BIOPSY THREE MACROSCOPICALLY AFFECTED LYMPH NODES PERFORMED PATIENT COMPLAINED CHRONIC SEROMA UNDERWENT REMOVAL IMPLANT RESULT SEROMA RESOLVED PATIENT NOTICED NODULE RIGHT BREAST CONFIRMED ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING CORE NEEDLE BIOPSY CASE ALCL REPORTED LYMPHOMA NECESSARY PATHOLOGICAL MARKERS CONFIRMED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/08/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6323298|67155236|N|1||B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS DEVICE CURRENTLY REMAINS IMPLANTED REQUESTED PLANNED EXPLANT EVENTS LYMPHOMA PLEURAL EFFUSION LATE SEROMA COLLAPSED IPSILATERAL LUNG LYMPHADENOPATHY BREAST LUMPS DYSPNEA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING DEVICE DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|INSPIRA SMOOTH SILICONE GEL FILLED BREAST IMPLANT|SSF370|02/10/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6752840|81359304|N|1||FOLLOW-UP COMPLETE REPORTING COMPETENT AUTHORITY PROVIDE INFORMATION SAFEGUARD PRIVACY INVOLVED PATIENTSÂ¿ EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410MX|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6574800|75414969|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574800|75414970|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS Â¿STAGE CASES PRESENTED RECURRENT SEROMA TREATED SUCCESSFULLY IMPLANT REMOVAL TOTAL CAPSULECTOMY FOUR PATIENTS BILATERAL BREAST AUGMENTATION BBAÂ¿ MEDWATCH REPORT REPRESENTS FOUR STAGE CASES PATIENTS BILATERAL BREAST AUGMENTATION REGARDING TREATMENT ABSTRACT REPORTS CASES Â¿HAD SURGERY REMOVE IMPLANTS IPSILATERAL TOTAL CAPSULECTOMY OTHERS CONTRALATERAL CAPSULECTOMY PATHOLOGY BENIGN UNILATERAL CAPSULECTOMY BILATERAL EXCHANGE IMPLANTSÂ¿ CURRENT INFORMATION PROVIDED IMPOSSIBLE KNOW SPECIFIC TREATMENT USED CASES EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6434492|70859690|N|1||B4 EVENTS LYMPHOMA ALCL SEROMA LUMPNODULE EDEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY RECORD DHR REPORTS BASED RISK ANALYSIS PERFORMED AE TERM CODE LYMPHOMA-ALCL SELECTED ANALYSIS REPRESENTS HIGHEST RISK FALLING MONITOR RISK REGION APPLICABLE INVESTIGATION LEVEL 3 REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER 2493185 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410535|03/24/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2493185|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6751820|81359250|N|1||FOLLOW-UP COMPLETE REPORTING COMPETENT AUTHORITY PROVIDE INFORMATION SAFEGUARD PRIVACY INVOLVED PATIENTSÂ¿ EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|07/28/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6641177|77604162|N|1||FOLLOW-UP PERFORMED INFORMATION REGARDING EVENT NEW INFORMATION RECEIVED REPORTED SUPPLEMENTAL REPORT REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REVIEW DHR WORK ORDER 2436682 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MAY ASSOCIATED REPORTED DEVICE EVENT GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS QMS LISTING REPORT INDICATES NCMRS DEVIATIONS RELATED UNITS MANUFACTURED WORK ORDER 2436682 ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER 2436682 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS REPORTED EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF130-375|06/14/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2436682|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6638628|77497013|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/13/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6544056|74409595|N|1||B4 FOLLOW-UP CURRENTLY PERFORMED DETAILS REGARDING CASE NEW INFORMATION RECEIVED SENT SUPPLEMENTAL MEDWATCH REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REVIEW DHR DEVICE HISTORY RECORD WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR WORK ORDER B4 INDICATES REPROCESS TWO UNITS PRIMARY PACKAGING OPERATION HOWEVER COMPLETED DIFFERENT SERIAL NUMBER UNIT RELATION NEITHER CAUSE REPORTED EVENT DHR ASSEMBLY REPORT ORACLE VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS REPORTED EVENTS ADDRESSED LABELING ALLERGAN TESTED EFFECTS RADIATION THERAPY PATIENTS BREAST IMPLANTS LITERATURE SUGGESTS RADIATION THERAPY MAY INCREASE LIKELIHOOD CAPSULAR CONTRACTURE NECROSIS IMPLANT EXTRUSION POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT PERFORM SELF-EXAMINATION BREASTS EVERY MONTH CANCER SCREENING HOWEVER MAY DIFFICULT IMPLANTS ASK SURGEON HELP DISTINGUISH IMPLANT BREAST TISSUE PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGES IMPLANT SHAPE MAY SIGNS RUPTURE IMPLANT SIGNS REPORTED SURGEON POSSIBLY EVALUATED MRI BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|TRM310|05/04/2017||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1327562|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6574799|75414182|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574799|75414183|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS STAGE CASE ALCL TWO BILATERAL RISK-REDUCING MASTECTOMIES RRM IMPLANT RECONSTRUCTION MEDWATCH REPORT REPRESENTS TWO STAGE CASES PATIENTS BILATERAL RISK-REDUCING MASTECTOMIES IMPLANT RECONSTRUCTION REGARDING TREATMENT ABSTRACT REPORTS CASES Â¿HAD SURGERY REMOVE IMPLANTS IPSILATERAL TOTAL CAPSULECTOMY OTHERS CONTRALATERAL CAPSULECTOMY PATHOLOGY BENIGN UNILATERAL CAPSULECTOMY BILATERAL EXCHANGE IMPLANTSÂ¿ CURRENT INFORMATION PROVIDED IMPOSSIBLE KNOW SPECIFIC TREATMENT USED CASES EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574818|75418664|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS STAGE ALCL CASE PATIENT UNILATERAL MASTECTOMY IMPLANT RECONSTRUCTION BREAST CANCER REGARDING TREATMENT ABSTRACT STATES STAGE CASES PRESENTED RECURRENT SEROMA TREATED SUCCESSFULLY IMPLANT REMOVAL TOTAL CAPSULECTOMY EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574818|75418663|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6635007|77400539|N|1||ARTICLE CITATION SHOCKING DIAGNOSIS BREAST IMPLANTS GAVE CANCER B6 B6 MAY 14 2017 EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT DETAILS CANNOT OBTAINED PATIENT EXPLANTING PHYSICIAN CONTACT INFORMATION PROVIDED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/12/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6545873|74473872|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE ANAPLASTIC LARGE CELL LYMPHOMA PATIENTÂ¿S INITIAL DIAGNOSIS PROVIDED Â¿FIBROCYSTIC BREAST DISEASEÂ¿ AMENDED LYMPHOMA ALCL PATIENT ADDITIONALLY EXPERIENCED LEFT SIDE SWELLING SEROMA CAPSULECTOMY PERFORMED DEVICE REMOVED APPROXIMATELY 200 RNL CHALKY WHITE FLUID FOUND UPON ENTERING CAPSULE PHYSICIAN ADDITIONALLY REPORTED LARGE THICK RIND AROUND CAPSULE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410740|05/04/2017||||N|R||0HP|FTR|1.0|08/24/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||236550|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6545873|74473871|N|1||B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY RECORD DHR PROVIDES REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MAY ASSOCIATED REPORTED DEVICE EVENT GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY |STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410740|05/04/2017||||N|R||0HP|FTR|1.0|08/24/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||236550|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6315895|67104048|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/09/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6574798|75415102|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY SIMILAR BRUISE SEROMA OCCURS WATERY PORTION BLOOD COLLECTS AROUND SURGICAL INCISION AROUND BREAST IMPLANT BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574798|75415103|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS STAGE ALCL CASE PATIENT UNILATERAL MASTECTOMY IMPLANT RECONSTRUCTION BREAST CANCER REGARDING TREATMENT ABSTRACT STATES STAGE CASES PRESENTED RECURRENT SEROMA TREATED SUCCESSFULLY IMPLANT REMOVAL TOTAL CAPSULECTOMY EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574819|75418485|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMABÂ¿ L JOHNSON J ODONOGHUE H STARK N COLLIS LENNARD BUTTERWORTH N MCLEAN YOUSSEF G GUI LYBURN J BRISTOL J HURREN SMITH R JACKLIN CUNNINGHAM F MACNEILL PUBLISHED CANCER RESEARCH FEB2017 ELECTRONICALLY PUBLISHED APR2017 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED LABELING OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PATIENTS AGE COULD EXPLANATION INCREASE ALCL BREAST CANCER RARE TYPE NON-HODGKINÂ¿S LYMPHOMA CANCER INVOLVING CELLS IMMUNE SYSTEM BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6574819|75418486|D|1||REVIEWED ABSTRACT Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCLÂ¿THE UK EXPERIENCE FIRST REPORTED CASE NEOADJUVANT BRENTUXIMAB ABSTRACT REPORTS Â¿PATIENTS PRESENTED STAGE IIA DISEASE ONE PATIENT PREVIOUS BBA FOLLOWING ROUTINE IMPLANT EXCHANGE DEVELOPED BIA-ALCL MASS DRAIN SITE PATIENT TREATED LOCAL EXCISION ADJUVANT CHOP RADIOTHERAPY PATIENT WELL FOUR YEARSÂ¿ EVENT ALCL CAPTURED LYMPHOMA NECESSARY HISTOLOGICAL MARKERS CONFIRMED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/18/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6428377|70695168|D|1||DAY ROUTINE MAMMOGRAM SWELLING RIGHT BREAST SURGEON SUSPECTED RUPTURED CAPSULE SURGERY B6 2014 IMPLANT REMOVED FLUID SUSPICIOUS TESTING INDICATED LYMPHOMA ANOTHER SURGERY B6 2014 SECURE TISSUE TESTING - LEFT IMPLANT ALSO REMOVED TIME REPORT CONFIRMED ANAPLASTIC LARGE CELL LYMPHOMA RIGHT BREAST HISTORY 1990 - LUMPECTOMY DIAGNOSIS LOBULAR CANCER SITU RIGHT BREAST 1991 - BILATERAL MASTECTOMIES RECONSTRUCTION SILICONE IMPLANTS B6 2004 - RUPTURED CAPSULE LEFT BREAST - IMPLANT REMOVED REPLACED CELLULITIS DEVELOPED LEFT BREAST RIGHT IMPLANT REMOVED REPLACED B6 2005 CELLULITIS TREATED HOT SPOT LEFT SIDE APPEARED STRAY LYMPH NODE STAYED 2 YEARS APPEARED SMALLER FINALLY DISAPPEARED ONCOLOGIST ATTEMPTED BIOPSY SPOT UNSUCCESSFUL LOCATION - UNABLE GET ENOUGH TISSUE DIAGNOSIS CHEMO RADIATION CASE MAY SUBMITTED FDA SURGEON DR B6 B6 ONCOLOGIST DR B6 B6|SILICONE BREAST IMPLANT||03/22/2017||||N|I||I|FTR|3.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE|||||||UNK|||||||True
6428377|70695168|D|1||DAY ROUTINE MAMMOGRAM SWELLING RIGHT BREAST SURGEON SUSPECTED RUPTURED CAPSULE SURGERY B6 2014 IMPLANT REMOVED FLUID SUSPICIOUS TESTING INDICATED LYMPHOMA ANOTHER SURGERY B6 2014 SECURE TISSUE TESTING - LEFT IMPLANT ALSO REMOVED TIME REPORT CONFIRMED ANAPLASTIC LARGE CELL LYMPHOMA RIGHT BREAST HISTORY 1990 - LUMPECTOMY DIAGNOSIS LOBULAR CANCER SITU RIGHT BREAST 1991 - BILATERAL MASTECTOMIES RECONSTRUCTION SILICONE IMPLANTS B6 2004 - RUPTURED CAPSULE LEFT BREAST - IMPLANT REMOVED REPLACED CELLULITIS DEVELOPED LEFT BREAST RIGHT IMPLANT REMOVED REPLACED B6 2005 CELLULITIS TREATED HOT SPOT LEFT SIDE APPEARED STRAY LYMPH NODE STAYED 2 YEARS APPEARED SMALLER FINALLY DISAPPEARED ONCOLOGIST ATTEMPTED BIOPSY SPOT UNSUCCESSFUL LOCATION - UNABLE GET ENOUGH TISSUE DIAGNOSIS CHEMO RADIATION CASE MAY SUBMITTED FDA SURGEON DR B6 B6 ONCOLOGIST DR B6 B6|SILICONE BREAST IMPLANT||03/22/2017||||N|I||I|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE|||||||UNK|||||||True
6428377|70695168|D|1||DAY ROUTINE MAMMOGRAM SWELLING RIGHT BREAST SURGEON SUSPECTED RUPTURED CAPSULE SURGERY B6 2014 IMPLANT REMOVED FLUID SUSPICIOUS TESTING INDICATED LYMPHOMA ANOTHER SURGERY B6 2014 SECURE TISSUE TESTING - LEFT IMPLANT ALSO REMOVED TIME REPORT CONFIRMED ANAPLASTIC LARGE CELL LYMPHOMA RIGHT BREAST HISTORY 1990 - LUMPECTOMY DIAGNOSIS LOBULAR CANCER SITU RIGHT BREAST 1991 - BILATERAL MASTECTOMIES RECONSTRUCTION SILICONE IMPLANTS B6 2004 - RUPTURED CAPSULE LEFT BREAST - IMPLANT REMOVED REPLACED CELLULITIS DEVELOPED LEFT BREAST RIGHT IMPLANT REMOVED REPLACED B6 2005 CELLULITIS TREATED HOT SPOT LEFT SIDE APPEARED STRAY LYMPH NODE STAYED 2 YEARS APPEARED SMALLER FINALLY DISAPPEARED ONCOLOGIST ATTEMPTED BIOPSY SPOT UNSUCCESSFUL LOCATION - UNABLE GET ENOUGH TISSUE DIAGNOSIS CHEMO RADIATION CASE MAY SUBMITTED FDA SURGEON DR B6 B6 ONCOLOGIST DR B6 B6|SILICONE BREAST IMPLANT||03/22/2017||||N|I||I|FTR|2.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE|||||||UNK|||||||True
6428377|70695168|D|1||DAY ROUTINE MAMMOGRAM SWELLING RIGHT BREAST SURGEON SUSPECTED RUPTURED CAPSULE SURGERY B6 2014 IMPLANT REMOVED FLUID SUSPICIOUS TESTING INDICATED LYMPHOMA ANOTHER SURGERY B6 2014 SECURE TISSUE TESTING - LEFT IMPLANT ALSO REMOVED TIME REPORT CONFIRMED ANAPLASTIC LARGE CELL LYMPHOMA RIGHT BREAST HISTORY 1990 - LUMPECTOMY DIAGNOSIS LOBULAR CANCER SITU RIGHT BREAST 1991 - BILATERAL MASTECTOMIES RECONSTRUCTION SILICONE IMPLANTS B6 2004 - RUPTURED CAPSULE LEFT BREAST - IMPLANT REMOVED REPLACED CELLULITIS DEVELOPED LEFT BREAST RIGHT IMPLANT REMOVED REPLACED B6 2005 CELLULITIS TREATED HOT SPOT LEFT SIDE APPEARED STRAY LYMPH NODE STAYED 2 YEARS APPEARED SMALLER FINALLY DISAPPEARED ONCOLOGIST ATTEMPTED BIOPSY SPOT UNSUCCESSFUL LOCATION - UNABLE GET ENOUGH TISSUE DIAGNOSIS CHEMO RADIATION CASE MAY SUBMITTED FDA SURGEON DR B6 B6 ONCOLOGIST DR B6 B6|SILICONE BREAST IMPLANT||03/22/2017||||N|I||I|FTR|4.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE|||||||UNK|||||||True
6498283|72956470|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6352879|68133173|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/23/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6497172|72917373|D|1||DEVELOPED ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS|SALINE BREAST IMPLANTS 350CC||04/14/2017||||N|I||I|FWM|2.0||SALINE BREAST IMPLANTS||1309976|||||NAN|||||68HP||True
6497172|72917373|D|1||DEVELOPED ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS|SALINE BREAST IMPLANTS 350CC||04/14/2017||||N|I||I|FWM|1.0||SALINE BREAST IMPLANTS||1309976|||||NAN|||||68HP||True
2390055|19870278|D|1||RECEIVED MENTOR BREAST IMPLANTS 1986 B6 2008 DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA GIVEN CHEMOTHERAPY RADIATION ONCOLOGIST B6 TREATED RIGHT IMPLANT CONTINUED RED SWOLLEN PROCEDED EXPLANTATION PLASTIC SURGEON B6 IMPLANTING EXPLANTING RECENTLY IVE READ LINK TYPE CANCER BREAST IMPLANTS EXACTLY TYPE FELT IMPORTANT REPORT CASE DIAGNOSIS REASON USE COSMETIC|MENTOR SALINE BREAST IMPLANTS|UNK|12/21/2011||||N|||0HP|FWM|1.0||SALINE BREAST IMPLANTS|||||||MENTOR|||||UNK||True
1888850|1687082|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE SEROMA ANAPLASTIC LARGE CELL LYMPHOMA ALCL FU FINDINGS PT TEXTURED SALINE BREAST IMPLANT MFR UNK ALLERGAN TAKES CONSERVATIVE APPROACH REPORTING FU FINDINGS PT WELL CARE APPOINTMENT TWO MONTHS MULTIPLE BIOPSIES TWO DAYS LATER DEVELOPED BREAST SWELLING PT GENERAL SURGERY CONSULTATION EVAL THREE PERCUTANEOUS DRAINAGE PROCEDURES BIOPSIES DIAGNOSIS ALCL MADE PRIMARY VS SECONDARY BREAST ALCL UNCLEAR STAGE IV DIAGNOSIS MULTI-AGENT CHEMOTHERAPY PROVIDED REFRACTORY CHEMOTHERAPY MEDIASTINAL LYMPH NODES IDENTIFIED CT SCAN FU FINDINGS PT SUPRA CLAVICULAR AXILLARY NODES ADDITION PRESENTING SWOLLEN BREAST LIVER CHEST WALL MEDIASTINAL LYMPHADENOPATHY RIGHT PLEURAL EFFUSION LUNG NODULES ABDOMINAL WALL RETROPERITONEAL LYMPH NODES FINDINGS INVESTIGATION CONTINUES|UNKNOWN SALINE IMPLANT|UNK SALINE IMPLANT|10/19/2010|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210599|16724199|D|1||RECEIVED ABSTRACT ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA BREAST OCCURRING PTS SILICONE BREAST IMPLANTS PUBLISHED FINAL ARTICLE ENTITLED LEUKEMIA LYMPHOMA AUG 20115281481-1487 WITHIN ARTICLE PT IDENTIFIED PT 7 COSMETIC PT AUGMENTATION DIAGNOSED EXCISIONAL BIOPSY NODULE LEFT BREAST ADJACENT IMPLANT IMMEDIATELY TREATED SIX CYCLES CHOP ACHIEVED WENT REMISSION IMPLANTS REMOVED FOLLOWED RADIATION LEFT BREAST PET SCAN 6 MONTHS COMPLETION RADIATION SHOWED RELAPSE RIGHT BREAST AXILLA ABDOMEN GIVEN ESHAP ETOPOSIDE METHYLPREDNISOLONE HIGH-DOSE ARA-C CISPLATIN SALVAGE FOLLOWED STEM CELL COLLECTION FOLLOWING AUTOLOGUS TRANSPLANT PT REMISSION 6 YEARS MW LEFT SIDE REFER MFR REPORT 2024601-2011-00674 RIGHT SIDE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2112878|2143713|D|1||ALCL CASE REPORT B6 FEMALE B6 ALCL DIAGNOSIS DATE DIAGNOSIS - B6 2011 ANATOMIC SITE ALCL LEFT BREAST IMPLANT CAPSULE PRIMARY SITE CONFIRMED PATHOLOGY INITIAL CLINICAL PRESENTATION B6 2010 B6 FEMALE HISTORY DUCTAL CARCINOMA SITU LEFT BREAST DIAGNOSED 1998 SUBSEQUENTLY UNDERWENT LEFT MASTECTOMY SPECIMEN WEIGHT 596 GRAMS UNDERWENT IMMEDIATE RECONSTRUCTION PLACEMENT SUBMUSCULAR TISSUE EXPANDER PLASTIC SURGEON 1 TISSUE EXPANDER PLACED COMPLETELY SUBPECTORAL ALSO SUBSERRATUS POCKET EXPANDER REMOVED 1999 REPLACED MCGHAN 440 ML DUAL-CHAMBER SILICONE SALINE-FILLED IMPLANT RECEIVED POSTOPERATIVE CHEMOTHERAPY RADIATION THERAPY WITHIN YEAR DEVELOPED SIGNIFICANT HARDENING DISTORTION LEFT RECONSTRUCTED BREAST GRADUAL ELEVATION IMPLANT TIGHTENING TISSUE AROUND IMPLANT DISCOMFORT LEFT CHEST WALL SEEN EVALUATION 2006 PLASTIC SURGEON 2 RE-OPERATED LEFT BREAST REMOVED EXISTING IMPLANT PERFORMED PERIPROSTHETIC CAPSULOTOMIES SPECIFIED OPERATIVE NOTE SUBMITTED CAPSULAR TISSUE HISTOLOGIC EXAMINATION INTERPRETED NEGATIVE REPLACED SMALLER SALINE IMPLANT ALLERGAN-STYLE 68MP SALINE IMPLANT SIZE 390-420 ML RECONSTRUCTION SOFT SEVERAL MONTHS WITHIN 1 YEAR RECURRENCE CAPSULAR CONTRACTURE TIGHTENING TISSUE AROUND IMPLANT GRADUAL ELEVATION IMPLANT LOCATION DISCOMFORT LEFT CHEST WALL SEEN EVALUATION 2009 PLASTIC SURGEON 4 RECOMMENDED CONSIDER REVISION RECONSTRUCTION ADDITION CELLULAR DERMAL MATRIX REDUCE POTENTIAL RECURRENCE CAPSULAR CONTRACTURE AROUND DEVICE PLASTIC SURGEON 4 ALSO RECOMMENDED AUTOLOGOUS ABDOMINAL FLAP RECONSTRUCTION PROCEDURES PT INTERESTED CONSIDERING DIEP FLAP PLASTIC SURGEON 4 REFERRED B6 SURGEON 5 EVALUATION CONSIDERATION FREE FLAP BREAST RECONSTRUCTION PROCEDURE PTS PAST MEDICAL HISTORY ADDITIONALLY SIGNIFICANT HISTORY HYPOTHYROIDISM BLADDER PROLAPSE MEDICATIONS INCLUDED SYNTHROID 88 MCG DAILY VITAMIN ADVIL NONSMOKER DRINKS ALCOHOL RARELY INITIAL PHYSICAL EXAMINATION B6 2010 SHOWED PT 155 CM TALL 703 KG LEFT BREAST ABSENT TRANSVERSE STEWART-TYPE MASTECTOMY INCISION IMPLANT PRESENT SUBPECTORAL POSITION LEFT SIDE BAKER GRADE IV CAPSULE CONTRACTURE AROUND DEVICE RIGIDLY AFFIXED CHEST WALL SOMEWHAT TENDER MANIPULATION WOUNDS WELL HEALED EVIDENCE SCAR HYPERTROPHY RIGHT BREAST PTOTIC DEGREE PSEUDOPTOSIS LATERAL BOTTOMING WISE-PATTERN SCAR PREVIOUS MASTOPEXY - RESULTING SUBSTANTIAL SHAPE VOLUME ASYMMETRY LEFT SIDE STERNAL NOTCH INFRAMAMMARY FOLD DISTANCE 20 CM RIGHT SIDE STERNAL NOTCH INFRAMAMMARY FOLD DISTANCE 23 CM MID-CLAVICULAR POINT NIPPLE DISTANCE RIGHT 21 CM EXAMINATION ABDOMEN SHOWED GENEROUS AMOUNT TISSUE LOWER 13 ABDOMEN ABDOMINAL FLAP CONSIDERATION INITIAL IMPRESSION B6 2010 B6 FEMALE RECURRENT CAPSULAR CONTRACTURE FOLLOWING 2 PREVIOUS IMPLANT-BASED RECONSTRUCTION SURGERIES LEFT SIDE LEFT BREAST RECONSTRUCTION SHOWED ELEVATION INFRAMAMMARY FOLD SEVERE CAPSULAR CONTRACTURE AROUND EXISTING IMPLANT RECOMMENDED REMOVAL EXISTING LEFT BREAST IMPLANT RECONSTRUCTION ORIGINS LEFT PECTORALIS MAJOR MUSCLE RECONSTRUCTION LEFT BREAST FREE ABDOMINAL FLAP OPERATIVE FINDINGS B6 2011 LEFT BREAST IMPLANT CAPSULE OPENED CONTAINED CLOUDY YELLOW FLUID ENORMOUS PRESSURE FLUID SQUIRTED CAPSULAR INCISION TRAVELED LEAST 56 INCHES COLLECTION GELATINOUS MATERIAL WITHIN CAPSULE WELL INTACT SALINE BREAST IMPLANT CAPSULE THICKENED COVERED PLAQUE-LIKE LESIONS INTERNALLY TOTAL CAPSULECTOMY PERFORMED PECTORALIS MAJOR MUSCLE REATTACHED 5TH RIB ORIGINS PERIPROSTHETIC FLUID CAPTURED MATERIAL SENT PATHOLOGIC CYTOLOGIC EVALUATION INCLUDING FROZEN SECTION CONSISTENT DIAGNOSIS ALCL REMAINING RECONSTRUCTION ABANDONED PENDING FINAL PATHOLOGY EVALUATION SPECIMEN DETAILED PATHOLOGY FINDINGS LEFT BREAST PERI-PROSTHETIC MATERIAL LARGE ATYPICAL CELLS PRESENT CONSISTENT INVOLVEMENT ANAPLASTIC LARGE CELL LYMPHOMA IMPLANT LEFT BREAST IMPLANT CAPSULE INVOLVEMENT ANAPLASTIC LARGE CELL LYMPHOMA B6|MODERATE PROFILE SMOOTH ROUND SALINE BREAST IMPLANT||05/27/2011||||Y|||0HP|FWM|1.0||68MP 390CC||1316501|||||MCGHAN|||||68MP 390CC||True
2097844|18413658|D|1||COMPANY SALES REPRESENTATIVE REPORTED ANAPLASTIC LARGE CELL LYMPHOMA ALCL RIGHT BREAST CONFIRMED HEALTH PROFESSIONAL CYTOLOGY CONFIRMED DIAGNOSIS CD30 POSITIVE ALK NEGATIVE PATIENT HISTORY LEFT SIDE BREAST CANCER PATIENT PRESENTED SEROMA SYSTEMIC SYMPTOMS|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|05/04/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2162357|2127483|D|1||REPORT NULL-TYPE ANAPLASTIC LARGE CELL LYMPHOMA ARISING SILICONE BREAST IMPLANT CAPSULE WRITTEN PLASTIC RECONSTRUCTIVE SURGERY JUNE 2011 VOL 127 NUMBER 6 REVIEWED ADDITIONAL INFO REQUESTED AUTHOR AUTHOR SUBMITTED MINIMAL DEVICE INFO ABLE INFORM PRODUCT SUPPORT PT IMPLANTED 19 YEARS AGO SMOOTH SILICONE DEVICE REPLACED TEXTURED DEVICE 2006 UNSURE STYLE 2007 PT CAPSULECTOMY DEVICE REMAINS IMPLANTED FOUND INTACT FINALLY 2009 REPLACED MCGHAN 110-220 TEXTURED SILICONE IMPLANT IMPLANTS REMOVED ACCORDING ARTICLE SERIOUS HEMATIC FLUID AROUND RIGHT PROSTHESIS CAPSULECTOMY PERFORMED PATHOLOGIC FINDINGS CONSISTENT DIAGNOSIS NULL-TYPE ANAPLASTIC LYMPHOMA KINASE NEGATIVE NON-HODGKINS ANAPLASTIC LARGE CELL LYMPHOMA|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 110|07/07/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210614|15512186|D|1||RECEIVED ABSTRACT ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA BREAST OCCURRING PTS SILICONE BREAST IMPLANTS PUBLISHED FINAL ARTICLE ENTITLED LEUKEMIA LYMPHOMA AUG 20115281481-1487 WITHIN ARTICLE PT IDENTIFIED PT 6 COSMETIC AUGMENTATION PT FOUND NODULE INFRAMAMMARY FOLD LEFT BREAST GREW SEVERAL MONTHS NEGATIVE MAMMOGRAM LEFT IMPLANT REMOVED TISSUE FIBROUS CAPSULE DIAGNOSED ALCL PT TREATED 6 CYCLES CHOP EXPERIENCED TUMOR REGROWTH WITHIN 2 WEEKS COMPLETION ICE SALVAGE GIVEN RADIATION INEFFECTIVE FINALLY RECEIVED AUTOLOGUS TRANSPLANT USING CBV CYCLOPHOSPHAMIDE CARMUSTINE ETOPOSIDE CONDITIONING REGIMEN REMISSION 75 YEARS LAST FU MW LEFT SIDE REFER MFR REPORT 2024601-2011-00674 RIGHT SIDE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2218186|15143339|D|1||B6 FEMALE HISTORY SALINE BREAST AUGMENTATION 2001 COMPLAINTS ITCHING PAIN 1 YEAR INVOLVING LEFT BREAST PT MAMMOGRAM NOTICING FIRMNESS LEFT BREAST ONE MONTH MAMMOGRAMSONOGRAM REVEALED CIRCUMFERENTIAL FLUID COLLECTION SURROUNDING ENTIRE LEFT BREAST EXTENDING AXILLARY REGION ULTRASOUND GUIDED FLUID ASPIRATION PERFORMED B6 2011 REVEALED ATYPICAL LYMPHOID PROLIFERATION CONSISTENT CD30 POSITIVE ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA SURGERY PERFORMED B6 2011 REMOVE IMPLANTS CONFIRMATION PATHOLOGY|MCGHAN MEDICAL||08/16/2011||||N|||0|FWM|1.0||BREAST IMPLANT SALINE||57787B|71 SOUTH LOS CARNEROS||GOLETA|US|ALLERGAN|93111|CA|93111||||True
2210613|2193837|D|1||ABSTRACT RECEIVED ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA BREAST OCCURRING PTS SILICONE BREAST IMPLANTS REPORTED PUBLISHED FINAL ARTICLE ENTITLED LEUKEMIA LYMPHOMA AUG 20115281481-1487 WITHIN ARTICLE PT IDENTIFIED PT 1 INDICATES COSMETIC AUGMENTATION ORIGINALLY PRESENTED SWELLING LEFT BREAST DRAINAGE FLUID FLUID SHOWED LARGE AMOUNTS ATYPICAL LYMPHOCYTES FLUID ACCUMULATION RECUR 2 YEARS TIME EXPERIENCED RAPID SWELLING LEFT BREAST WORK-UP YIELDED DIAGNOSIS ALCL ALK- PT PRESENTED CITY HOPE SECOND OPINION CHOP RECOMMENDED TREATMENT CARRIED ELSEWHERE OUTCOME UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210610|16745564|D|1||RECEIVED ABSTRACT ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA BREAST OCCURRING PTS SILICONE BREAST IMPLANTS REPORTED PUBLISHED FINAL ARTICLE ENTITLED LEUKEMIA LYMPHOMA AUG 20115281481-1487 WITHIN ARTICLE PT IDENTIFIED PT 7 COSMETIC PT AUGMENTATION DIAGNOSED EXCISIONAL BIOPSY NODULE LEFT BREAST ADJACENT IMPLANT IMMEDIATELY TREATED SIX CYCLES CHOP ACHIEVED WENT REMISSION IMPLANTS REMOVED FOLLOWED RADIATION LEFT BREAST PET SCAN 6 MONTHS COMPLETION RADIATION SHOWED RELAPSE RIGHT BREAST AXILLA ABDOMEN GIVEN ESHAP ETOPSIDE METHYLPREDNISOLONE HIGH-DOSE ARA-C CISPLATIN SALVAGE FOLLOWED STEM CELL COLLECTION FOLLOWING AUTOLOGUS TRANSPLANT PT REMISSION 6 YEARS MW RIGHT SIDE REFER MEDWATCH MFR REPORT 2024601-2011-00663 LEFT SIDE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2027271|1955552|D|1||B6 FEMALE DIAGNOSED BREAST-IMPLANT RELATED ANAPLASTIC LARGE CELL LYMPHOMA PT BILATERAL MASTECTOMIES SALINE IMPLANT RECONSTRUCTION 1992 DEVELOPED LEFT SIDED IDIOPATHIC LARGE VOLUME SEROMA 2009 IMPLANTS REMOVED PARTIAL CAPSULECTOMY PERFORMED DIFFERENT PLASTIC SURGEON REPLACEMENT IMPLANTS TIME PATHOLOGY REPORTS NEGATIVE TIME RECURRENT SEROMA FOLLOWING EXPLANTATION REQUIRING REPEAT CAPSULECTOMY DRAIN PLACEMENT B6 2010 NEGATIVE PATHOLOGY REPORT PT PRESENTED DELAYED TWO-STAGE RECONSTRUCTION PRACTICE PERFORMED B6 2011 LEFT BREAST SEROMA SMALL CAPSULE IDENTIFIED COMPLETELY REMOVED PATHOLOGY REPORTS CONFIRMED ALCL LEFT BREAST CAPSULE ALK-1 NEGATIVE SALINE BREAST IMPLANT UNKNOWN MANUFACTURER SURE TEXTURED SMOOTH PT RECORDS SURGEON REMOVED IMPLANTS RECALL SALINE PATHOLOGY REPORT INDICATE TEXTURED VS SMOOTH|UNK||03/17/2011||||N|||0|FWM|1.0||SALINE BREAST IMPLANT||UNK|||||UNK|||||||True
2222963|2168811|D|1||PT BREAST IMPLANTS DEVELOPED ANAPLASTIC LARGE CELL LYMPHOMA 17 YEARS UNDERGOING BREAST AUGMENTATION B6 1994 IMPLANTS ROUND TEXTURED SALINE IMPLANTS MANUFACTURED MCGHAN PT ASYMPTOMATIC APPROXIMATELY B6 2011 DEVELOPED BODY-WIDE PRURITIS NOTED INCREASE SIZE RIGHT BREAST DEVELOPMENT RIGHT PARASTERNAL MASS|MCGHAN|27-168301|08/20/2011||||Y|||0HP|FWM|1.0||TEXTURED SALINE BREAST IMPLANT||BP8422|||||MCGHAN|||||||True
2150825|2102553|D|1||HEALTH PROFESSIONAL REPORTS ANAPLASTIC LARGE CELL LYMPHOMA SEROMA GRANULOMATOUS MASS LOCATED PATIENTS RIGHT BREAST PATIENT HISTORY PREEXISTING BILATERAL BREAST CANCER PRIMARY BREAST RECONSTRUCTION MCGHAN SALINE STYLE 163-360 DEVICES IMPLANTED BILATERALLY 1999 PATIENT PRESENTED SYMPTOMS ACUTE LOCALIZED SWELLING RIGHT BREAST RECONSTRUCTION CAPSULE PERFORMED B6 2011 SEROMA DRAINED FLUID SENT CYTOLOGY BIOPSY TAKEN TISSUE MASS B6 2011 FINDINGS CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA DENSE FIBROSIS CONTAINING ATYPICAL CELLS CD30 POSITIVE ALK NEGATIVE PATIENT SUBSEQUENT EXPLANT SURGERY CAPSULECTOMY B6 2011 TREATMENTS INCLUDING CHEMOTHERAPY RADIATION UNKNOWN TIME PATIENT WELL EXPLANTED DEVICE RETURNED ALLERGAN|STYLE 163 SALINE FILLED BREAST IMPLANT|163-360|06/02/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2348477|18501906|D|1||HEALTHCARE PROFESSIONAL REPORTS VIA VOLUNTARY MW B4 CASE ALCL INFECTION PAIN BREAST ENLARGEMENT HEALTH PROFESSIONAL REPORTS WHITE FEMALE PRESENTED OFFICE 2010 INFECTED RIGHT BREAST IMPLANT PREVIOUS SILICONE BREAST IMPLANTS 17 YRS PRIOR LITTLE YR SYMPTOMS INCLUDING PAIN ENLARGEMENT RECENTLY REDNESS FAILED COURSE ANTIBIOTIC THERAPY TIME PRESENTATION ALSO EPIDERMOLYSIS HANDS FEET PERIAREOLAR REGION EXAM CONSISTENT INFECTED BREAST IMPLANT THEREFORE IMPLANT REMOVED OFFICE LOCAL ANESTHESIAS EPIDERMOLYSIS EVENTUALLY CLEARED INFECTION IMPROVED HOWEVER DEVELOPED INFLAMMATORY ABSCESS INFRAMAMMARY PORTION RIGHT BREAST REQUIRED OPERATIVE EXCISION DEBRIDEMENT ANESTHESIA TISSUE REMOVED SENT LABORATORY CAME BACK ANAPLASTIC LARGE CELL LYMPHOMA PT CONSULT TREATMENT RECEIVED CHEMOTHERAPY REQUESTED REMOVAL LEFT BREAST IMPLANT WELL UNEVENTFUL FOUND RUPTURED UPON REMOVAL PRODUCT RETAINED AVAILABLE EXAMINATION PT CONTINUED CARE TIME|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/30/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2348477|62765167|D|1||HEALTHCARE PROFESSIONAL REPORTED CASE ANAPLASTIC LARGE CELL LYMPHOMA CAPTURED LYMPHOMA PATHOLOGY REPORT AVAILABLE CONFIRM DIAGNOSIS ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/30/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210616|2207031|D|1||RECEIVED ABSTRACT ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA BREAST OCCURRING PTS SILICONE BREAST IMPLANTS REPORTED PUBLISHED FINAL ARTICLE ENTITLED LEUKEMIA LYMPHOMA AUG 20115281481-1487 WITHIN ARTICLE PT IDENTIFIED PT 5 INDICATE AUGMENTATION RECONSTRUCTION PT MINIMAL INFO PROVIDED ARTICLE REGARDING PT INFO NOTED PATHOLOGY CONSULTATION TISSUE FIBROUS CAPSULE RIGHT BREAST IMPLANT|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
1985458|1846143|D|1||ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS RECONSTRUCTION BREAST CANCER DATES USE B6 2007 DIAGNOSIS REASON USE REPLACING SALINE IMPLANTS 1 RUPTURE MENTOR SILICONE BREAST IMPLANTS PUT B6 2007 RIGHT BREAST REMOVED B6 2008 REPLACED DAY MENTOR SILICONE IMPLANT REMOVED B6 2008 VIA RADICAL MASTECTOMY FOUR WRONG DIAGNOSES BREAST CANCER MADE 9 WEEKS MASTECTOMY ALCL DIAGNOSIS MADE TREATED HIGH DOSING CHEMO SEVERAL KINDS STEM CELL TRANSPLANT ADDL CHEMO RADIATION EVENT ABATED USE EVENT REAPPEARED REINTRODUCTION YES|MENTOR||02/07/2011||||N|||0HP|FTR|1.0||SILICONE BREAST IMPLANTS|||||||MENTOR|||||||True
2210612|2207030|D|1||RECEIVED ABSTRACT ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA BREAST OCCURRING PTS SILICONE BREAST IMPLANTS REPORTED PUBLISHED FINAL ARTICLE ENTITLED LEUKEMIA LYMPHOMA AUG 20115281481-1487 WITHIN ARTICLE PT IDENTIFIED PT 2 UNK AUGMENTATION PT RECONSTRUCTION PT DIAGNOSED TISSUE FIBROUS CAPSULE LEFT BREAST IMPLANT INFO PROVIDED PT MINIMAL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2210600|2186240|D|1||RECEIVED ABSTRACT ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA BREAST OCCURRING PTS SILICONE BREAST IMPLANTS REPORTED PUBLISHED FINAL ARTICLE ENTITLED LEUKEMIA LYMPHOMA AUG 20115281481-1487 WITHIN ARTICLE PT IDENTIFIED PT 4 COSMETIC AUGMENTATION PT RECEIVED INTRAPARENCHYMAL SILICONE INJECTIONS 30 YEARS PRIOR DIAGNOSIS REPLACED 3 YEARS LATER TIME DIAGNOSIS RIGHT IMPLANT REMOVED ALONG FLUID LYMPHOMATOUS TISSUE CAPSULE PT TREATED 6 CYCLES CHOP RADIATION RECURRED RECURRENCE 2 MONTHS UNSUCCESSFUL ATTEMPTS COLLECT STEM CELLS PT PURSUED ALTERNATIVE TREATMENTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2140645|2119287|D|1||ALK NEGATIVE ALCL - ANAPLASTIC LARGE CELL LYMPHOMA POSSIBLY RELATED BREAST IMPLANTS HX HL - TREATED MANTLE FIELD RADIATION THERAPY BREAST CANCER TREATED SURGERY CHEMO TAMOXIFEN|BREAST IMPLANTS||06/22/2011||||N|||0|FWM|1.0||BREAST IMPLANTS|||||||nan|||||||True
2338306|2365004|D|1||REPORT LYMPHOMA BREAST CAPSULE SILICONE IMPLANT-RECONSTRUCTED PT PUBLISHED AMERICAN SURGEON SEPT 2010 VOL 76 PG 1030-31 REVIEWED ADDL INFO REQUESTED AUTHOR AUTHOR RESPONDED DATE WITHIN ARTICLE AUTHOR NOTES B6 WOMAN TISSUE DIAGNOSIS ADENOCARCINOMA LEFT BREAST UNDERWENT LEFT MODIFIED RADICAL MASTECTOMY PROPHYLACTIC RIGHT BREAST SIMPLE MASTECTOMY 1999 IMMEDIATELY FOLLOWED PRIMARY RECONSTRUCTION SILICONE IMPLANTS LYMPH NODE BASIN FREE DISEASE PT RECEIVED CHEMOTHERAPY RADIATION THERAPY SIX YEARS LATER PRESENTED PRIMARY CARE LUMP RECONSTRUCTED RIGHT BREAST EXAMINATION 3CM NON-TENDER MOBILE CYSTIC MASS RIGHT BREAST 9 OCLOCK POSITION COMPRESSION IMPLANT CAUSED ENLARGEMENT LESION REPORT NIPPLE DISCHARGE RETRACTION SKIN AREOLA COMPLEX NORMAL PALPABLE LYMPH NODES PRIMARY CARE PHYSICIAN PERFORMED NEEDLE ASPIRATION MASS ORANGE COLOR CYTOLOGIC FEATURES ADENOCARCINOMA UNDERWENT BILATERAL IMPLANT REMOVAL EXCISION CYSTIC MASS BIOPSIES CAPSULES LEFT BREAST IMPLANT INTACT CAPSULE NORMAL APPEARANCE RIGHT BREAST IMPLANT INTACT WELL HOWEVER ANTERIOR POSTERIOR WALLS CAPSULE COATED NECROTIC HETEROGENEOUS MATERIAL INITIAL BIOPSIES RIGHT BREAST CAPSULE SHOWED POORLY DIFFERENTIATED ADENENOCARCINOMA IMMUNOPOSITIVE CD30 EMA T-CELL MARKERS CD45RO CD43 FINAL PATHOLOGY MASS REVIEW SECOND PATHOLOGIST UNIVERSITY HOSPITAL ANAPLASTIC LARGE CELL LYMPHOMA ALK- CELL PHENOTYPE POST OP RECOVER UNEVENTFUL PT COURSE CHOP PROTOCOL PTS LYMPHOMA DISCOVERED CYSTIC LESION INVOLVING RIGHT BREAST CAPSULE PRELIMINARY CYTOLOGIC FEATURE LESION POORLY DIFFERENTIATED ADENENOCARCINOMA SIMILAR PRIOR DIAGNOSIS LEFT BREASTONLY IMMUNOHISTOCHEMISTRY SPECIMEN CORRECTLY DIAGNOSED ALCL T-CELL LYMPHOMA TREATED CHOP CHEMOTHERAPY PROTOCOL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|11/09/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2030915|1919205|D|1||B6 2010 DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL ALK-NEGATIVE POSSIBLY RELATED CAUSED BREAST IMPLANTS RECEIVED B6 2002 AUGMENTATION EXPERIENCED COMPLICATIONS LEFT IMPLANT DIAGNOSED CAPSULAR CONTRACTION IMPLANT REPLACED B6 2008 STILL EXPERIENCING CAPSULAR CONTRACTION REPLACEMENT B6 2010 - B6 2011 RECEIVED 12 DOSES CHEMOTHERAPY RECEIVED 20 DOSES RADIATION THERAPY PREPARING STEM CELL TRANSPLANT SCHEDULED B6 2011 B6 2010 NEEDLE BIOPSY - DIAGNOSIS LYMPHOMA B6 2010 SURGICAL BIOPSY - DIAGNOSIS ALCL B6 2010 SURGICAL BIOPSY - DIAGNOSIS ALCL|NATRELLE||03/17/2011||||N|||0HP|FWM|1.0||SALINE - FILLED BREAST IMPLANT||RIGHT: 579142|||IRVINE|US|ALLERGAN||CA|||STYLE # 468||True
2030915|1919205|D|1||B6 2010 DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL ALK-NEGATIVE POSSIBLY RELATED CAUSED BREAST IMPLANTS RECEIVED B6 2002 AUGMENTATION EXPERIENCED COMPLICATIONS LEFT IMPLANT DIAGNOSED CAPSULAR CONTRACTION IMPLANT REPLACED B6 2008 STILL EXPERIENCING CAPSULAR CONTRACTION REPLACEMENT B6 2010 - B6 2011 RECEIVED 12 DOSES CHEMOTHERAPY RECEIVED 20 DOSES RADIATION THERAPY PREPARING STEM CELL TRANSPLANT SCHEDULED B6 2011 B6 2010 NEEDLE BIOPSY - DIAGNOSIS LYMPHOMA B6 2010 SURGICAL BIOPSY - DIAGNOSIS ALCL B6 2010 SURGICAL BIOPSY - DIAGNOSIS ALCL|NATRELLE||03/17/2011||||N|||0HP|FWM|2.0||SALINE - FILLED BREAST IMPLANT|||||IRVINE|US|ALLERGAN||CA|||STYLE # 468||True
1976502|1898383|D|1||PATIENT DIAGNOSED ALCL - ANAPLASTIC LARGE CELL LYMPHOMA - AROUND RIGHT SALINE BREAST IMPLANT IMPLANTS ORIGINALLY PLACED 1998 IMPLANTS REMOVED TREATED LYMPHOMA|SALINE BREAST IMPLANT||01/26/2011||||N|||0LP|FWM|1.0||SALINE BREAST IMPLANT|||||||ALLERGAN|||||||True
2025987|1914162|D|1||HEALTH PROFESSIONAL INITIALLY REPORTS PATIENT HISTORY PREEXISTING BREAST CANCER RECONSTRUCTION SURGERY BILATERAL TISSUE EXPANDERS MCGHAN SALINE TEXTURED IMPLANTS PLACED PATIENT PRESENTED SWELLING LEFT BREAST SIX YEARS POST RECONSTRUCTION SALINE DEVICES EXPLANTED PER PATIENTS REQUEST EXCHANGED ALLERGAN SILICONE SMOOTH DEVICES FLUID SENT PATHOLOGYCYTOLOGY OPERATIVE NOTE DESCRIBE FLUID MODERATE BROWN LIQUID OLD BLOOD SENT CYTOLOGY RESULTS SHOWED CD30+ ALK- LEFT SEROMA CYTOLOGY DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA CHEMOTHERAPY RADIATION THERAPY DONE DEVICE EXPLANTED DEVICE RETURNED ALLERGAN ANALYSIS PATIENT WELL SCHEDULED FOLLOW-UP ULTRA-SOUND CT SCAN FOLLOWED ONCOLOGIST|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-500|03/16/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
1976511|1898917|D|1||ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSIS ASSOCIATED SILICONE BREAST IMPLANT DIAGNOSIS REASON USE BREAST RECONSTRUCTION|nan||01/26/2011||||N|||0HP|FTR|1.0||BREAST IMPLANT|||||||nan|||||||True
2210597|2206520|D|1||RECEIVED ABSTRACT ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA BREAST OCCURRING PTS SILICONE BREAST IMPLANTS PUBLISHED FINAL ARTICLE ENTITLED LEUKEMIA LYMPHOMA AUG 20115281481-1487 WITHIN ARTICLE PT IDENTIFIED PT 3 COSMETIC AUGMENTATION PT INITIALLY IMPLANTS REMOVED IMMEDIATELY TREATED SIX CYCLES CHOP RESPOND TREATMENT IMPLANTS REMOVED TREATED RADIATION MASS INCREASING SIZE RECEIVING RADIATION FINALLY WENT REMISSION FOLLOWING 3 CYCLES ICE SALVAGE THERAPY PT SOON LOST FU|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2162376|2140768|D|1||PATIENT REPORTED CASE ANAPLASTIC LARGE CELL LYMPHOMA FDA CONFIRMED CASE PHYSICIAN PATIENT HISTORY BILATERAL BREAST AUGMENTATION SUBSEQUENT BILATERAL SEROMAS TWO YEARS POST AUGMENTATION BIOPSY SEROMA FLUID POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA T-CELL TYPE ALK NEGATIVE LEFT BREAST BILATERAL CAPSULECTOMIES EXPLANTS PERFORMED CHEMOTHERAPY RADIATION THERAPY PATIENT WELL OBSERVATION TIME|STYLE 168 SALINE FILLED BREAST IMPLANT|168-420|07/07/2011|||DA|N|R||0HP|FWM|1.0|10/23/2008|nan||1046378|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2121010|2056222|D|1||RECEIVED VOLUNTARY B4 FDA STATING PATIENT DIAGNOSED ALCL  ANAPLASTIC LARGE CELL LYMPHOMA - AROUND RIGHT SALINE BREAST IMPLANT CALL PLACED SURGEONS OFFICE GATHER ADDL INFO DEVICE PT DEMOGRAPHICS PATHOLOGY DEVICE PLACED 1998 DEVICES REMOVED TREATED LYMPHOMA TIME SUBMISSION ADDL INFO RECEIVED OFFICE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|05/26/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2369793|17557106|D|1||PT DEVELOPED SEROMA CAPSULAR CONTRACTURE LEFT BREAST SILICONE BREAST AUGMENTATION B6 2007 COMPLETE LEFT BREAST CAPSULECTOMY IMPLANT EXCHANGE PERFORMED B6 2011 PATHOLOGY SUBSEQUENTLY REPORTED IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA|ALLERGAN NATRELLE|15-575|12/08/2011||||N|||0HP|FTR|1.0||BREAST IMPLANT|||||IRVINE|US|ALLERGAN||CA|||15||True
2210596|2193346|D|1||RECEIVED ABSTRACT ENTITLED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA BREAST OCCURRING PATIENTS SILICONE BREAST IMPLANTS PUBLISHED FINAL ARTICLE ENTITLED LEUKEMIA LYMPHOMA AUG 20115281481-1487 WITHIN ARTICLE PT IDENTIFIED PT 8 COSMETIC AUGMENTATION CASE PT PRESENTED FLUID ACCUMULATION LEFT BREAST SECOND DRAINAGE LARGE VOLUME FLUID WAITING CYTOLOGY REPORT TEXTURED IMPLANTS REMOVED REPLACED SMOOTH SALINE IMPLANTS DIAGNOSIS ALCL ALK-WAS MADE CONFIRMED B4 T-CELL REARRANGEMENT STUDIES TREATMENT CHOP RECOMMENDED TREATED ELSEWHERE OUTCOME UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/10/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2341597|18977395|D|1||NEW DIAGNOSIS ANAPLASTIC LARGE CELL LYMPHOMA RIGHT BREAST PT BREAST IMPLANT AUGMENTATION IMPLANT PLACED B6 2011 MCGHAN STYLE 168 ROUND TEXTURED MAMMARY SALINE IMPLANT 27 -168211 LOT NUMBER NH6968 ONE YEAR HISTORY HARDENING LIFTING RIGHT BREAST ABNORMAL MAMMOGRAM ULTRASOUND PROMPTED BREAST MRI 66 X55 CM MASS SEEN MRI ULTRASOUND GUIDED BREAST BIOPSY B6 2011 REVEALED ANAPLASTIC LARGE CELL LYMPHOMA ALK- NEGATIVE PT RECEIVE CHOP CHEMOTHERAPY|MCGHAN STYLE 168|27-168211|11/10/2011||||N|||0|FWM|1.0||ROUND TEXTURED MAMMARY IMPLANT||NH6968|||||MCGHAN|||||168||True
2119775|2053625|D|1||B6 B6 WHITE FEMALE PRESENTED OFFICE B6 2010 INFECTED RIGHT BREAST PREVIOUS SILICONE BREAST IMPLANTS 17 YEARS PRIOR LITTLE YEAR SYMPTOMS INCLUDING PAIN ENLARGEMENT RECENTLY REDNESS FAILED COURSE ANTIBIOTIC THERAPY TIME PRESENTATION ALSO EPIDERMOLYSIS HANDS FEET PERIAREOLAR REGION EXAM CONSISTENT INFECTED BREAST IMPLANT THEREFORE IMPLANT REMOVED OFFICE LOCAL ANESTHESIA EPIDERMOLYSIS EVENTUALLY CLEARED INFECTION IMPROVED HOWEVER DEVELOPED INFLAMMATORY ABSCESS INFRAMAMMARY PORTION RIGHT BREAST REQUIRED OPERATIVE EXCISION DEBRIDEMENT ANESTHESIA TISSUE REMOVED SENT LABORATORY CAME BACK ANAPLASTIC LARGE CELL LYMPHOMA BREAST EVENTUALLY WENT HEAL SEEN CONSULTATION B6 RECEIVED CHEMOTHERAPY POSSIBLE ASSOCIATION CANCER IMPLANT ALONG ASYMMETRY ISSUES REQUESTED REMOVAL LEFT IMPLANT DONE UNEVENTFULLY NOTE IMPLANT LEFT SIDE RUPTURED IDENTIFICATION ABLE MADE INDICATING MCGHAN 360CC SILICONE GEL TEXTURED IMPLANT PRODUCT RETAINED AVAILABLE EXAMINATION PT CONTINUES CARE TIME|MCGHAN TEXTURED SILICONE GEL BREAST IMPLANT, 360CC|UNK|06/03/2011||||Y|||000|FTR|1.0||BREAST IMPLANT||UNK|||||MCGHAN|||||UNK||True
2551207|2685956|D|1||DEVELOPED ANAPLASTIC LARGE CELL LYMPHOMA ALK INVOLVING BREAST IMPLANT|UNK|UNK|04/23/2012||||Y|||0|FWM|2.0||SALINE BREAST IMPLANTS||UNK|UNK||UNK||UNK|||||UNK||True
2551207|2685956|D|1||DEVELOPED ANAPLASTIC LARGE CELL LYMPHOMA ALK INVOLVING BREAST IMPLANT|UNK|UNK|04/23/2012||||Y|||0|FWM|1.0||SALINE BREAST IMPLANTS||UNK|UNK||UNK||UNK|||||UNK||True
2617537|2730865|D|1||PT DEVELOPED ANAPLASTIC LARGE CELL LYMPHOMA RELATED BREAST IMPLANT - MCGHAN 650 CC DATES USE 30 YEARS REASON USE BREAST AUGMENTATION|MCGHAN 650CC||06/11/2012||||Y|||0|FWM|1.0||BREAST IMPLANT||MCGHAN 650|||||MCGHAN||||||UNK|True
2517651|20917029|D|1||CASE ALCL ASSOCIATED RUPTURED SILICONE BREAST IMPLANT PT PRESENTED GROSS INFECTION R BREAST 30 YRS FOLLOWING BILATERAL MASTECTOMY RECONSTRUCTIONS SILICONE BREAST PROSTHESES RUPTURED SILICONE IMPLANTS REMOVED SUCCESSFULLY SIDES GROSS INFECTION NOTED R EXCESS SKIN TRIMMED PATHOLOGY SKIN SHOWED ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT PT DEMENTED DAUGHTER STATES SURGERY SOMETIME EARLY 1980S DETAILS UNK PT MADE FULL RECOVERY SURGERY PLANS CHEMOTHERAPY PTS FAMILY REPORTS WEIGHT LOSS LAST YEAR QUESTION LESIONS SEEN SPLEENLIVER INCIDENTALLY CT SCAN LAST 2 YRS - NEVER COULD LOCATE REPORT PREOP PHOTOS AVAILABLE UNFORTUNATELY IMPLANT DISCARDED FAR KNOW IMPLANT DISINTEGRATED|UNKNOWN|UNK|04/01/2012||||N|||0|FTR|1.0||SILICONE BREAST IMPLANT||UNK|UNK||UNK||UNK|||||UNK||True
2873438|3241646|D|1||PT B6 FEMALE PRESENTED UNILATERAL LATE SEROMA RIGHT BREAST 16 YRS UNDERGOING COSMETIC BREAST AUGMENTATION SALINE IMPLANTS RECENT HISTORY TRAUMA INFECTION EVENT EXPLAIN FINDINGS INITIALLY EVALUATED BREAST SURGEON ORDERED BREAST MRI SUSPECTING IMPLANT LEAK MRI SHOWED IMPLANT INTACT MASS VISUALIZED LARGE AMOUNT FLUID SURROUNDING BREAST IMPLANT REFERRED PLASTIC SURGERY EVAL PT SENT ULTRASOUND GUIDED ASPIRATION FLUID SURROUNDING BREAST IMPLANT CULTURE RESULTS FLUID SHOWED BACTERIA PATHOLOGY RESULTS CONFIRMED ANAPLASTIC LARGE CELL LYMPHOMA EVALUATED HEMATOLOGISTONCOLOGIST PERFORMED STAGING WORKUP UNDERWENT SURGICAL REMOVAL IMPLANTS SURROUNDING CAPSULES B6 2012 B4 RIGHT BREAST FLUID ATYPICAL LYMPHOCYTIC INFILTRATE CONSISTENT SEROMA ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA PAP STAIN SMEAR STAINED CELL BLOCK SHOWS ATYPICAL LYMPHOCYTIC INFILTRATE COMPOSED PREDOMINANTLY LARGE NEOPLASTIC CELL INFILTRATES ANAPLASTIC FEATURES NEOPLASTIC LYMPHOCYTES EXPRESS CD30 CD45 CD5 CD3 SUBSET EMA SUBSET BCL-2 ALK1 ER PR AE13 CD34 CD20 PAX5 CD68 CD10 MIB STAIN POSITIVE LESS 10 NEOPLASTIC LYMPHOCYTES OVERALL FINDINGS CONSISTENT SEROMA ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA FREQUENTLY OCCURS ADJACENT BREAST IMPLANTS CASES REPORTED ASSOCIATED INDOLENT CLINICAL COURSE TCR GENE REARRANGEMENT PENDING EVALUATE CLONALITY NEOPLASTIC LYMPHOCYTES EVENT ABATED USE STOPPED DOSE REDUCED YES|UNKNOWN - NOT LABELED||12/07/2012||||N|||0HP|FWM|1.0||TEXTURED ROUND SALINE BREAST IMPLANT 475 CC|||||||nan|||||||True
2459139|19868903|D|1||RIGHT TOTAL MASTECTOMY POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANT CAPSULE|UNKNOWN|UNK|02/17/2012||||N|||0|FWM|1.0||BREAST IMPLANT||UNK|UNK||UNK||UNK|||||||True
2718829|3055395|D|1||PT B6 FEMALE UNDERWENT LEFT MASTECTOMY 1996 DUCTAL CARCINOMA SITU TISSUE EXPANDER SALINE IMPLANT RECONSTRUCTION PRESENTED B6 2010 PERI-IMPLANT HEMATOMA THOUGHT POSSIBLY POST-TRAUMATIC UNDERWENT EVACUATION HEMATOMA CHANGE SILICONE GEL IMPLANT PATHOLOGY SPECIMENS NEGATIVE TUMOR PRESENTED B6 2012 SPONTANEOUS HEMATOMA SURGERY MULTIPLE BIOPSIES REVEALED ANAPLASTIC LARGE CELL LYMPHOMA ALCL LIMITED PERIPROSTHETIC CAPSULE HEMATOMA FLUID EXTENSIVE HEMATOLOGIC METASTATIC WORKUP NEGATIVE UNDERWENT REMOVAL IMPLANT TOTAL PERIPROSTHETIC CAPSULECTOMY CAPSULAR PATHOLOGY SHOWED ALCL|MENTOR SMOOTH ROUND HIGH PROFILE GEL, 450CC|350-4505BC|08/23/2012||||Y|||0HP|FTR|1.0||SILICONE GEL BREAST IMPLANT||6004844|||SANTA BARBARA|US|MENTOR||CA|||350-4505BC||True
2578247|2650283|D|1||ADDITIONAL INFORMATION PROVIDED RECEIVED LITERATURE ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS FIVE B6 CASES PUBLISHED PLASTIC RECONSTRUCTIVE SURGERY B6 2012 B4 WITHIN ARTICLE AUTHOR DESCRIBES SEROMA WITHIN ARTICLE AUTHOR DESCRIBES B6 UNDERWENT RIGHT MASTECTOMY AXILLARY DISSECTION IMMEDIATE BEAST RECONSTRUCTION LATISSIMUS DORSI FLAP TISSUE EXPANDER B6 1996 REQUIRE ADJUVANT THERAPY EXPANDER REPLACED 390CC ROUND SMOOTH IMPLANT B6 1996 REVISION PERFORMED RIGHT BREAST CAPSULE B6 1997 B6 1999 SALINE DEVICE REPLACED TEXTURED SALINE IMPLANT B4 B6 2007 PATIENT DEVELOPED SEROMA SEROMA ASPIRATED REVEALED ALCL DEVICE LEFT PLACE CHEMOTHERAPY SEROMA RECURRED THUS UNDERWENT TOTAL CAPSULECTOMY IMPLANT REMOVAL B6 2007 TREATMENT COMPLETED CHEMOTHERAPY RADIATION DISEASE FREE EVENT ORIGINALLY REPORTED VIA EASR B6 2011|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|05/09/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2786161|19225058|D|1||HEALTHCARE PROFESSIONAL NOTES LYMPHOMA RECD MW B4 NOTES ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED APPROXIMATELY 11 YEARS FOLLOWING POST BILATERAL MASTECTOMY RECONSTRUCTION TEXTURED EXPANDERS MCGHAN TEXTURED SALINE BREAST IMPLANTS DEVICE INFO SURGEON INFO PROVIDED HISTOLOGICALCYTOLOGY INFO PROVIDED MINIMAL INFO PROVIDED INVESTIGATION CLOSED REOPENED IFWHEN NEW INFO PROVIDED FORWARDED ALONG|UNK SALINE IMPLANT|UNK SALINE IMPLANT|09/24/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2564353|2651879|D|1||ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS FIVE B6 CASES PUBLISHED PLASTIC RECONSTRUCTIVE SURGERY B6 2012 B4 WITHIN ARTICLE AUTHOR DESCRIBES B6 WOMAN PRESENTED 2011 RIGHT BREAST LUMP HISTORY NOTES WIDE LOCAL EXCISION RIGHT BREAST DUCTAL CARCINOMA SITU FOLLOWED RADIOTHERAPY 1995 1998 MASTECTOMY RECURRENT DISEASE RECONSTRUCTION PEDICLED LATISSIMUS DORSI FLAP 2006 REVISION RIGHT BREAST AUGMENTATION SUBPECTORALIS LATISSIMUS DORSI FLAP LEFT BREAST AUGMENTATION SYMMETRY SUBFASCIAL TEXTURED MCGHAN IMPLANTS UNDERWENT OPEN BIOPSY TWO MASSES FOUND ONE MEDIAL ONE LATERAL MEDIAL MASS FOUND IMPLANT RUPTURED IMMEDIATELY IMPLANT REMOVED TOTAL CAPSULECTOMY PERFORMED IMPLANT REPLACED ASSUMPTION MASS SILICOMA HISTOPATHOLOGIC ANALYSIS REVEALED MASSES ALK- ALCL CD30+ REMAINDER CAPSULE NEGATIVE REMAINDER WOUND FAILED HEAL RIGHT BREAST IMPLANT REMOVED CT SCAN PET SCAN NORMAL BONE MARROW BEGAN CHEMOTHERAPY CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE AWAITING RADIATION CURRENTLY RECURRENCE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/01/2012|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2702764|17972089|D|1||RECEIVED MEDWATCH B4 FORM B6 2012 REPORT HEALTHCARE PROFESSIONAL REPORTING PT REMOVED IMPLANTS DEVELOPMENT LEFT PERO-IMPLANT SEROMA CAPSULAR CONTRACTURE BAKER GRADE UNKNOWN LYMPHOMA RIGHT SIDE IMPLANT REMOVAL COMPLAINT DEVICE LEFT BREAST CAPSULE RESECTED POSITIVE ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA HEALTHCARE PROFESSIONAL PROVIDES TEST RESULTS REPORTED PET NEGATIVE BONE MARROW BIOPSY NEGATIVE MALIGNANCY PT CURRENTLY UNDERGOING CHEMOTHERAPY ERADICATE RESIDUAL DISEASE FOLLOWED EXTERNAL RADIATION THERAPY INVOLVED FIELD LEFT BREAST MULTIPLE ATTEMPTS MADE GATHER DEVICE ADDITIONAL INFORMATION HOWEVER DATE ADDITIONAL INFORMATION PROVIDED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|08/13/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2578281|2650718|D|1||ADDITIONAL INFORMATION RECEIVED LITERATURE ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS FIVE AUSTRALIAN CASES PUBLISHED PLASTIC RECONSTRUCTIVE SURGERY APRIL 2012 PG 610E-617E WITHIN ARTICLE AUTHOR DESCRIBES B6 AUGMENTATION PATIENT SURGERY 25 YEARS PRIOR PRESENTED PRIMARY CARE PHYSICIAN GENERAL MALAISE LETHARGY DETAILS UNAVAILABLE AUTHOR NOTES PERFORMED HOST INVESTIGATIONS MAMMOGRAM ULTRASOUND SUGGEST RUPTURE PERIPROSTHETIC FLUID COLLECTION THICK CAPSULE SURGERY SCHEDULED REMOVE REPLACE RUPTURED IMPLANTS TIME SURGERY IMPLANTS FOUND INTACT CAPSULE GRANULOMATOUS GROWTHS WITHIN MODERATE AMOUNT SEROMA DRAINED NEW IMPLANTS INSERTED CAPSULECTOMIES PERFORMED OLD IMPLANTS FOUND ROUND TEXTURED SILICONE GEL-FILLED UNKNOWN MAKE HISTOLOGICAL ANALYSIS RIGHT BREAST CAPSULE CONSISTENT LOCALIZED SYSTEMIC ALCL ALK- SYMPTOMS LETHARGY MALAISE RESOLVED WENT CHEMOTHERAPY DECLINED RADIATION LAST SEEN DISEASE FREE EVENT ORIGINALLY SENT VIA B4 24JAN2011|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/09/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2648318|15024103|D|1||LATE SEROMA LEFT BREAST BILATERAL BREAST IMPLANTS SUBMUSCULAR ALLERGAN TEXTURED IMPLANTS DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA|ALLERGAN TEXTURED SALINE IMPLANTS||07/06/2012||||Y|||0|FWM|1.0||SALINE BREAST IMPLANTS|||||||ALLERGAN|||||||True
2622560|2762059|D|1||PT DEVELOPED ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST ASSOCIATION BREAST IMPLANT ORIGINAL IMPLANTS REPORTEDLY SALINE PLACED 1987 B6 HOSP IMPLANTS REMOVED NEW SALINE IMPLANTS PLACED 1995 B6 REPORTED MCGHAN TEXTURED SALINE IMPLANT 380ML VOLUME B6 2012 DEVELOPMENT LEFT PERI-IMPLANT SEROMA BILATERAL IMPLANTS REMOVED LEFT BREAST CAPSULE RESECTED POSITIVE ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA PET NEGATIVE BONE MARROW BIOPSY NEGATIVE MALIGNANCY PT CURRENTLY CHEMOTHERAPY ERADICATE RESIDUAL DISEASE FOLLOWED XRT INVOLVED FIELD LEFT BREAST PT ALSO PREVIOUS BREAST IMPLANT REMOVED 1995 DONT KNOW ANYTHING ADDL IMPLANT|MCGHAN||06/10/2012||||N|||0|FWM|1.0||TEXTURED SALINE BREAST IMPLANT||UNK|||||MCGHAN|||||||True
2888498|60381987|D|1||RESEARCH REVIEW RN PRODUCT SUPPORT SPECIALIST FOLLOWING ARTICLE CAME ATTENTION SILICONE IMPLANT PRIMARY BREAST ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA FACT FICTION INT J CLN EXP PATHOL 2010 31 117-127|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/20/2012|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
2888498|60340181|D|1||REPORTED EVENTS WITHIN JOURNAL ARTICLE SILICONE IMPLANT PRIMARY BREAST ALK1-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA FACT FICTION INT J CLN EXP PATHOL 201031117-127 JOURNAL ARTICLE STATES FIVE HALF YEARS FOLLOWING SURGERY PATIENT FOUND LEFT BREAST SWELLING PAINLESS MASS MAGNETIC RESONANCE IMAGING MRI CHEST SHOWED FLUID COLLECTION AROUND PATIENTS IMPLANT FINE NEEDLE ASPIRATION FLUID AROUND BREAST IMPLANT SHOWED LARGE ATYPICAL MONO NUCLEAR CELLS IRREGULAR NUCLEAR CONTOURS PROMINENT NUCLEOLI BACKGROUND SMALL LYMPHOCYTES SUSPICIOUS RECURRENCE PATIENTÂ¿S INFILTRATING DUCTAL CARCINOMA IMPLANT SURGICALLY REMOVED SUBMITTED PATHOLOGICAL EXAMINATIONÂ¿ ARTICLE STATES Â¿THE MORPHOLOGIC IMMUNOHISTOCHEMICAL MOLECULAR FINDINGS SUPPORT DIAGNOSIS ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ PATIENT TREATED Â¿6 CYCLES CHOPÂ¿ EVIDENCE DISEASE 10 MONTHS TREATMENTÂ¿|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/20/2012|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
2645572|2874280|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE ANAPLASTIC LARGE CELL LYMPHOMA SEROMA CAPSULAR CONTRACTURE BAKER GRADE UNK PTÂ¿S NOTES INDICATE AUGMENTATION SURGERY PERFORMED 1990 SMOOTH SILICONE IMPLANT 1999 PT UNDERWENT REVISION SURGERY TEXTURED SILICONE IMPLANT PLACED 365CC CYTOLOGY REPORT SUBMITTED NOTES PT RIGHT BREAST SEROMA 300 CC YELLOW FLUID DRAINED SENT CYTOLOGY CYTOLOGY POSITIVE CD30 TIA1 CD3 FOCAL CD56 ALK CD20 NEGATIVE|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-330|06/29/2012||05/31/2012|DA|R|Y||0HP|FTR|1.0|03/15/2003|nan||40897|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2822645|3025069|D|1||PT UNDERWENT BILATERAL SILICONE BREAST IMPLANTS 1989 STARTING B6 2011 DEVELOPED DISCOMFORT LEFT CHEST WALL LARGE FLUID COLLECTION SURROUNDING LEFT IMPLANT FOUND B6 2012 FLUID DRAINAGE SHOWED ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA CELLS WITHOUT MASS UNDERWENT REMOVAL BILATERAL BREAST IMPLANTS B6 2012 EVENT ABATED USE STOPPED DOSE REDUCED YES|MCGHAN 300 CC|UNKNOWN|11/01/2012||||Y|||0LP|FWM|1.0||BREAST IMPLANT||UNKNOWN|||||UNK|||||UNKNOWN||True
2766557|2912622|D|1||BREAST IMPLANT - RELATED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED BREAST IMPLANTS CELL REMOVED - B6 2012 PT IMPLANTS PLACED 20 YEARS AGO|BREAST IMPLANTS MCGHAN||09/24/2012|||||||0|FWM|2.0||BREAST IMPLANTS|||||||MCGHAN|||||||True
2766557|2912622|D|1||BREAST IMPLANT - RELATED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED BREAST IMPLANTS CELL REMOVED - B6 2012 PT IMPLANTS PLACED 20 YEARS AGO|BREAST IMPLANTS MCGHAN||09/24/2012|||||||0|FWM|1.0||BREAST IMPLANTS|||||||MCGHAN|||||||True
2844637|3044749|D|1||REPORTED ANAPLASTIC LARGE CELL LYMPHOMA CONTRACTURE ASSOCIATED ASYMMETRY RESEARCH ARTICLE 2008 AMERICAN JOURNAL SURGICAL PATHOLOGY WONG ET AL ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT CAPSULE CASE REPORT REVIEW LITERATURE FOLLOW-UP FINDINGS DOCTOR STATES ALLERGAN DEVICE UNABLE EXONERATE DEVICE INSUFFICIENT STUDY EVIDENCE B4|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/16/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2708456|2756351|D|1||ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED APPROXIMATELY 11 YEARS FOLLOWING POST BILATERAL MASTECTOMY RECONSTRUCTION TEXTURED SALINE TISSUE EXPANDERS MCGHAN TEXTURED SALINE BREAST IMPLANTS|MCGHAN||08/16/2012||||N|||0|FWM|1.0||TEXTURED SALINE BREAST IMPLANT||UNK|||SANTA BARBARA|US|MCGHAN||CA|||||True
2834717|16866252|D|1||ANAPLASTIC LARGE CELL LYMPHOMA IMPLANTS|STYLE 153 360ML ALLERGAN DOUBLE||10/05/2012||||N|||0|FTR|2.0||BREAST IMPLANT|||||||ALLERGAN|||||||True
2834717|16866252|D|1||ANAPLASTIC LARGE CELL LYMPHOMA IMPLANTS|STYLE 133 LV 400ML ALLERGAN TISS||10/05/2012||||N|||0|FTR|1.0||BREAST IMPLANT|||||||ALLERGAN|||||||True
2883100|21051084|D|1||PATIENT PRIOR BILATERAL BREAST IMPLANTS MCGHAN 390ML IMPLANTS CURRENTLY KNOWN ALLERGAN INAMED EXPERIENCING BILATERAL CAPSULAR CONTRACTURE ENLARGING RIGHT BREAST  SURGEON SUSPECTED SEVERE RIGHT BREAST IMPLANT RUPTURE RADIOLOGIC STUDIES  ELECTED REMOVE IMPLANTS DONE TODAY  REPLACEMENT IMPLANTS DONE  PATHOLOGY REPORT SURGICAL FINDINGS INCLUDED LEFT BREAST IMPLANT SUSPICIOUS FINDINGS RIGHT BREAST FOUND RESOLVING HEMATOMA EXTRUDED IMPLANT APPEARED INTACT  PATHOLOGY RIGHT BREAST IMPLANT CAPSULE REVEALED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT CURRENTLY RECEIVING TREATMENT LYMPHOMA  PATHOLOGIST AWARE FDA REQUESTING REPORTS IMPLANTS ASSOCIATED TYPE LYMPHOMA|INAMED|*|10/31/2012||||N|||*|FWM|1.0||BREAST IMPLANT||*|71 SOUTH LOS CARNEROS ROAD||GOLETA|US|ALLERGAN|93117|CA|93117||*|*|True
3030985|21262828|D|1||LEFT SIDE REPORTED ANAPLASTIC LARGE CELL LYMPHOMA CONTRACTURE ASSOCIATED ASYMMETRY RESEARCH ARTICLE PUBLISHED 2008 AMERICAN JOURNAL SURGICAL PATHOLOGY WONG ET AL ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT CAPSULE CASE REPORT REVIEW LITERATURE FU FINDINGS DOCTOR STATES ALLERGAN DEVICE UNABLE EXONERATE DEVICE INSUFFICIENT STUDY EVIDENCE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|11/29/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3487103|16685068|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA B-SYMPTOMS VIA MW B4 MW NOTES REPORTER CALLED BEHALF PT DIAGNOSED ALCL PT PRESENTED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED 2013 HISTORY HODGKINS LYMPHOMA DIAGNOSED 2011 TWO EVENTS CAME PT UNDERWENT BREAST AUGMENTATION 1994 2010 PT PRESENTED ABNORMAL MAMMOGRAM PERFORMED 2010 BREAST PAIN SKIN COLOR CHANGE SKIN TEXTURE CHANGE INFLOWING DIFFUSION FORM RIGHT BREAST RIGHT NECK SHOULDER PT RUNNING FEVER THROUGHOUT ENTIRE PROCESS MRI SUBSEQUENT TEST PT DIAGNOSED HODGKINS LYMPHOMA UNDERWENT MANTLE RADIATION 2012 PT UNDERWENT SURGERY ESSENTIALLY BREAST MASS PT ALSO DESIRED MASTECTOMY REMOVAL RIGHT LEFT IMPLANTS CAPSULES PATHOLOGY OPERATION SOON REPORTED PT ALSO ALCL MASS COME LYMPHOMA|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/07/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||BOLETA|US|ALLERGAN||CA|||||True
3165371|62390606|D|1||HEALTH PROFESSIONAL REPORTED  SUBPECTORAL SALINE IMPLANT IDENTIFIED RIGHT CAPSULAR INFOLDING - CAPSULAR CONTRACTURES IDENTIFIED SMALL-MODERATE VOLUME FLUID SEEN AROUND IMPLANT ADDITIONALLY PATIENT REPORTS HEALTH PROFESSIONAL ITCHING RIGHT BREAST PATIENT MASTECTOMY TEN YEARS AGO POST OP PATIENT MILD INFECTION RESOLVED ANTIBIOTICS PATIENT RECENTLY DIAGNOSED SUPRACLAVICULAR AXILLARY LYMPHADENOPATHY RECENT PET SHOWED ENLARGED RIGHT EPITROCHLEAR LYMPH NODE BIOPSY SHOWED HODGKIN LYMPHOMA NODULAR SCLEROSIS BONE MARROW BIOPSY NEGATIVE LYMPHOMA PATIENT TREATED ABVD SUBSEQUENT SPECIMENS REVIEW PERI-PROSTHETIC FLUID RIGHT CHEST REPORTED ATYPICAL LYMPHOID CELLS CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA PERIPROSTHETIC FLUID SUBSEQUENT EXCISIONAL BIOPSY RIGHT BREAST CAPSULE IMMUNOHISTOCHEMICAL STAINS SHOW ATYPICAL LYMPHOID CELLS POSITIVE CD15 CD30 FINDINGS RAISE POSSIBILITY HODGKINS LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL EVENT CAPTURED LYMPHOMA DEVICE REMOVED PATIENT PARTIAL CAPSULECTOMY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/07/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3165371|62391233|D|1||HEALTH PROFESSIONAL REPORTED  Â¿A SUBPECTORAL SALINE IMPLANT IDENTIFIED RIGHT CAPSULAR INFOLDING Â¿ CAPSULAR CONTRACTURES IDENTIFIED SMALL-MODERATE VOLUME FLUID SEEN AROUND IMPLANTÂ¿ ADDITIONALLY PATIENT REPORTS HEALTH PROFESSIONAL Â¿ITCHING RIGHT BREASTÂ¿PATIENT MASTECTOMY TEN YEARS AGOÂ¿POST OP PATIENT MILD INFECTION RESOLVED ANTIBIOTICSÂ¿ PATIENT RECENTLY DIAGNOSED SUPRACLAVICULAR AXILLARY LYMPHADENOPATHY Â¿RECENT PET SHOWED Â¿ENLARGED RIGHT EPITROCHLEAR LYMPH NODEÂ¿ BIOPSY SHOWED Â¿HODGKIN LYMPHOMA NODULAR SCLEROSIS BONE MARROW BIOPSY NEGATIVE LYMPHOMA PATIENT TREATED ABVD SUBSEQUENT SPECIMENS REVIEW PERI-PROSTHETIC FLUID RIGHT CHEST REPORTED ATYPICAL LYMPHOID CELLS CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA PERIPROSTHETIC FLUID SUBSEQUENT EXCISIONAL BIOPSY RIGHT BREAST CAPSULE IMMUNOHISTOCHEMICAL STAINS SHOW ATYPICAL LYMPHOID CELLS POSITIVE CD15 CD30 FINDINGS RAISE POSSIBILITY HODGKINÂ¿S LYMPHOMAÂ¿ PATHOLOGICAL MARKERS CONFIRM ALCL EVENT CAPTURED LYMPHOMA DEVICE REMOVED PATIENT PARTIAL CAPSULECTOMY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/07/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3487123|4026308|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA B-SYMPTOMS VIA MW B4 MW NOTES REPORTER CALLED BEHALF PT DIAGNOSED ALCL PT PRESENTED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED 2013 HISTORY HODGKINS LYMPHOMA DIAGNOSED 2011 TWO EVENTS CAME PT UNDERWENT BREAST AUGMENTATION 1994 2010 PT PRESENTED ABNORMAL MAMMOGRAM PERFORMED 2010 BREAST PAIN SKIN COLOR CHANGE SKIN TEXTURE CHANGE INFLOWING DIFFUSION RIGHT BREAST RIGHT CHECK SHOULDER PT RUNNING FEVER THROUGHOUT ENTIRE PROCESS MRI SUBSEQUENT TESTS PT DIAGNOSED HODGKINS LYMPHOMA UNDERWENT MANTLE RADIATION 2012 PT UNDERWENT SURGERY ESSENTIALLY BREAST MASS PT ALSO DESIRED MASTECTOMY REMOVAL RIGHT LEFT IMPLANTS CAPSULES PATHOLOGY OPERATION SOON REPORTED PT ALSO ALCL MASS COME LYMPHOMA|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/07/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3405834|62723956|D|1||ADDITIONAL INFORMATION REPORTED JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT CASE REPORT REVIEW LITERATURE DETORRES ET AL  REPORTS PRACTICAL ONCOLOGY RADIOTHERAPY 18 2013 DEVELOPED FOLLOW AXILLARY LYMPH NODE EXCISIONAL BIOPSY NODE SHOWED ALK NEGATIVE ALCL PET-TAC SHOWS FOCAL INCREASED FDG UPTAKE LEFT AXILLAR REGION BREAST PROSTHETIC FLUID AREA PATHOLOGICAL FINDINGS PATIENT RECEIVED 4 CYCLES CHOP CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE CHEMOTHERAPY PROSTHESES REMOVED PATIENT RECEIVED POSTOPERATIVE ADJUVANT RADIOTHERAPY CHEST WALL REGIONAL LYMPH NODES TOTAL DOSE 36 GY PATHOLOGY FOLLOW-UP CONFIRMING CD30+ THEREFORE EVENT REMAIN REPORTABLE LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/04/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3405834|62724174|D|1||RECEIVED ARTICLE PRODUCT WATCH ENTITLED ALCL ASSOCIATED BREAST IMPLANT CASE REPORT REVIEW LITERATURE WRITTEN DETORRES ET AL WITHIN ARTICLE NOTED PATIENT SEROMA LYMPHOMA MANUFACTURER DEVICE UNKNOWN ADDITIONAL INFORMATION REPORTED JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT CASE REPORT REVIEW LITERATURE DETORRES ET AL REPORTS PRACTICAL ONCOLOGY RADIOTHERAPY 18 2013 DEVELOPED FOLLOW AXILLARY LYMPH NODE EXCISIONAL BIOPSY NODE SHOWED ALK NEGATIVE ALCL PET-TAC SHOWS FOCAL INCREASED FDG UPTAKE LEFT AXILLAR REGION BREAST PROSTHETIC FLUID AREA PATHOLOGICAL FINDINGS PATIENT RECEIVED 4 CYCLES CHOP CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE CHEMOTHERAPY PROSTHESES REMOVED PATIENT RECEIVED POSTOPERATIVE ADJUVANT RADIOTHERAPY CHEST WALL REGIONAL LYMPH NODES TOTAL DOSE 36 GY PATHOLOGY FOLLOW-UP CONFIRMING CD30+ THEREFORE EVENT REMAIN REPORTABLE LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/04/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3031007|3327052|D|1||REPORTED ANAPLASTIC LARGE CELL LYMPHOMA CONTRACTURE ASSOCIATED ASYMMETRY RESEARCH ARTICLE PUBLISHED 2008 AMERICAN JOURNAL SURGICAL PATHOLOGY WONG ET AL ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT CAPSULE CASE REPORT REVIEW LITERATURE EVENT SUBMITTED INITIALLY VIA B6 Q4 B6 2008 B6 2010 B6 2011|STYLE 168 SALINE FILLED BREAST IMPLANT|UNK STYLE 168|11/29/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3023802|10610793|N|1||B4 DEVICE LABELLING ADDRESSES SEROMA ALCL ANAPLASTIC LARGE CELL LYMPHOMA BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMENT PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFO FDAS ANALYSIS REVIEW ALCL PTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSAND PROSTHETICSBREASTIMPLANTSUCM239995HTM|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410360|03/26/2013|||DA|N|R||0HP|FTR|1.0|10/03/2012|nan||1507531|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3340784|3809032|D|1||ANAPLASTIC LARGE CELL LYMPHOMA|SALINE MAMMARY PROSTHESIS|350-16XX|01/09/2013||||N|R||0HP|FWM|1.0||BREAST IMPLANT|||||IRVING|US|MENTOR||TX|||||True
3134127|10793581|N|1||B4 B4 LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA ALCL ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANT CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM R CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFORMATION FDAS ANALYSIS REVIEW ALCL PTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSETHETICSBREASTIMPLANTSUCM239995HTM 410 LABELING ADDRESSES CAPSULAR CONTRACTURE CAPSULAR CONTRACTURE - PTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PTS PRIMARY AUGMENTATION RECONSTRUCTION PTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT RUPTURE ONE COMMON REASONS REOPERATION B4 LABELING ADDRESSES SEROMA ADDITIONAL COMPLICATIONS - BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME PAIN HEMATOMASEROMA CHANGES NIPPLE BREAST SENSATION IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134127|61102729|D|1||ADDITIONAL INFORMATION NOTED ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA BREAST ARISING AROUND MAMMARY IMPLANT CAPSULE- B6 REPORT WRITTEN AESTHETIC PLASTIC SURGERY 2013 ARTICLE NOTES REGARDING RIGHT SIDE REVIEW PREVIOUS SPECIMENS PERFORMED PREVIOUS TISSUE SAMPLES SHOWED INFLAMMATORY PROCESS HOWEVER SMALL AREA LARGE CELL LYMPHOMA FOUND ADDITIONAL NOTE RIGHT SIDE INTRACAPSULAR ROUND LESION 04 CM DIAMETER PRESENT CHEST WALL CLOSE PARASTERNAL LINE SPECIFIED PARASTERNAL NODULE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134127|3458905|D|1||ANAPLASTIC LARGE CELL LYMPHOMA BREAST ARISING AROUND MAMMARY IMPLANT CAPSULE B6 REPORT WRITTEN B4 REPORTS ALCL SEROMA CAPSULAR CONTRACTURE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134124|61099626|D|1||ADDITIONAL INFORMATION NOTED ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA BREAST ARISING AROUND MAMMARY IMPLANT CAPSULE ITALIAN REPORT WRITTEN AESTHETIC PLASTIC SURGERY 2013 ARTICLE NOTES REGARDS RIGHT SIDE NECROSIS CHRONIC INFLAMMATION SIGNS PRESENT SKIN IMPLANT BECAME RED PAINFUL PATIENT FEBRILE EPISODES TREATMENT NOTED EVENT SEROMA BROAD-SPECTRUM ANTIBIOTIC|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134124|18173802|N|1||B4 410 DEVICE LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA ALCL ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANT CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM ER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFORMATION FDAS ANALYSIS REVIEW ALCL PTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICAL DEVICESPRODUCTSAND MEDICALPROCEDURESIMPLANTSANDPROSETHETICSBREASTIMPLANTSUCM239995HTM 410 LABELING ADDRESSES SEROMA PAIN ADDITIONAL COMPLICATIONS - BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME PAIN HEMATOMASEROMA CHANGES NIPPLE BREAST SENSATION IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3134124|17839593|D|1||ANAPLASTIC LARGE CELL LYMPHOMA BREAST ARISING AROUND MAMMARY IMPLANT CAPSULE B6 REPORT WRITTEN AESTHETIC PLASTIC SURGERY 2013 REPORTS ALCL SEROMA PAIN|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3030984|3326574|D|1||RESEARCH REVIEW RN PRODUCT SUPPORT SPECIALIST FOLLOWING ARTICLE CAME ATTENTION ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING BREAST ARCH PATHOLOGY LAB MEDICAL JOURNAL- VOL 133 SEP 2009 WITHIN ARTICLE AUTHOR NOTES SEROMA LYMPHOMA ADDL INFO ARTICLE ENTITLE BREAST IMPLANT CAPSULE-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIC-ALCL DIAGNOSTIC PATHOLOGY JOURNAL NEW EVENTS REPORT|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|11/29/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3487125|4004895|D|1||HEALTHCARE PROFESSIONAL REPORTS VIA B4 CASE LATE SEROMA LYMPHOMA REPORT COMES UNIDENTIFIED HEALTHCARE PROFESSIONAL B4 NOTES MAY CONCERN PURSUANT PARTNERSHIP FDA CONCERNING BREAST IMPLANT-ASSOCIATED ALCL REPORTING CASE ALCL ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT PT FIRST PRESENTED BREAST AUGMENTATION SEVERAL YEARS PRIOR NOTICED SWELLING LEFT BREAST EVENTUALLY BECAME PAINFUL CAUSED SEEK TREATMENT WORKUP EVENTUALLY REVEALED SEROMA AROUND BREAST IMPLANT FLUID CAME BACK CD 30 POSITIVE ALK NEGATIVE CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA IMPLANTS REMOVED BILATERALLY FELT ADEQUATE TREATMENT PROBLEM CONTINUES UNDERGO SURVEILLANCE US ADDITION HEMATOLOGYONCOLOGY TEAM NOTE FOUND NONRUPTURED 410 CC TEXTURED SILICONE IMPLANT MAY CUI AVAILABLE UNITED STATES PTS CARE COORDINATED PLASTIC SURGERY HEMATOLOGYONCOLOGY TEAMS BREAST IMPLANTS REMOVED REPLACED PT UNDERGO SURVEILLANCE MRI ULTRASOUND|UNK CUI GEL|UNK CUI GEL|11/07/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3011109|3312625|D|1||RECEIVED MW B4 WITHOUT SOURCE INFORMATION WITHIN MW NOTES ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED LEFT BREAST PT STYLE 468 TEXTURED SALINE BREAST IMPLANT MCGHAN EXPLANT DATE NOTED B6 2012 INFORMATION COMPLETE INVESTIGATION EVENT HOWEVER INFORMATION BECOMES AVAILABLE FILE REVIEWED SUBMITTED|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|03/13/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3390404|3798157|D|1||BILATERAL SUBGLANDULAR TEXTURED SILICONE GEL BREAST IMPLANTS IMPLANTED 15 YEARS AGO RECENT DEVELOPMENT 700 CC OPAQUE PERI-IMPLANT SEROMA CAPSULAR THICKENING INF LEFT BREAST STATUS POST BILATERAL IMPLANT EXPLANTATION BILATERAL CAPSULECTOMY DIAGNOSIS LEFT BREAST IMPLANT- ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ALCL LEFT BREAST CAPSULECTOMY PATHOLOGICAL SPECIMEN L BREAST SEROMA FLUID POSITIVE ALCL CELLS FOLLOWING REPEAT BILATERAL CAPSULECTOMY DIAGNOSIS BILATERAL BREAST AUGMENTATIONCOSMESIS|TEXTURED SILICONE GEL IMPLANT 220CC||10/02/2013||||N|||000|FTR|1.0||BREAST IMPLANTS|||||||MCGHAN|||||||True
3095897|22114235|D|1||PT BREAST CANCER 6 YEARS AGO UNDERWENT UNILATERAL MASTECTOMY EXPANDER RADIATION EXPANDER LATER REMOVED PERMANENT SILICONE IMPLANT PLACED MENTOR 450CC HIGH PROFILE SILICONE TEXTURED GEL CONTRALATERAL MASTOPEXY SYMMETRY SAW RECENTLY ASYMMETRIC BREASTS OPERATED COUPLE WEEKS AGO B6 2013 LARGE SEROMA FIBRINOUS GELATINOUS TISSUE IMPLANT SENT CYTOLOGY PATHOLOGY CULTURE CAME BACK ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANTS CYTOLOGY GELATINOUS TISSUE BACTERIA IDENTIFIED FAR KNOW 34 CONFIRMED CASES FDA USA LETTING FDA MENTOR KNOW SITUATION UNFORTUNATELY SMART ENOUGH SAVE IMPLANT WEEKS AGO SURGERY PLAN TAKING BACK OPERATING ROOM NEW IMPLANT REMOVAL CAPSULECTOMY SEEING ONCOLOGIST WELL|MENTOR SILTEX BREAST IMPLANT|354-4450|04/30/2013||||N|||0HP|FTR|1.0||SILTEX BREAT IMPLANT, 450CC HIGH PROFILE TEXTURED GEL||5769207|||||MENTOR|||||354-4450||True
3428755|21496558|D|1||ALCL CASE REPORT PT B6 PRESENTED LATE SEROMA CAPSULAR CONTRACTURE PAIN RIGHT BREAST B6 2013 PT DELAYED SURGICAL INTERVENTION SEROMA TEMPORARILY BETTER PHYSICIAN INSISTED INTERVENTION DEVICE REMOVED B6 2013 DIAGNOSIS B6 2013 RIGHT BREAST SEROMA FLUID - MALIGNANT CELLS PRESENT FLUID CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA LARGE CELLS NOTED OUTSIDE FIBROUS CAPSULE CAPSULAR INVASION EXTRACAPSULAR EXTENSION NOTED|SILICONE GEL - FILLED TEXTURED BREAST IMPLANT|20621-525U|10/18/2013|||DA|N|R||0HP|FTR|1.0|04/01/2008|nan|||11220 GRADER ST|STE 100|DALLAS|US|SILIMED|75238|TX|75238||20621||True
3170177|21675522|D|1||REPORTER CALLED BEHALF PT DIAGNOSED ALCL PT PRESENTED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED B6 2013 HISTORY HODGKINS LYMPHOMA DIAGNOSED B6 2011 TWO EVENTS CAME PT UNDERWENT BREAST AUGMENTATION 1994 REPORT FILED RESPONSE FOLLOWING REPORT WWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTUCM239995HTM 2010 PT PRESENTED ABNORMAL MAMMOGRAM DONE B6 2010 BREAST PAIN SKIN COLOR CHANGE SKIN TEXTURE CHANGE INFLOWING DIFFUSION RIGHT BREAST RIGHT NECK SHOULDER PT RUNNING FEVER THROUGHOUT ENTIRE PROCESS MRI SUBSEQUENT TESTS PT DIAGNOSED HODGKINS LYMPHOMA UNDERWENT MANTLE RADIATION B6 2012 PT UNDERWENT SURGERY ESSENTIALLY BREAST MASS PT ALSO DESIRED MASTECTOMY REMOVAL RIGHT LEFT IMPLANTS CAPSULES PATHOLOGY OPERATION SOON REPORTED PT ALSO ALCL MASS COME LYMPHOMA|MCGHAN 420 CC BREAST IMPLANTS (RIGHT & LEFT)||06/13/2013|||||||0|FWM|1.0||SALINE BREAST IMPLANT|||||||MCGHAN|||||||True
3269181|3756340|D|1||SUDDEN ONSET SWELLING LATE SEROMA LEFT BREAST IMPLANT RECONSTRUCTION PREVIOUSLY 2-STAGE BREAST RECONSTRUCTION PLACEMENT BILATERAL TISSUE EXPANDERS B6 2005 MCGHAN REF 67-133LV13 EXPANDERS LEFT SN B4 LOT 623514 RIGHT SN B4 LOT 1030255 IMPLANTS PLACED B6 2005 INAMED REF 27-FF125-375 LEFT SN B4 LOT 335112 RIGHT SN B4 LOT 380839 PRESENTATION LATE SEROMA ALMOST 8 YRS IMPLANT PLACEMENT SEROMA FLUID ASPIRATED ULTRASOUND GUIDANCE POSITIVE MALIGNANT CELL ANAPLASTIC LARGE CELL LYMPHOMA ALCL INPATIENT SURGERY REMOVAL BILATERAL BREAST IMPLANTS TOTAL CAPSULECTOMIES PERFORMED PATHOLOGY REVEALED ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING EXTENDING BEYOND LEFT CAPSULE CONTRALATERAL RIGHT SIDE SEROMA FLUID AROUND TIME SURGERY FLUID SENT CYTOLOGY ALSO FOUND POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA EVIDENCE DISTANT DISEASE TISSUE EXPANDERS USED 1ST STAGE BREAST RECONSTRUCTION PRIOR PLACEMENT IMPLANT EXPANDERS PLACED B6 2005 REMOVED B6 2005 FINAL IMPLANTS PLACED EXPANDERS MCGHAN 133LV INAMED EXPANDERS REFERENCECATALOG 76-133LV13 SERIAL NUMBERS LOT NUMBERS DESCRIBED INITIAL NARRATIVE EVENT REASON USE 1 - POSTMASTECTOMY BREAST RECONSTRUCTION 2 - POSTMASTECTOMY BREAST RECONSTRUCTION EVENT ABATED USE STOPPED DOSE REDUCED 1 - YES 2 - YES|410FF BREAST IMPLANT LEFT|27-FF125-375|08/01/2013||||Y|||0LP|FWM|1.0||BREAST IMPLANT, HIGHLY-TEXTURED FORM-STABLE||335112|||||INAMED|||||||True
3269181|3756340|D|1||SUDDEN ONSET SWELLING LATE SEROMA LEFT BREAST IMPLANT RECONSTRUCTION PREVIOUSLY 2-STAGE BREAST RECONSTRUCTION PLACEMENT BILATERAL TISSUE EXPANDERS B6 2005 MCGHAN REF 67-133LV13 EXPANDERS LEFT SN B4 LOT 623514 RIGHT SN B4 LOT 1030255 IMPLANTS PLACED B6 2005 INAMED REF 27-FF125-375 LEFT SN B4 LOT 335112 RIGHT SN B4 LOT 380839 PRESENTATION LATE SEROMA ALMOST 8 YRS IMPLANT PLACEMENT SEROMA FLUID ASPIRATED ULTRASOUND GUIDANCE POSITIVE MALIGNANT CELL ANAPLASTIC LARGE CELL LYMPHOMA ALCL INPATIENT SURGERY REMOVAL BILATERAL BREAST IMPLANTS TOTAL CAPSULECTOMIES PERFORMED PATHOLOGY REVEALED ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING EXTENDING BEYOND LEFT CAPSULE CONTRALATERAL RIGHT SIDE SEROMA FLUID AROUND TIME SURGERY FLUID SENT CYTOLOGY ALSO FOUND POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA EVIDENCE DISTANT DISEASE TISSUE EXPANDERS USED 1ST STAGE BREAST RECONSTRUCTION PRIOR PLACEMENT IMPLANT EXPANDERS PLACED B6 2005 REMOVED B6 2005 FINAL IMPLANTS PLACED EXPANDERS MCGHAN 133LV INAMED EXPANDERS REFERENCECATALOG 76-133LV13 SERIAL NUMBERS LOT NUMBERS DESCRIBED INITIAL NARRATIVE EVENT REASON USE 1 - POSTMASTECTOMY BREAST RECONSTRUCTION 2 - POSTMASTECTOMY BREAST RECONSTRUCTION EVENT ABATED USE STOPPED DOSE REDUCED 1 - YES 2 - YES|410FF BREAST IMPLANT RIGHT|27-FF125-375|08/01/2013||||Y|||0LP|FWM|2.0||BREAST IMPLANT, HIGHLY-TEXTURED FORM-STABLE||380839|||||INAMED|||||||True
3269181|3756340|D|1||SUDDEN ONSET SWELLING LATE SEROMA LEFT BREAST IMPLANT RECONSTRUCTION PREVIOUSLY 2-STAGE BREAST RECONSTRUCTION PLACEMENT BILATERAL TISSUE EXPANDERS B6 2005 MCGHAN REF 67-133LV13 EXPANDERS LEFT SN B4 LOT 623514 RIGHT SN B4 LOT 1030255 IMPLANTS PLACED B6 2005 INAMED REF 27-FF125-375 LEFT SN B4 LOT 335112 RIGHT SN B4 LOT 380839 PRESENTATION LATE SEROMA ALMOST 8 YRS IMPLANT PLACEMENT SEROMA FLUID ASPIRATED ULTRASOUND GUIDANCE POSITIVE MALIGNANT CELL ANAPLASTIC LARGE CELL LYMPHOMA ALCL INPATIENT SURGERY REMOVAL BILATERAL BREAST IMPLANTS TOTAL CAPSULECTOMIES PERFORMED PATHOLOGY REVEALED ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING EXTENDING BEYOND LEFT CAPSULE CONTRALATERAL RIGHT SIDE SEROMA FLUID AROUND TIME SURGERY FLUID SENT CYTOLOGY ALSO FOUND POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA EVIDENCE DISTANT DISEASE TISSUE EXPANDERS USED 1ST STAGE BREAST RECONSTRUCTION PRIOR PLACEMENT IMPLANT EXPANDERS PLACED B6 2005 REMOVED B6 2005 FINAL IMPLANTS PLACED EXPANDERS MCGHAN 133LV INAMED EXPANDERS REFERENCECATALOG 76-133LV13 SERIAL NUMBERS LOT NUMBERS DESCRIBED INITIAL NARRATIVE EVENT REASON USE 1 - POSTMASTECTOMY BREAST RECONSTRUCTION 2 - POSTMASTECTOMY BREAST RECONSTRUCTION EVENT ABATED USE STOPPED DOSE REDUCED 1 - YES 2 - YES|MCGHAN BREAST IMPLANT RIGHT|67-133LV13|08/01/2013||||Y|||0LP|FWM|4.0||BREAST IMPLANT||1030255|||||MCGHAN|||||||True
3269181|3756340|D|1||SUDDEN ONSET SWELLING LATE SEROMA LEFT BREAST IMPLANT RECONSTRUCTION PREVIOUSLY 2-STAGE BREAST RECONSTRUCTION PLACEMENT BILATERAL TISSUE EXPANDERS B6 2005 MCGHAN REF 67-133LV13 EXPANDERS LEFT SN B4 LOT 623514 RIGHT SN B4 LOT 1030255 IMPLANTS PLACED B6 2005 INAMED REF 27-FF125-375 LEFT SN B4 LOT 335112 RIGHT SN B4 LOT 380839 PRESENTATION LATE SEROMA ALMOST 8 YRS IMPLANT PLACEMENT SEROMA FLUID ASPIRATED ULTRASOUND GUIDANCE POSITIVE MALIGNANT CELL ANAPLASTIC LARGE CELL LYMPHOMA ALCL INPATIENT SURGERY REMOVAL BILATERAL BREAST IMPLANTS TOTAL CAPSULECTOMIES PERFORMED PATHOLOGY REVEALED ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING EXTENDING BEYOND LEFT CAPSULE CONTRALATERAL RIGHT SIDE SEROMA FLUID AROUND TIME SURGERY FLUID SENT CYTOLOGY ALSO FOUND POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA EVIDENCE DISTANT DISEASE TISSUE EXPANDERS USED 1ST STAGE BREAST RECONSTRUCTION PRIOR PLACEMENT IMPLANT EXPANDERS PLACED B6 2005 REMOVED B6 2005 FINAL IMPLANTS PLACED EXPANDERS MCGHAN 133LV INAMED EXPANDERS REFERENCECATALOG 76-133LV13 SERIAL NUMBERS LOT NUMBERS DESCRIBED INITIAL NARRATIVE EVENT REASON USE 1 - POSTMASTECTOMY BREAST RECONSTRUCTION 2 - POSTMASTECTOMY BREAST RECONSTRUCTION EVENT ABATED USE STOPPED DOSE REDUCED 1 - YES 2 - YES|MCGHAN BREAST IMPLANT LEFT|67-133LV13|08/01/2013||||Y|||0LP|FWM|3.0||BREAST IMPLANT||623514|||||MCGHAN|||||||True
3199749|10822419|N|1||MEDWATCH SUBMITTED 05202013 ALLERGAN LABELING ADDRESSES EVENT BREAST LUMPS FOLLOWS BREAST SELF-EXAMINATIONS FOLLOWING BREAST AUGMENTATION CONTINUE PERFORM BREAST SELF-EXAMINATION MONTHLY MAY DIFFICULT BREAST IMPLANT PLACE CONTINUE PERFORM MONTHLY BREAST SELF EXAMINATION EFFICIENTLY ASK SURGEON HELP IDENTIFY DIFFERENCE IMPLANT BREAST TISSUE ABLE IDENTIFY IMPLANT BREAST TISSUE DECREASE NECESSITY EXCESSIVE SQUEEZING IMPLANT EXAMINATION NEW LUMPS EVALUATED BIOPSY APPROPRIATE BIOPSY PERFORMED SURE INFORM MEDICAL PROFESSIONAL PERFORMING BIOPSY BREAST IMPLANTS CARE TAKEN AVOID INJURING IMPLANT 410 DEVICE LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA ALCL BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL COMPLETE UP-TO-DATE INFO FDAS ANALYSIS REVIEW ALCL PTS BREAST IMPLANTS PLEASE VISIT HTTPWWWFDAGOVMEDICALDEVICESPRODUCTSANDMEDICALPROCEDURESIMPLANTSANDPROSTHETICSBREASTIMPLANTSUCM239995HTM|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-378|05/20/2013|||DA|N|R||0HP|FTR|1.0|04/24/2011|nan||1267625|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2933318|3225696|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED LETTER REPORTING PT BILATERAL BREAST AUGMENTATION MCGHAN SALINE IMPLANTS DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA LIMITED INFO AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFO OBTAINED HOWEVER ADDL INFO DEVICE INFO IMPLANTINGEXPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL FILE REVIEWED UPDATED|CUI TEXTURED SALINE FILLED BREAST IMPLANT|UNK STYLE RTV|01/25/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
2933317|17460937|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED LETTER REPORTING PATIENT UNDERWENT BREAST AUGMENTATION SURGERY ALLERGAN SALINE FILLED BREAST IMPLANTS DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA LIMITED INFORMATION AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFORMATION OBTAINED HOWEVER ADDITIONAL INFORMATION DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL FILE REVIEWED UPDATED|STYLE 168 SALINE FILLED BREAST IMPLANT|UNK STYLE 168|01/23/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2903656|3063201|D|1||ALCL CASE REPORT DIAGNOSIS ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA CD30+ SP LEFT AXILLARY LN BIOPSY 52110 PT B6 FEMALE STAGE IV ALK NEGATIVE ANAPLASTIC LARGE-CELL LYMPHOMA DIAGNOSED B6 2010 CURRENTLY UNDERGOING CHEMOTHERAPY FOLLOWED ONCOLOGY BILATERAL BREAST AUGMENTATION SILICONE IMPLANTS 30 YEARS AGO RUPTURE RIGHT SIDE IMPLANTS REMOVED REPLACED 2005 LOCAL PLASTIC SURGEON STATES SUBPECTORAL INFRAMAMMARY FOLD INCISION BELIEVES RIGHT IMPLANT 325 CC LEFT 350 CC ONE RECENT CT SCANS PERFORMED LYMPHOMA STAGING APPEARED EVIDENCE RUPTURE RIGHT BREAST IMPLANT REMOVED IMPLANTS B6 2012 REPLACED DUE POSSIBLE LINK BREAST IMPLANTS ALCL|INAMED||12/28/2012|||||||0HP|FTR|2.0||SILICONE BREAST IMPLANT||NONE|||IRVINE|US|ALLERGAN||CA|||STYLE 110|REF# 110-390|True
2903656|3063201|D|1||ALCL CASE REPORT DIAGNOSIS ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA CD30+ SP LEFT AXILLARY LN BIOPSY 52110 PT B6 FEMALE STAGE IV ALK NEGATIVE ANAPLASTIC LARGE-CELL LYMPHOMA DIAGNOSED B6 2010 CURRENTLY UNDERGOING CHEMOTHERAPY FOLLOWED ONCOLOGY BILATERAL BREAST AUGMENTATION SILICONE IMPLANTS 30 YEARS AGO RUPTURE RIGHT SIDE IMPLANTS REMOVED REPLACED 2005 LOCAL PLASTIC SURGEON STATES SUBPECTORAL INFRAMAMMARY FOLD INCISION BELIEVES RIGHT IMPLANT 325 CC LEFT 350 CC ONE RECENT CT SCANS PERFORMED LYMPHOMA STAGING APPEARED EVIDENCE RUPTURE RIGHT BREAST IMPLANT REMOVED IMPLANTS B6 2012 REPLACED DUE POSSIBLE LINK BREAST IMPLANTS ALCL|INAMED||12/28/2012||10/01/2012||R|||0HP|FTR|1.0||SILICONE BREAST IMPLANT||NONE|||IRVINE|US|ALLERGAN||CA|||STYLE 110|REF# 110-420|True
2930345|17450111|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED LETTER REPORTING PATIENT BILATERAL BREAST AUGMENTATION MCGHAN SILICONE GEL FILLED BREAST IMPLANTS DIAGNOSED CB-30 POSITIVE ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA LIMITED INFORMATION AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFORMATION OBTAINED HOWEVER ADDITIONAL INFORMATION DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL FILE REVIEWED UPDATED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|01/22/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA||||NI|True
3070387|3264818|D|1||MAY CONCERN PURSUANT PARTNERSHIP FDA B4 CONCERNING BREAST IMPLANT-ASSOCIATED ALCL REPORTING CASE ALCL ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT PT B6 FEMALE FIRST PRESENTED LAST B6 BREAST AUGMENTATION B6 SEVERAL YEARS PRIOR NOTICED SWELLING LEFT BREAST EVENTUALLY BECAME PAINFUL CAUSED SEEK TREATMENT WORKUP EVENTUALLY REVEALED SEROMA AROUND BREAST IMPLANT FLUID CAME BACK CD 30 POSITIVE ALK NEGATIVE CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA IMPLANTS REMOVED BILATERALLY FELT ADEQUATE TREATMENT PROBLEM CONTINUES UNDERGO SURVEILLANCE US ADDITION HEMATOLOGYONCOLOGY TEAM NOTE FOUND NONRUPTURED 410 CC TEXTURED SILICONE IMPLANTS MADE CUI AVAILABLE UNITED STATES PTS CARE COORDINATED PLASTIC SURGERY HEMATOLOGYONCOLOGY TEAMS B6 BREAST IMPLANTS REMOVED REPLACED PT UNDERGO SURVEILLANCE MRI ULTRASOUND|TEXTURED SILICONE BREAST IMPLANT||04/16/2013|||DA|N|||0HP|FTR|1.0||TESTURED SILICONE BREAST IMPLANT, 410 CC||UNK|||||COX-UPHOFF INTERNATIONAL|||||||True
3530889|61048210|D|1||ALLERGAN LEGAL REPORTED DIFFUSE EXTRAVASATED FLUID NOTED AROUND RIGHT BREAST IMPLANT CONSISTENT LEAK CYTOLOGY NOTES FLUID PERCUTANEOUS ASPIRATE RIGHT BREAST FLUID COLLECTION POSITIVE MALIGNANT CELLS ANAPLASTIC LARGE CELL LYMPHOMA  FLUID SEEN AROUND IMPLANT DEEMED SEROMA ADDITIONAL EVENT REPORTED DIAGNOSIS CELIAC DISEASE TREATMENT SPECIFIED MEDICATION SYMPTOMS CELIAC DISEASE MEDWATCH RIGHT SIDE SEE MFR REPORT  2024601-2013-00971 LEFT SIDE|STYLE 468 SALINE FILLED BREAST IMPLANT|468-495|12/17/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|71 SOUTH LOS CARNEROS ROAD||GOLETA|US|ALLERGAN|93117|CA|93117||||True
3519392|3961243|D|1||RECEIVED REPORT ALCL VIA B4 LIMITED INFORMATION NOTED FORM STATES ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED LEFT BREAST PATIENT STYLE 468 TEXTURED SALINE BREAST IMPLANT B6 CONTACT INFORMATION PROVIDED THEREFORE INVESTIGATION ABLE PERFORMED TIME|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|12/03/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2933302|3232091|D|1||ALLERGANS LEGAL DEPARTMENT RECEIVED LETTER REPORTING PATIENT UNDERWENT BREAST AUGMENTATION SURGERY IMPLANTATION GEL FILLED IMPLANT DIAGNOSED SEROMA ASSOCIATED PRIMARY ANAPLASTIC LARGE CELL LYMPHOMA ADJACENT IMPLANT LIMITED INFORMATION AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFORMATION OBTAINED HOWEVER ADDITIONAL INFORMATION DEVICE INFORMATION IMPLANTINGEXPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL FILE REVIEWED UPDATED|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|01/23/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3474087|17927884|D|1||TEXTURED SILICONE BREAST IMPLANT DEVELOPMENT ALK-1 NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA BREAST ADDITIONAL INFO DATES USE 17 YEARS DIAGNOSIS REASON USE RECONSTRUCTIVE COSMETIC BREAST IMPLANT PRIOR MASTECTOMIES|BREAST IMPLANT, TEXTURED SILICONE||11/13/2013||||Y|||0HP|FTR|1.0||BREAST IMPLANT|||||||UNK|||||||True
3031001|3257910|D|1||REPORTED ANAPLASTIC LARGE CELL LYMPHOMA RESEARCH ARTICLE PUBLISHED 2008 AMERICAN JOURNAL SURGICAL PATHOLOGY ENTITLED ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT CAPSULE CASE REPORT REVIEW LITERATURE FOLLOW-UP FINDINGS DOCTOR STATES ALLERGAN DEVICE UNABLE EXONERATE DEVICE INSUFFICIENT STUDY EVIDENCE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|11/29/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA, NE|US|ALLERGAN||CA|||||True
2960519|3138896|D|1||PT BILATERAL SILICONE IMPLANTS PLACED B6 1970S AUGMENTATION ISSUES SILICONE LEAK 1990S REMOVAL BILATERAL IMPLANTS REMOVAL FIBROTIC FIRM TISSUE CAPSULE LEFT 2008 PRESENTED NEW PALPABLE MASS LEFT BREAST PARENCHYMA B6 2013 PERFORMED CORE BIOPSY PALPABLE MASS HYPOECHOIC CONCERNING BEDSIDE ULTRASOUND BIOPSY RESULTS SHOW ANAPLASTIC LARGE CELL LYMPHOMA|UNKNOWN||02/07/2013||||N|||0|FTR|1.0||SILICONE BREAST IMPLANT|||UNK||UNK||UNK|||||||True
3738245|4226865|D|1||EXPLANTING PHYSICIAN REPORTS MASSIVE SEROMA TIME SURGERY LARGE SEROMA THICKENED CAPSULE FOUND IMPLANT INTACT HISTOLOGY IMPLANT CAPSULE SHOWED ANAPLASTIC LARGE CELL LYMPHOMA ORIGINAL IMPLANT FOLLOWING MASTECTOMY CYTOLOGY PATHOLOGY CONFIRMATION RECD LIMITED INFORMATION TIME INFORMATION BECOMES AVAILABLE REPORTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF155-740|03/31/2014|||DA|N|R||0HP|FTR|1.0|02/15/2004|nan||47173|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3738245|11860603|N|1||DEVICE LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA ALCL BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMAWHEN TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF155-740|03/31/2014|||DA|N|R||0HP|FTR|1.0|02/15/2004|nan||47173|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3642248|4203744|D|1||LITERATURE REVIEW CHEMOTHERAPY-RESISTANT BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA MURALIDHARAN PARTHASARATHY ET AL BMJ CASE REP 2013 ARTICLE REPORTS PT PRESENTING SYMPTOMS DISCOMFORT HARDENING LEFT BREAST EXAM REVEALED VAGUE MASS MEASURING 5 CM UPPER OUTER QUADRANT LEFT BREAST TOGETHER PALPABLE AXILLARY LYMPH NODES THREE YEARS PRIOR PT TREATED SEROMA DRAINED SEROMA NOTED TIME BILATERAL CAPSULAR CONTRACTURE NOTED LEFT RIGHT DIAGNOSTICS CONFIRMED ALCL LEFT BREAST CHEMOTHERAPY TREATMENT CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE PT REASSESSED LEFT BREAST MASS UNCHANGED SECOND LINE CHEMOTHERAPY GIVEN CISPLATIN GEMCITABINE REPEAT CORE BIOPSY CONFIRMED PERSISTENT ALK NEGATIVE ALCL PT LEFT MASTECTOMY REMOVAL LEFT BREAST IMPLANT FOLLOWED RADIATION THERAPY PT SINCE RECOVERED SIGNS RECURRENCE ALTHOUGH MFR DEVICE UNK ALLERGANS APPROACH COMPLIANCE RESOLVE DOUBT FAVOR REPORTING|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/31/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
3642248|55007799|D|1||LITERATURE REVIEW CHEMOTHERAPY-RESISTANT BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA MURALIDHARAN PARTHASARATHY ET AL BMJ CASE REP 2013 ARTICLE REPORTS PATIENT PRESENTING SYMPTOMS DISCOMFORT HARDENING LEFT BREAST EXAM REVEALED VAGUE MASS MEASURING 5 CM UPPER OUTER QUADRANT LEFT BREAST TOGETHER PALPABLE AXILLARY LYMPH NODES THREE YEARS PRIOR PATIENT TREATED SEROMA DRAINED SEROMA NOTED TIME BILATERAL CAPSULAR CONTRACTURE NOTED LEFT RIGHT DIAGNOSTICS CONFIRMED ALCL LEFT BREAST CHEMOTHERAPY TREATMENT CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE PATIENT REASSESSED LEFT BREAST MASS UNCHANGED SECOND LINE CHEMOTHERAPY GIVEN CISPLATIN GEMCITABINE REPEAT CORE BIOPSY CONFIRMED PERSISTENT ALK NEGATIVE ALCL PATIENT LEFT MASTECTOMY REMOVAL LEFT BREAST IMPLANT FOLLOWED RADIATION THERAPY PATIENT SINCE RECOVERED SIGNS RECURRENCE ALTHOUGH MANUFACTURER DEVICE UNKNOWN ALLERGANS APPROACH COMPLIANCE RESOLVE DOUBT FAVOR REPORTING|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/31/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
3896044|4422726|D|1||PT REPORTED RIGHT SIDE LUMP ANAPLASTIC LARGE CELL LYMPHOMA MEDICAL SAFETY TEAM DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CRITERIA DIAGNOSE ALCL LIMITED INFO AVAILABLE CASE INITIAL INVESTIGATION UNLIKELY CHANCE INFO OBTAINED HOWEVER ADDL INFO DEVICE INFO IMPLANTINGEXPLANTING PHYSICIAN LABS RELATED LIMITED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSED ALCL FILE REVIEWED UPDATED|STYLE 168 SALINE FILLED BREAST IMPLANT|168-210|06/12/2014|||DA|N|R||0HP|FWM|1.0|07/27/2012|nan||1643163|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3946570|54659173|D|1||HEALTHCARE PROFESSIONAL REPORTS INCIDENCE ANAPLASTIC LARGE CELL LYMPHOMA ALCL APPEARS ASSOCIATED USE TEXTURED BREAST IMPLANTS ENCOUNTERED 3 CASES WITHIN PAST 3 YEARS 130 CASES REPORTED WORLDWIDE TWO PATIENTS MCGHAN IMPLANTS IE TEXTURING PROCESS ALLERGAN CURRENTLY USE MEDICAL SAFETY TEAM DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL MULTIPLE ATTEMPTS MADE OBTAIN INFORMATION INCLUDING CYTOLOGYPATHOLOGY REPORTS DEVICE INFORMATION ETC IFWHEN ADDITIONAL INFORMATION BECOME AVAILABLE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3946570|4604105|D|1||HEALTHCARE PROFESSIONAL REPORTS INCIDENCE ANAPLASTIC LARGE CELL LYMPHOMA ALCL APPEARS ASSOCIATED USE TEXTURED BREAST IMPLANTS ENCOUNTERED 3 CASES WITHIN PAST 3 YEARS 130 CASES REPORTED WORLDWIDE TWO PTS MCGHAN IMPLANTS IE TEXTURING PROCESS ALLERGAN CURRENTLY USE MEDICAL SAFETY TEAM DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL MULTIPLE ATTEMPTS MADE OBTAIN INFO INCLUDING CYTOLOGYPATHOLOGY REPORTS DEVICE INFO ETC IFWHEN ADDL INFO BECOME AVAILABLE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNK||CA|||||True
3827677|4447620|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA SEROMA WITHIN ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANTS DIAGNOSTIC CYTOPATHOLOGY VOL 00 00 CHAI ET AL REPORTED CASE 52 YO PT HISTORY RECONSTRUCTION FOLLOWING BILATERAL MASTECTOMY BREAST CANCER SIDE CANCER NOTED ARTICLE DEVICE INFO NOTED SILICONE INFO PROVIDED ALSO NOTES PERIPROSTHETIC SWELLING PT UNDERWENT CAPSULECTOMY CHOP CURRENT STATUS NOTED EVIDENCE DISEASE MEDICAL HISTORY NOTED TIME PRESENTATION 35 YEARS CYTOLOGY REPRESENTS POSITIVE CD45 CD4 CD43 CD30 EMA NEGATIVE ALK MFR INFO INFO BECOMES AVAILABLE SUBMITTED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/08/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3827707|22261095|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA SEROMA WITHIN ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANTS DIAGNOSTIC CYTOPATHOLOGY VOL 00 00 CHAI ET AL AUTHOR NOTES 48 YEAR OLD PT HISTORY RECONSTRUCTION FOLLOWING MASTECTOMY BREAST CANCER SIDE CANCER NOTED ARTICLE DEVICE INFO NOTED SILICONE INFO PROVIDED ALSO NOTES PERIPROSTHETIC SWELLINGFLUID PT UNDERWENT CAPSULECTOMY CURRENT STATUS NOTED EVIDENCE DISEASE MEDICAL HISTORY NOTED TIME PRESENTATION 4 YEARS MFR INFO|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/08/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
3895999|16446469|D|1||L BREAST IMPLANTED LARGE CELL LYMPHOMA SP L BREAST IMPLANT PLACEMENT 2003 1998- B6 DIAGNOSED L BREAST CA L LUMPECTOMY RADIATION DONE 2002-L LATISSIMUS DORSI MYOCUTANEOUS FLAP RECONSTRUCTION TISSUE EXPANDER MENTOR REFB4 LOT 248391 R SUBQ MASTECTOMY IMMEDIATE RECONSTRUCTION SALINE IMPLANT MENTOR REFB4 SILTEX CONTOUR PROFILE MAMM PROSTH LOT 251827 SN B4 ADDED 450ML IMPLANT PATH REPORT B6 2002 NEGATIVE CARCINOMA EITHER BREAST B62013 SECOND STAGE RECONSTRUCTION L BREAST EXPANDER REMOVED MCGHAN 163 SALINE IMPLANT PLACED REF B4 SN B4 LOT 582791 380CC PRESENTED DR B6 B6 2014 PAIN SWELLING L BREAST-GRADE IV CAPSULE CONTRACTURE NOTED WISH SCHEDULE SURGERY TIME SECOND CONSULTATION B6 2014 NEW LUMP L BREAST ULTRASOUND MRI L BREAST BIOPSY DONE B6 2014 REMOVED INTACT IMPLANT L BREAST MCGHAN STYLE 163 SALINE TEXTURED IMPLANT L TOTAL CAPSULECTOMY L BREAST PATH REPORT SHOWS ALCL ANAPLASTIC LARGE CELL LYMPHOMA|MCGHAN|27-163361|06/20/2014|||||||0HP|FWM|1.0||SALINE IMPLANT||582791|||SANTA BARBARA||INAMED|93111||93111||STYLE 163||True
3883642|4565748|D|1||ADDITIONAL INFO RECEIVED LITERATURE ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS FIVE AUSTRALIAN CASES PUBLISHED PLASTIC RECONSTRUCTIVE SURGERY B6 2012 PG 610E-617E WITHIN ARTICLE AUTHOR DESCRIBES B6 UNDERWENT BILATERAL AUGMENTATION 110-360 INAMED TEXTURED ROUND DEVICES VIA INFRAMAMMARY SUB GLANDULAR POCKET B6 2008 PT PRESENTED SPONTANEOUS LEFT BREAST SWELLING ALTHOUGH FEVER MILD DISCOMFORT LEFT BREAST DIFFUSELY SWOLLEN PT NORMAL MAMMO 2008 2009 ULTRASOUND REVEALED SEROMA CT SCAN SHOWED INFOLDING IMPLANT 7 9 OCLOCK APPARENT MASS SLIGHTLY INCREASED DENSITY B6 2009 SURGERY PLANNED REMOVE PRESUMED RUPTURED IMPLANT TIME SURGERY STRAW COLORED SEROMA 200CC FOUND IMPLANT INTACT WITHIN CAPSULE TWO AREAS GRANULOMATOUS TISSUE THICK MASS INFEROMEDIALLY CAPSULE MASS SENT MICROBIOLOGY CULTURE HISTOPATHOLOGY LYMPHOID CELLS HIGHLY ATYPICAL SHOWING ENLARGED IRREGULARLY CONFIGURED NUCLEI IMMUNOHISTOCHEMICAL ANALYSIS SHOWED CD30 + ALK- B-CELL MARKER NEGATIVE T-CELL MARKER PARTIAL PATCHILY-POSITIVE CD3 CD43 CD45RO CD5 TISSUE FINDINGS CONSISTENT LOCALIZED FORM SYSTEMIC ALCL LARGE T-CELL LYMPHOMA BREAST HEALED RECURRENT MASS APPEARED WEEKS LATER STAGING CT CHEST ABD PELVIS PET SCAN SHOWED EVIDENCE DISEASE OUTSIDE BREAST UNDERWENT CHEMO CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE B6 2009 MASS FAILED RESPOND PROGRESSED WOUND LYMPHOMA METASTASIZED THORACOLUMBAR REGION RIGHT LUNG SEEN B6 2009 PET SCAN TREATED RADIATION SECOND ROUND CHEMO USING GEMCITABINE IFOSFAMIDE VINORELBINE RESPONDED WELL UNDERWENT BONE MARROW TRANSPLANT 122009 TWO YEARS DIAGNOSIS REMAINS REMISSION EVENT ORIGINALLY SUBMITTED VIA B4 B4 2011|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110361|06/18/2014|||DA|N|R||0HP|FTR|1.0|09/30/2010|nan||1148082|||ARKLOW, COUNTY, WICKLOW|EI|ALLERGAN|||||||True
3827676|4503337|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA SEROMA WITHIN ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANTS DIAGNOSTIC CYTOPATHOLOGY VOL 00 00 CHAI ET AL REPORTED 49 YEAR OLD PT PRESENTED SWELLING PERI-PROSTHETIC FLUID PT RECONSTRUCTION FOLLOWING MASTECTOMY BREAST CANCER SIDE CANCER NOTED ARTICLE DEVICE INFORMATION NOTED SALINE INFORMATION INCLUDING MANUFACTURER PROVIDED MEDICAL HISTORY NOTED TIME PRESENTATION 8 YEARS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|05/08/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA, NE|US|UNK||CA|||||True
3827676|54779306|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA SEROMA WITHIN ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANTS DIAGNOSTIC CYTOPATHOLOGY VOL 00 00 CHAI ET AL REPORTED B6 PATIENT PRESENTED SWELLING PERI-PROSTHETIC FLUID PATIENT RECONSTRUCTION FOLLOWING MASTECTOMY BREAST CANCER SIDE CANCER NOTED ARTICLE DEVICE INFORMATION NOTED SALINE INFORMATION INCLUDING MANUFACTURER PROVIDED MEDICAL HISTORY NOTED TIME PRESENTATION 8 YEARS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|05/08/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA, NE|US|UNK||CA|||||True
3611913|4170417|D|1||REPORTED EVENTS CUTANEOUS ALCL CASE 2 BREAST PRESENTATION MASS EFFECT FLUID AROUND IMPLANT STATED JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING BREAST ARCH PATHOLOGY LAB MEDICAL JOURNAL- VOLUME 133 SEPTEMBER 2009 ALTHOUGH MANUFACTURER DEVICE UNKNOWN ALLERGANS APPROACH COMPLIANCE RESOLVE DOUBT FAVOR REPORTING|UNK SALINE IMPLANT|UNK SALINE IMPLANT|01/30/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA, NE||ALLERGAN||CA|||||True
3693307|11615224|N|1||EVENT INITIALLY SUBMITTED VIA EASR B6 2010 ADVERSE EVENT TERM CODE CANCER NON BREAST UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER NONBREAST LYMPHOMA - ALCL DUE INCREASED SPECIFICITY DEVICE LABELING ADDRESSES FOLLOWING ADVERSE EVENTS PER FOUR STUDY TRIALS SALINE IMPLANTS IRRITATION FOLLOWING LIST POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY RISKS INCLUDE ADDITIONAL SURGERY IRRITATIONINFLAMMATION PER CORE STUDY SILICONE IMPLANT IRRITATION REPORTED RATE 0 DEVICE LABELING REVIEWED EVENTS LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA LISTED CORE STUDY SILICONE STUDY TRIALS LABELING SALINE BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/14/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3693307|4293361|D|1||CASE REPORT B6 OLD PT RECEIVED RESEARCH ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT CAPSULE CASE REPORT REVIEW LITERATURE AMERICAN JOURNAL SURGICAL PATHOLOGY PUBLISHED 2008 CASE STUDY PUBLISHED PREVIOUSLY ANOTHER PHYSICIAN ET AL SEPTEMBER 2006 VIRCHOWS ARCH ANAPLASTIC LARGE-CELL NON-HODGKINS LYMPHOMA BREAST PERIPROSTHETIC LOCALIZATION 32 YEARS TREATMENT PRIMARY BREAST CANCER - CASE REPORT PT DIAGNOSED BREAST CANCER TREATED BREAST-ABLATIVE SURGERY PT RECONSTRUCTION SURGERY POLYURETHANE-COATED SILICONE IMPLANTS SIXTEEN YEARS MFR UNK PT PRESENTED LEFT SIDE SKIN ULCER LEFT BREAST ANAPLASTIC LARGE CELL NON-HODGKINS LYMPHOMA CUTANEOUS ANAPLASTIC LARGE CELL TYPE STATED WITHIN ARTICLE POSSIBLE DIAGNOSES SUMMARY ABSTRACT STATES IMMUNOPROFILE TUMOR SHOWED NEGATIVITY CYTOKERATINS LED DIAGNOSIS CD30 - POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA PT REFUSED DIAGNOSTIC TREATMENT|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/14/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3946569|4537478|D|1||HEALTHCARE PROFESSIONAL REPORTS INCIDENCE ANAPLASTIC LARGE CELL LYMPHOMA ALCL APPEARS ASSOCIATED USE TEXTURED BREAST IMPLANTS ENCOUNTERED 3 CASES WITHIN PAST 3 YEARS 130 CASES REPORTED WORLDWIDE TWO PTS MCGHAN IMPLANTS IE TEXTURING PROCESS ALLERGAN CURRENTLY USE MEDICAL SAFETY TEAM DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL MULTIPLE ATTEMPTS MADE OBTAIN INFO INCLUDING CYTOLOGYPATHOLOGY REPORTS DEVICE INFO ETC IFWHEN ADDL INFO BECOME AVAILABLE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
4037715|4723086|D|1||LEFT BREAST IMPLANT ASSOCIATED SEROMA LEFT BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BILATERAL BREAST IMPLANTS PLACED RECONSTRUCTION 2002|UNK||08/21/2014|||||||0HP|FTR|1.0||SILICONE BREAST IMPLANT|||||||nan|||||||True
3874163|4506744|D|1||ANAPLASTIC LARGE CELL LYMPHOMA ALCL BREAST IMPLANT RELATED DISCOVERED UPON REMOVING BREAST IMPLANT CAPSULE SEROMA FLUID RIGHT BREAST PT TEXTURED SALINE-FILLED ALLERGAN IMPLANTS PLACED COSMETIC BREAST ENLARGEMENT B6 2009 PT NOTICED BREAST ASYMMETRY SUMMER 2013 PROGRESSED RIGHT BREAST NOTICEABLY LARGER LEFT SIDE ULTRASOUND STUDY DONE B6 2014 SHOWING APPEARED FLUID AROUND RIGHT IMPLANT - POSSIBLE DEFLATION IMPLANT INTACT UPON REMOVAL LARGE SURROUNDING SEROMA SUSPICION ALCL RIGHT BREAST IMPLANT TOTAL CAPSULECTOMY IMPLANT REMOVAL DONE CAPSULE SEROMA FLUID SPECIMENS SENT HISTOLOGYPATHOLOGY EVALUATION|NATRELLE SALINE IMPLANT|168-330|06/11/2014|||||||0HP|FWM|1.0||SALINE IMPLANT|||||||ALLERGAN|||||168 NATRELLE SALINE- FILLED||True
3946563|19797996|D|1||HEALTHCARE PROFESSIONAL REPORTS INCIDENCE ANAPLASTIC LARGE CELL LYMPHOMA ALCL APPEARS ASSOCIATED USE TEXTURED BREAST IMPLANTS ENCOUNTERED 3 CASES WITHIN PAST 3 YEARS 130 CASES REPORTED WORLDWIDE TWO PATIENTS MCGHAN IMPLANTS IE TEXTURING PROCESS ALLERGAN CURRENTLY USE MEDICAL SAFETY TEAM DETERMINED COMBINED RESULTS IMMUNE-CHEMICAL HISTOLOGICAL CYTOLOGICAL ANALYSIS SPECIMENS SCIENTIFICALLY ACCEPTABLE CRITERIA DIAGNOSE ALCL MULTIPLE ATTEMPTS MADE OBTAIN INFO INCLUDING CYTOLOGYPATHOLOGY REPORTS DEVICE INFO ETC IFWHEN ADDITIONAL INFO BECOME AVAILABLE FORWARDED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/14/2014|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3642249|17838426|D|1||EVENT ANAPLASTIC LARGE CELL LYMPHOMA REPORTED JOURNAL ARTICLE PRIMARY SECONDARY T-CELL LYMPHOMAS BREAST GABRIELA ET AL APPL IMMUNOHISTOCHEM MOL MORPHOL VOLUME 17 NUMBER 4 JULY 2009 ALTHOUGH MFR DEVICE UNK ALLERGANS APPROACH COMPLIANCE RESOLVE DOUBT FAVOR REPORTING|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|02/05/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3827678|54778045|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA SEROMA WITHIN ARTICLE  ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANTS DIAGNOSTIC CYTOPATHOLOGY VOL 00 00 CHAI ET AL AUTHOR NOTES 49 YEAR OLD PATIENT HISTORY AUGMENTATION SURGERY DATE UNKNOWN DEVICE INFORMATION NOTED SILICONE INFORMATION PROVIDED ALSO NOTES PERIPROSTHETIC SWELLING PERI-IMPLANT FLUID TREATMENT CAPSULECTOMY CHOP FOLLOW SEVEN MONTHS SHOWS EVIDENCE DISEASE MANUFACTURER INFORMATION PROVIDED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/08/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
3827678|4503338|D|1||HEALTHCARE PROFESSIONAL REPORTS CASE LYMPHOMA SEROMA WITHIN ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANTS DIAGNOSTIC CYTOPATHOLOGY VOL 00 00 CHAI ET AL AUTHOR NOTES 49 YR OLD PT HISTORY AUGMENTATION SURGERY DATE UNK DEVICE INFO NOTED SILICONE INFO PROVIDED ALSO NOTES PERIPROSTHETIC SWELLING PERI-IMPLANT FLUID TREATMENT CAPSULECTOMY CHOP FU SEVEN MONTHS SHOWS EVIDENCE DISEASE MFR INFO PROVIDED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/08/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
4250989|19765661|D|1||PT RECURRENT RIGHT PERICAPSULAR FLUID BEGINNING B6 2014 CONSTANT DULL PAIN SWELLING DRAINED TWICE PRIOR DATE ULTRASOUND ASPIRATION B6 2014 SPECIMEN APPROXIMATELY 17 ML YELLOW STRAW COLORED WATERY FLUID TISSUE FREE-FLOATING THROUGHOUT SPECIMEN B APPROXIMATELY 10CC YELLOW STRAW-COLORED FLUID TISSUE FREE-FLOATING THROUGHOUT DIAGNOSIS SPECIMEN CYTOLOGY RIGHT BREAST -CD30-POSITIVE MALIGNANT NEOPLASM CYTOSPIN SECTION CELL BLOCK SHOW SHEETS LARGE MALIGNANT CELLS LARGE VESICULAR NUCLEI CONTAINING PUNCTATE PROMINENT NUCLEOLI MODERATE AMOUNTS EOSINOPHILIC CYTOPLASM HALLMARK CELLS IDENTIFIED BATTERY IMMUNOPEROXIDASE STRAINS OBTAINED ORDER CHARACTERIZE CELLS FOLLOWING RESULTS POSITIVE CD30 FINDINGS THOS CD30-POSITIVE MALIGNANT NEOPLASM GIVEN CLINICAL SETTING RECURRENT SEROMAS PT IMPLANTS FINDINGS CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA PT UNDERWENT REMOVAL IMPLANT IMMEDIATE REPLACEMENT B6 2008 COURSE UNEVENTFUL B6 2014|STYLE 410|410FX|11/04/2014|||||||0HP|FTR|1.0||BREAST IMPLANT||13423996|||GOLETA|US|ALLERGAN|93117|CA|93117||FX-410615||True
3693305|4292884|D|1||RESEARCH ARTICLE PUBLISHED 2008 AMERICAN JOURNAL SURGICAL PATHOLOGY ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT CAPSULE CASE REPORT REVIEW LITERATURE REPORTED B6 PT HISTORY RIGHT SIDE BREAST CANCER RECONSTRUCTION ALLERGAN SALINE TEXTURED BREAST IMPLANT B6 2005 PT PRESENTED SEROMA SUBSEQUENTLY DIAGNOSED ALCL CELL TYPE CASE STUDY REPORTED ORIGINALLY ANOTHER DOCTOR ET AL ANNALS PLASTIC SURGERY B6 2007|STYLE 363 SALINE FILLED BREAST IMPLANT|27-363651|03/14/2014|||DA|N|R||0HP|FWM|1.0||nan||532328|||GOLETA|US|ALLERGAN||CA|||||True
3693305|11615223|N|1||EVENT INITIALLY REPORTED VIA EASR B6 2010 ADVERSE EVENT TERM CODE CANCER NON BREAST UPDATE SAFETY DATA BASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER NONBREAST LYMPHOMA - ALCL DUE INCREASED SPECIFICITY DEVICE LABELING REVIEWED EVENTS LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA STUDY TRIALS LABELING SALINE IMPLANTS|STYLE 363 SALINE FILLED BREAST IMPLANT|27-363651|03/14/2014|||DA|N|R||0HP|FWM|1.0||nan||532328|||GOLETA|US|ALLERGAN||CA|||||True
3611928|4157112|D|1||REPORTED EVENTS ALK- ALCL CASE 3 BREAST PRESENTATION PAIN SWELLING SCAR FLUID STATED JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING BREAST ARCH PATHOLOGY LAB MEDICAL JOURNAL-VOL 133 SEP 2009 ALTHOUGH MFR DEVICE UNK ALLERGANS APPROACH COMPLIANCE RESOLVE DOUBT FAVOR REPORTING|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|01/30/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
4300460|17278557|D|1||ULTRASOUND EXAM FINE NEEDLE ASPIRATION PERIPROSTHETIC EFFUSION DIAGNOSIS BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA DONE|ST 510MX 445||12/01/2014|||||||0|FTR|1.0||BREAST IMPLANTS|||||||ALLERGAN|||||||True
5186386|29786531|D|1||HEALTH PROFESSIONAL REPORTED APPEARANCE PERI PROSTHETIC RECIDIVIST LIQUID HISTOLOGICAL EXAMINATION RESULTED COMPATIBLE ANAPLASTIC LARGE CELL LYMPHOMA DEVICE EXPLANTED TOTAL CAPSULECTOMY PERFORMED SIDE UNSPECIFIED EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED CONFIRM ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX150-620|10/29/2015||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1325729|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5186386|29786530|N|1||DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX150-620|10/29/2015||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1325729|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5108565|26936205|D|1||HEALTH PROFESSIONAL REPORTED SPONTANEOUS RECURRENT SEROMA RIGHT BREAST POSITIVE CYTOLOGY ANAPLASTIC LYMPHOMA DEVICE REMOVED CAPSULE ANALYZED RESULT ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE DIAGNOSED CAPSULE SPECIFIED ALCL CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED SEE MFR  9617229-2015-00372 LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1509947|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5108565|26936204|N|1|| DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1509947|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5067426|25380333|D|1||HEALTH PROFESSIONAL REPORTED PATIENT PRESENTED SWELLING + FIRMNESS RIGHT BREAST FEVER PAIN HISTORY BLUNT TRAUMA BREAST ULTRASOUND ORDERED + ANTIBIOTIC STARTED ULTRASOUND REPORT STATES RIGHT FAIRLY LARGE QUANTITY FLUID NOTED SURROUNDING IMPLANT MARKED AXILLARY TAIL ALTHOUGH COULD RELATED INFECTIOUS PROCESS FLUID CONTAIN DEBRIS SEPTATIONS HENCE SEROMA QUESTIONED 12 OCLOCK POSITION 5 CM NIPPLE RIGHT 7MM CYST SECOND CYST 1 OCLOCK POSITION 3 CM NIPPLE 5 MM SIZE NOTED SIDE FLUID ASPIRATION REPORT STATES CELLS IMMUNOPOSITIVE CD30 IMMUNONEGATIVE CD20 CD3 CD43 ALK DIAGNOSIS STATES NON-HODGKINS LYMPHOMA CD30 + ANAPLASTIC LARGE CELL LYMPHOMA DEVICE REMAINS IMPLANTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM120-280|09/10/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4791712|22282406|N|1||B4 DEVICE LABELING ADDRESSES POSSIBILITY ADVERSE EVENTS POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY DISCUSS PT WARNINGS PRECAUTIONS IMPORTANT FACTORS CONSIDER POSSIBLE ADVERSE EVENTS ALLERGANS CORE CLINICAL STUDY RESULTS BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-270|05/21/2015||07/22/2015|DA|R|Y||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2084366|900 PARKWAY GLOBAL PARK|ZONA FRANCA|LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5048951|24795080|N|1||DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-270|09/02/2015||||N|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||540807|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5048951|24795081|D|1||HEALTH PROFESSIONAL REPORTED VIA VOLUNTARY MEDWATCH 5042321 PATIENT NOTED INCREASED SIZE LEFT BREAST FIRM MASS MEDIALLY ALSO LEFT BREAST ULTRASONIC-GUIDED NEEDLE BIOPSY BREAST MASS PROVIDED RETRO-PECTORAL LEFT AXILLARY LYMPH NODES DONE SHOWED ANAPLASTIC LARGE CELL LYMPHOMA ALK NEG BREAST NODES PETCT SHOWED BREAST MASS HIGHLY HYPERMETABOLIC ENLARGED HYPERMETABOLIC LEFT AXILLARY NODES PATIENT RECEIVED CHEMOTHERAPY CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE ETOPOSIDE GOOD RESPONSE BREAST IMPLANT REMOVAL RECOMMENDED PER FOLLOW-UP HEALTH PROFESSIONAL ADDITIONALLY REPORTED PATIENT LEFT SIDE CAPSULAR CONTRACTURE NOTED BULGING LEFT SIDE BAKER GRADE PROVIDED HEALTH PROFESSIONAL CONFIRMED LEFT SIDE DEVICE REMAINS IMPLANTED PATIENT DECLINED REMOVED EVENT CAPTURED LYMPHOMA CONFIRMATION ALCL RECEIVED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-270|09/02/2015||||N|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||540807|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286885|33230445|D|1||PHYSICIAN REPORTED RIGHT SIDE DEVICE REMOVAL REPLACEMENT DIAGNOSIS ANAPLASTIC LARGE CELL LYMPHOMA ALCL PATHOLOGICAL MARKERS PROVIDED CASE CAPTURED LYMPHOMA CONFIRMATION RECEIVED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|12/10/2015|||DA|N|R||0HP|FTR|1.0|10/21/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1157331|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286885|33230384|N|1||DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS  CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|12/10/2015|||DA|N|R||0HP|FTR|1.0|10/21/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1157331|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5270622|32776696|N|1||MEDWATCH SUBMITTED 12072015 DEVICE LABELING ADDRESSES PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|12/07/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||565193|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5088633|26204676|N|1||MEDWATCH SUBMITTED 09182015 DEVICE LABELING PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNK|||||||True
5088633|54646607|D|1||PHYSICIAN REPORTED CASE BREAST IMPLANT ALCL ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY CONFIRMED EFFUSION SIDE UNKNOWN TREATMENT YET OCCURRED DEVICE REMAINS IMPLANTED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNK|||||||True
5088633|26204677|D|1||PHYSICIAN REPORTED CASE BREAST IMPLANT ALCL ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY CONFIRMED EFFUSION SIDE UNKNOWN TREATMENT YET OCCURRED DEVICE REMAINS IMPLANTED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNK|||||||True
5331748|34569574|N|1||MEDWATCH SUBMITTED 12292015 B4 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FF130-425|12/29/2015|||DA|N|R||0HP|FTR|1.0|04/19/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1832218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4680690|13211132|N|1||B4 DEVICE LABELING UNDERGOING TYPE SURGICAL PROCEDURE INVOLVES RISKS EFFECTS ANESTHESIA INFECTION SWELLING REDNESS BLEEDING PAIN EVEN DEATH RISKS SERIOUS RISKS NEED BALANCED BENEFITS SURGERY WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ANAPLASTIC LARGE CELL LYMPHOMA ALCL SCAR TISSUE FLUID ADJACENT IMPLANT ALCL BREAST CANCER - RARE TYPE NON-HODGKINS LYMPHOMA CANCER IMMUNE SYSTEM ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS PTS DIAGNOSED SOUGH MEDICAL TREATMENT IMPLANT-RELATED SYMPTOMS PAIN LUMPS SWELLING ASYMMETRY DEVELOPED INITIAL SURGICAL SITES FULLY HEALED CASES REPORTED ALCL TYPICALLY DIAGNOSED YEARS IMPLANT SURGERY ONE RECONSTRUCTION PT PIVOTAL STUDY REPORTED ALCL 10 YEARS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF140-440|04/09/2015|||DA|N|R||0HP|FTR|1.0|03/20/2012|nan||1408999|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4742777|16612615|N|1||UNIQUE IDENTIFIER UDI  APPLICABLE EVENT ANAPLASTIC LARGE CELL LYMPHOMA INITIALLY REPORTED B6 2011 ADVERSE EVENT TERM CODE CANCER UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER LYMPHOMA-ALCL DUE INCREASED SPECIFICITY PATIENT IDENTIFIER B6 RELATES PATIENTS RECORD PREVIOUSLY EXISTING EASY TRACK DATABASE CURRENT DATABASE PATIENT IDENTIFIER B6 DEVICE LABELING PATIENTS ADVISED IMPLANTS CONSIDERED LIFETIME DEVICES POTENTIALLY UNDERGO IMPLANT REMOVAL WITHOUT REPLACEMENT COURSE LIFE PATIENTS ALSO ADVISED CHANGES BREAST FOLLOWING EXPLANTATION IRREVERSIBLE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/30/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|LA AURORA DE HEREDIA||NE|CS|ALLERGAN|||||||True
5285719|38372148|D|1||COMPANY REPRESENTATIVE REPORTED PHYSICIAN STATED POSSIBLE ALCLNO SPECIFICS GIVEN FOLLOW-UP HEALTH PROFESSIONAL CONFIRMS MANUFACTURER ALLERGAN PATIENT PRESENTED RIGHT BREAST SWOLLEN RED FINE NEEDLE ASPIRATION REPORTS APPARENT TINY CALCIFICATIONSÂ¿ Â¿APPROXIMATELY ONE LITER YELLOW SLIGHTLY TURBID FLUID OBTAINEDÂ¿ IMPRESSION STATES Â¿THERE AREAS SOFT TISSUE NODULARITY ALONG MARGINS FLUID COLLECTION SUSPICIOUS LYMPHOMA CYTOLOGY SHOWS MALIGNANCY CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ PATHOLOGY REPORT NOTES CD30 POSITIVE ALK-1 NEGATIVE CAPSULECTOMY EXPLANTATION OCCURRED ADDITIONALLY HEALTH PROFESSIONAL REPORTED INCREASED TENDERNESS SMALL AREAS SKIN BREAKDOWN ANTERIOR CAPSULE WHITE NECROTIC APPEARING TISSUE SEVERAL SPOTS EXTENDED WAY DEEP DERMIS PAIN DEEMED SECONDARY EVENT NECROSIS|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5285719|33288642|N|1||MEDWATCH SUBMITTED 12102015 DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5285719|35139726|D|1||COMPANY REPRESENTATIVE REPORTED PHYSICIAN STATED POSSIBLE ALCL SPECIFICS GIVEN FOLLOW-UP HEALTH PROFESSIONAL CONFIRMS MANUFACTURER ALLERGAN PATIENT PRESENTED RIGHT BREAST SWOLLEN RED FINE NEEDLE ASPIRATION REPORTS APPARENT TINY CALCIFICATIONS APPROXIMATELY ONE LITER YELLOW SLIGHTLY TURBID FLUID OBTAINED IMPRESSION STATES AREAS SOFT TISSUE NODULARITY ALONG MARGINS FLUID COLLECTION SUSPICIOUS LYMPHOMA CYTOLOGY SHOWS MALIGNANCY CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY REPORT NOTES B4 POSITIVE ALK-1 NEGATIVE CAPSULECTOMY EXPLANTATION OCCURRED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5285719|39855319|D|1||COMPANY REPRESENTATIVE REPORTED PHYSICIAN STATED POSSIBLE ALCLNO SPECIFICS GIVEN FOLLOW-UP HEALTH PROFESSIONAL CONFIRMS MANUFACTURER ALLERGAN PATIENT PRESENTED RIGHT BREAST SWOLLEN RED FINE NEEDLE ASPIRATION REPORTS APPARENT TINY CALCIFICATIONSÂ¿ Â¿APPROXIMATELY ONE LITER YELLOW SLIGHTLY TURBID FLUID OBTAINEDÂ¿ IMPRESSION STATES Â¿THERE AREAS SOFT TISSUE NODULARITY ALONG MARGINS FLUID COLLECTION SUSPICIOUS LYMPHOMA CYTOLOGY SHOWS MALIGNANCY CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ PATHOLOGY REPORT NOTES CD30 POSITIVE ALK-1 NEGATIVE CAPSULECTOMY EXPLANTATION OCCURRED ADDITIONALLY HEALTH PROFESSIONAL REPORTED INCREASED TENDERNESS SMALL AREAS SKIN BREAKDOWN ANTERIOR CAPSULE WHITE NECROTIC APPEARING TISSUE SEVERAL SPOTS EXTENDED WAY DEEP DERMIS PAIN DEEMED SECONDARY EVENT NECROSIS|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5054360|24980549|N|1||DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT PLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY CASE-CONTROL STUDIES EVALUATE ASSOCIATION NATRELLEÂ® 410 BREAST IMPLANTS 5 RARE DISEASE OUTCOMES RARE CONNECTIVE TISSUE DISEASES NEUROLOGICAL DISEASES BRAIN CANCER CERVICALVULVAR CANCER LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410580|09/03/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2429863|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4385729|12634624|N|1||DEVICE LABELING ADDRESSES REPORTED EVENT ALCL FOLLOWS BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REP PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSISTWITH VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS DEVICE LABELING ADDRESSES REPORTED EVENT JUMPMASSCYST FOLLOWS B6 STUDY LEAST 1 REOPERATION PERFORMED 315 PATIENTS 365 10 YEARS TOTAL 424 REOPERATIONS PERFORMED PRIMARY REASON REOPERATION 10 YEARS AUGMENTATION PATIENTS IMPLANT DEFLATION 217 PERCENTAGE REOPERATIONS DUE LUMPMASSCYST INCREASED 85 293 REOPERATIONS 5 YEARS 139 424 REOPERATIONS 10 YEARS OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PTS AGE COULD EXPLANATION INCREASE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4385750|20562037|N|1||DEVICE LABELING ADDRESSES REPORTED EVENT ALCL FOLLOWS BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REP PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
5108543|32666145|D|1||HEALTH PROFESSIONAL REPORTED SEVERAL SPONTANEOUS SEROMA LEFT BREAST NEGATIVE CYTOLOGY SPONTANEOUSLY RESOLVED DEVICE REMOVED CAPSULE ANALYZED RESULT ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE DIAGNOSED CAPSULE SPECIFIED ALCL CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED SEE MFR  9617229-2015-00373 RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5108543|26936807|N|1||DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5108543|32280916|D|1||HEALTH PROFESSIONAL REPORTED SEVERAL SPONTANEOUS SEROMA LEFT BREAST NEGATIVE CYTOLOGY SPONTANEOUSLY RESOLVED DEVICE REMOVED CAPSULE ANALYZED RESULT ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE DIAGNOSED CAPSULE SPECIFIED ALCL CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED SEE MFR  9617229-2015-00373 RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5108543|49682505|D|1||HEALTH PROFESSIONAL REPORTED SEVERAL SPONTANEOUS SEROMA LEFT BREAST NEGATIVE CYTOLOGY SPONTANEOUSLY RESOLVED DEVICE REMOVED CAPSULE ANALYZED RESULT ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE DIAGNOSED CAPSULE SPECIFIED ALCL CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED SEE MFR  9617229-2015-00373 RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5108543|26936808|D|1||HEALTH PROFESSIONAL REPORTED SEVERAL SPONTANEOUS SEROMA LEFT BREAST NEGATIVE CYTOLOGY SPONTANEOUSLY RESOLVED DEVICE REMOVED CAPSULE ANALYZED RESULT ANAPLASTIC LARGE CELL LYMPHOMA ALCL SIDE DIAGNOSED CAPSULE SPECIFIED ALCL CAPTURED LYMPHOMA PATHOLOGICAL MARKERS RECEIVED SEE MFR  9617229-2015-00373 RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX140-560|09/28/2015||10/07/2015|DA|R|Y||0HP|FTR|1.0|09/25/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1490828|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4859987|5847605|D|1||HEALTH PROFESSIONAL REPORTED PT DEVELOPED LARGE VOLUME LATE SEROMA AROUND RIGHT RECONSTRUCTIVE BREAST IMPLANT FLUID ASPIRATED SENT CYTOLOGY CONFIRMED ANAPLASTIC LARGE CELL LYMPHOMA ALK-1 NEGATIVE SUBSEQUENT PET SCAN - MILD ACTIVITY INTERNAL MAMMARY LYMPH NODES AWAITING FINAL HAEMATOLOGY REVIEW DEVICE REMOVED FOLLOW-UP REPORTED FINE NEEDLE ASPIRATION SEROMA FLUID AROUND RIGHT IMPLANT CONFIRMED DIAGNOSIS ALK-1 NEGATIVE ALCL ALCL CONTAINED WITHIN CAPSULE PERIPROSTHETIC FLUID PATHOLOGY REPORT CONFIRMED  CD30 LARGE CELL POSITIVE  ALK-1 NEGATIVE OVERALL FINDINGS SUGGESTIVE ALK-1 NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA STAGE 1AE PET-CT SCAN REPORTS BILATERAL BORDERLINE ENLARGED INTERNAL MAMMARY LYMPH NODES SHOW MILDLY INCREASED METABOLIC ACTIVITY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FM-410500|06/19/2015|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4385762|5263418|D|1||MEDICAL STAFF REPORTED EXPLANTATION PERIPROSTHETIC RIGHT SIDE ANAPLASTIC LARGE CELL LYMPHOMA T-CELL FORMED EXUDATE WITHOUT INFILTRATION TUMOR CAPSULE ALCL YET CONFIRMED VIA DIAGNOSTICS THEREFORE EVENT LYMPHOMA REPORTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MF120-295|12/31/2014|||DA||R||0HP|FTR|1.0|02/08/2013|nan||1553196|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5078001|40431380|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE DEFLATION HEALTH PROFESSIONAL ADDITIONALLY REPORTED ENLARGED RIGHT BREAST SEROMA RIGHT BREAST IMPLANT POCKET PATIENT GIVEN ANTIBIOTICS IMPROVEMENT RECURRENT SUDDENLY ENLARGING RIGHT BREASTÂ¿ TIME SURGERY CLEAR STRAW COLORED FLUID APPROXIMATELY 450CC REMOVED PROTEINACEOUS EXUDATE FOUND AROUND POCKET IMPLANTÂ¿ PATHOLOGY REPORT STATES DIAGNOSIS Â¿CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK-NEGATIVE ALCL ASSOCIATED BREAST IMPLANT NEOPLASTIC CELLS CD30 CD4 CD43 POSITIVEÂ¿ PER ADDITIONAL INFORMATION HEALTH PROFESSIONAL NOTED SWELLING INVOLVING RIGHT BREAST BELIEVED INFECTION TREATED ANTIBIOTICS|STYLE 168 SALINE FILLED BREAST IMPLANT|168-420|09/15/2015||08/21/2015|DA|R|Y||0HP|FWM|1.0|05/01/2005|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||564274|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4385745|18428752|N|1||DEVICE LABELING ADDRESSES REPORTED EVENT ALCL FOLLOWS BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE DEREDIA|CS|UNK|||||||True
4648716|13098279|N|1||EVENT ANAPLASTIC LARGE CELL LYMPHOMA INITIALLY REPORTED VIA B4 B4 2010 ADVERSE EVENT TERM CODE CANCER EVENT REPORTED VIA B4 B4 2012 ADVERSE EVENT TERM CODE LYMPHOMA UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED LYMPHOMA ALCL DUE INCREASED SPECIFICITY B6 DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS POSTOPERATIVE HEMATOMA SEROMA MAY MINIMIZED METICULOUS ATTENTION HEMOSTASIS SURGERY POSSIBLY ALSO POSTOPERATIVE USE CLOSED DRAINAGE SYSTEM PERSISTENT EXCESSIVE BLEEDING MUST CONTROLLED IMPLANTATION POSTOPERATIVE EVACUATION HEMATOMA SEROMA MUST CONDUCTED CARE AVOID BREAST IMPLANT CONTAMINATION DAMAGE SHARP INSTRUMENTS USE CARE SUBSEQUENT PROCEDURES OPEN CAPSULOTOMY BREAST POCKET REVISION HEMATOMASEROMA ASPIRATION BIOPSYLUMPECTOMY AVOID DAMAGE IMPLANT B4 STUDY CONTINUE EVALUATE LONG-TERM B4 SAFETY EFFECTIVENESS PRODUCTS ADDITION ALLERGAN INITIATED SEPARATE B4 POST-APPROVAL STUDY B4 ADDRESS SPECIFIC ISSUES ALLERGANS CORE STUDY DESIGNED FULLY ANSWER WELL PROVIDE REAL-WORLD ASSESSMENT ENDPOINTS B4 ALLERGAN UPDATE LABELING REGULAR BASIS RESULTS TWO STUDIES B4 REPORTS CANCERS BRAIN RESPIRATORY CERVICALVULVAR PRIMARY RECONSTRUCTION REVISION-RECONSTRUCTION PATIENTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|03/31/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4648716|5757553|D|1||JOURNAL TITLED ANAPLASTIC LARGE CELL LYMPHOMA ARISING SILICONE BREAST IMPLANT CAPSULE STATES PATIENT PRESENTED SWELLING TENDERNESS LEFT BREAST IMPLANT SITE SURGERY SUBSTANTIAL AMOUNT STRAW COLORED FLUID DRAINED PERIPROSTHETIC CAPSULAR SPACE PROSTHESIS REMOVED FOLLOWED CAPSULECTOMY RESULTS TABLE ARTICLE SHOW CD300 POSITIVE ALK-1 NEGATIVE PT TREATED RADIOTHERAPY REVEALED SYSTEMIC DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|03/31/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5105218|26823377|N|1||DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|09/25/2015||||N|R||0HP|FTR|1.0|11/04/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1671333|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5285827|33170546|N|1||MEDWATCH SUBMITTED 12102015 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|12/10/2015|||DA|N|R||0HP|FWM|1.0|12/04/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1375592|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5061707|25188101|N|1||MEDWATCH SUBMITTED 09082015 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT PLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX125-370|09/08/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1331894|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4702227|13234344|N|1||B4 DEVICE LABELING BASED INFORMATION FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL 9 PRIMARY AUGMENTATION PATIENTS 19 NEW DIAGNOSIS BREAST CANCER 10 YEARS ALLERGAN PIVOTAL STUDY PRIMARY AUGMENTATION PATIENTS 1 REPORT SKIN CANCER 1 REPORT RENAL CELL CANCER 1 PRIMARY AUGMENTATION PATIENT PREGNANT TIME IMPLANTATION GAVE BIRTH CHILD LATER DEVELOPED HISTIOCYTOSIS 1 REVISION-AUGMENTATION PATIENT 08 NEW DIAGNOSIS BREAST CANCER 10 YEARS 1 PATIENT REPORT BLADDER CANCER 1 PATIENT REPORT MULTIPLE MYELOMA 17 RECONSTRUCTION PATIENTS 76 RECURRENCE BREAST CANCER 10 YEARS 1 REPORT NON-HODGKINS LYMPHOMA 1 REPORT UTERINE CANCER REVISION-RECONSTRUCTION PATIENTS REPORTED RECURRENCE BREAST CANCER 10 YEARS REPORTS CANCERS REVISION-RECONSTRUCTION PATIENTS ONE RECONSTRUCTION PATIENT PIVOTAL STUDY REPORTED ALCL 10 YEARS SOMETIMES SYMPTOMS ASSOCIATED GEL IMPLANT RUPTURE SYMPTOMS INCLUDE HARD KNOTS LUMPS SURROUNDING IMPLANT ARMPIT CHANGE LOSS SIZE SHAPE BREAST IMPLANT PAIN TINGLING SWELLING NUMBNESS BURNING HARDENING BREAST LITERATURE REPORTS ALSO MADE ASSOCIATING SILICONE BREAST IMPLANTS VARIOUS RHEUMATOLOGICAL SIGNS SYMPTOMS FATIGUE EXHAUSTION JOINT PAIN SWELLING MUSCLE PAIN CRAMPING TINGLING NUMBNESS WEAKNESS SKIN RASHES|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410335|04/16/2015||02/25/2013|DA|Y|Y||0HP|FTR|1.0|02/02/2011|nan||1223847|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4702227|5724962|D|1||HEALTH PROFESSIONAL REPORTED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT PRESENTED RIGHT BREAST SWELLING EVENT ANAPLASTIC LARGE CELL LYMPHOMA CAPTURED LYMPHOMA DIAGNOSTIC TESTING CONFIRM DIAGNOSIS ALCL DEVICE REMOVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410335|04/16/2015||02/25/2013|DA|Y|Y||0HP|FTR|1.0|02/02/2011|nan||1223847|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4616833|54647640|D|1||REPORTED EVENTS 24 UNPUBLISHED CASES BI-ALCL FOUND JOURNAL ABSTRACT Â¿1435 BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIALCL COMPREHENSIVE HISTOPATHOLOGICAL EVALUATION 40 CASES PROPOSAL PATHOLOGIC STAGING SYSTEMÂ¿ ANNUAL ABSTRACT MEETINGS DIAGNOSTIC TESTING PROVIDED EVENT CAPTURED LYMPHOMA SIDE UNKNOWN MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|LA AURORA DE HEREDIA||NE|CS|UNK|||||||True
4616833|5653848|D|1||REPORTED EVENTS 24 UNPUBLISHED CASES BI-ALCL FOUND JOURNAL ABSTRACT 1435 BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIALCL COMPREHENSIVE HISTOPATHOLOGICAL EVALUATION 40 CASES PROPOSAL PATHOLOGIC STAGING SYSTEM ANNUAL ABSTRACT MEETINGS DIAGNOSTIC TESTING PROVIDED EVENT CAPTURED LYMPHOMA SIDE UNKNOWN MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|03/18/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|LA AURORA DE HEREDIA||NE|CS|UNK|||||||True
4922479|6435381|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE DEVICE REMOVED DUE SEROMA SUDDENLY APPEARED SWELLING MAMMARY SEVERAL WEEKS REMOVAL RIGHT SIDE IMPLANT DOUBLE CAPSULE FOUND PATHOLOGICAL TESTING SEROMA CAPSULE REVEALED PATHOLOGICAL MARKERS CD30+ ALK- FOCAL INFLAMMATORY CHRONIC REARRANGEMENTS CONFIRMS DIAGNOSIS RIGHT SIDE ANAPLASTIC LARGE CELL LYMPHOMA ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF120-270|07/16/2015|||DA|N|R||0HP|FTR|1.0|08/25/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE, GEL-FILLED||1126779|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4702228|5721216|D|1||JOURNAL TITLED PRIMARY BREAST LYMPHOMA PT SILICONE BREAST IMPLANTS CASE REPORT  REVIEW LITERATURE STATES PT PRESENTED PLASTIC SURGERY CLINIC RIGHT-SIDED BREAST SWELLING POST AUGMENTATION MCGHAN 550 CC SILICONE GEL IMPLANTS REPORT ADDITIONALLY STATES RIGHT BREAST PERIPROSTHETIC FLUID COLLECTION ASPIRATED REVEALING 22CC STRAW-COLOURED FLUID ADDITIONALLY PALPABLE MASS APPRECIATED EXAM TIME STEREOTACTIC CORE NEEDLE BIOPSY MASS PERFORMED REVEALING ANAPLASTIC LARGE CELL LYMPHOMA DEVICE REMOVED PATHOLOGY RIGHT BREAST CAPSULE REVEALED MALIGNANT ANAPLASTIC LARGE CELL LYMPHOMA CELLS PT UNDERWENT CHEMOTHERAPY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/16/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|NE||NE||||True
4702228|13160829|N|1||EVENT ANAPLASTIC LARGE CELL LYMPHOMA INITIALLY REPORTED VIA B4 B4 2010 ADVERSE EVENT TERM CODE CANCER UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER LYMPHOMA-ALCL DUE INCREASED SPECIFICITY PT IDENTIFIER B6 RELATES PTS RECORD PREVIOUSLY EXISTING B4 DATABASE CURRENT DATABASE PT IDENTIFIER B6 DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDED IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO BEN REPORTED WOMEN IMPLANTS USE CARE SUBSEQUENT PROCEDURES OPEN CAPSULOTOMY BREAST POCKET REVISION HEMATOMASEROMA ASPIRATION BIOPSYLUMPECTOMY AVOID DAMAGE IMPLANT PT PERFORM BREAST SELF-EXAMINATIONS MONTHLY SHOWN DISTINGUISH IMPLANT BREAST TISSUE PT MANIPULATE SQUEEZE EXCESSIVELY PT TOLD PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGE IMPLANT SHAPE MAY SIGNS SYMPTOMATIC RUPTURE IMPLANT PT SIGNS TOLD REPORT POSSIBLY MRI EVAL SCREEN RUPTURE NATRELLE CORE STUDY CONTINUE EVALUATE LONG-TERM 10 YEARS SAFETY EFFECTIVENESS PROD ADDITION ALLERGAN INITIATED SEPARATE LARGE 10-YEAR POSTAPPROVAL STUDY BREAST IMPLANT FU STUDIES BIFS ADDRESS SPECIFIC ISSUES ALLERGANS CORE STUDY DESIGNED FULLY ANSWER WELL PROVIDE REAL-WORLD ASSESSMENT ENDPOINTS ENDPOINTS BIFS LARGE POSTAPPROVAL STUDY INCLUDE LONG-TERM LOCAL COMPLICATIONS CONNECTIVE TISSUE DISEASE CTD CTD SIGNS SYMPTOMS NEUROLOGICAL DISEASE NEUROLOGICAL SIGNS SYMPTOMS OFFSPRING ISSUES REPRODUCTIVE ISSUES CANCER SUICIDE MAMMOGRAPHY ISSUES MRI COMPLIANCE RESULTS ALLERGAN UPDATE LABELING REGULAR BASIS RESULTS TWO STUDIES 1 PRIMARY AUGMENTATION PT NEW DIAGNOSIS BREAST CANCER 7 YEARS CORE STUDY 13 BENIGN BREAST DISEASE RATE 1 MALIGNANT BREAST DISEASE RATE REVISION-AUGMENTATION PTS 1 PT NEW DIAGNOSIS BREAST CANCER THER 15 BENIGN BREAST DISEASE RATE 1 MALIGNANT BREAST DISEASE RATE 7 YEARS PRIMARY AUGMENTATION PTS 1 REPORT THYROID CANCER 1 REPORT BRAIN CANCER REPORTS CANCERS RESPIRATORY CERVICALVULVAR REVISION-AUGMENTATION PTS 8 PRIMARY RECONSTRUCTION PTS 8 NEW REPORTS BREAST CANCER 7 YEARS CORE STUDY 17 BENIGN BREAST DISEASE RATE 10 MALIGNANT BREAST DISEASE RATE 7 YEARS REVISION RECONSTRUCTION PTS REPORTS NEW DIAGNOSES REOCCURRENCE BREAST CANCER 7 BENIGN BREAST DISEASE RATE 7 YEARS REPORTS CANCERS BRAIN RESPIRATORY CERVICALVULVAR PRIMARY RECONSTRUCTION REVISION-RECONSTRUCTION PTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/16/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|NE||NE||||True
5155756|28464643|N|0||DEVICE LABELING PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY DEFLATION Â¿ BREAST IMPLANTS LIFETIME DEVICES SALINE BREAST IMPLANTS DEFLATE SHELL DEVELOPS TEAR HOLE DEFLATION OCCUR TIME IMPLANTATION LIKELY OCCUR LONGER IMPLANT IMPLANTED FOLLOWING THINGS MAY CAUSE IMPLANTS DEFLATE DAMAGE SURGICAL INSTRUMENTS FOLDING WRINKLING IMPLANT SHELL EXCESSIVE FORCE CHEST EG CLOSED CAPSULOTOMY CONTRAINDICATED TRAUMA COMPRESSION MAMMOGRAPHIC IMAGING SEVERE CAPSULAR CONTRACTURE BREAST IMPLANTS MAY ALSO SIMPLY WEAR TIME LABORATORY STUDIES IDENTIFIED CAUSES DEFLATION ALLERGANÂ¿S PRODUCT HOWEVER CONCLUSIVELY KNOWN WHETHER TESTS IDENTIFIED CAUSES DEFLATION|STYLE 168 SALINE FILLED BREAST IMPLANT|168-420|10/16/2015||||N|R||0HP|FWM|1.0|05/01/1996|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2-163072|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5155756|28464644|D|0||LAW FIRM REPORTED POSSIBLE LUMP BEHIND PATIENTS LEFT BREAST LEFT IMPLANT RUPTURE ADDITIONAL INFORMATION PROVIDED REVEALS PATIENT PRESENTED SMALL MASS LEFT CHEST WALL MEDIAL RECONSTRUCTION MASS RAPIDLY GROWN SIZE PUSHING IMPLANT LATERALLY GOTTEN QUITE UNCOMFORTABLE PATIENT SAW PHYSICIAN OBTAINED CT DEMONSTRATING LARGE MASS DEFORMING IMPLANT LOCATED SUB-PECTORALLY PATIENT ULTIMATELY DIAGNOSED LEFT SUB-PECTORAL MASS IDENTIFIED LYMPHOMA BIOPSY REVEALED PATIENT ALCL ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE CD30 RESULTS PATHOLOGY TESTS PROVIDED UNCONFIRMED REPORT ALCL CAPTURED LYMPHOMA TIME TREATMENT INCLUDED MULTIPLE HOSPITALIZATIONS LEFT SIDE DEVICE REMOVAL 16 ROUNDS CHEMOTHERAPY MULTIPLE SURGERIES ADDITIONAL NOTES INCLUDE BASAL CELL CARCINOMA MALIGNANT MELANOMA HERPES ZOSTER SIDE SPECIFIED MELANOMA RELATED DEVICE FIRST DIAGNOSED PRIOR IMPLANTATION RECORD LEFT SIDE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-420|10/16/2015||||N|R||0HP|FWM|1.0|05/01/1996|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2-163072|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286834|33227133|N|1||DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/10/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286834|33227134|D|1||HEALTH PROFESSIONAL REPORTED PERIPROSTHETIC OEDEMA LEADING PARTIAL CAPSULECTOMY CAPSULECTOMY LEFT SIDE PATIENT DIAGNOSED ALCL ANAPLASTIC LARGE CELL LYMPHOMA CD30+ ALK-|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/10/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4385769|19013900|N|1||UDI NA DEVICE LABELING ADDRESSES REPORTED EVENT ALCL FOLLOWS BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REP PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALLER NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL DEVICE LABELING ADDRESSES REPORTED EVENT SEROMA FOLLOWS POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA, NE|CS|UNK|||||||True
4957654|19502324|D|1||HEALTH PROFESSIONAL REPORTED CALCIFICATION CAPSULE ANAPLASTIC LARGE CELL LYMPHOMA ALCL PATHOLOGY REMOVED LEFT BREAST CAPSULECTOMY SPECIMEN EXCHANGE IMPLANT ALCL CONFIRMED PATHOLOGICAL MARKERS RECEIVED EVENT CAPTURED LYMPHOMA TIME|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4957654|26958644|D|1||FOLLOW-UP PHYSICIAN REVEALS FOLLOWING LEFT SIDE EVENTS CAPSULAR CONTRACTURE BAKER IIIIV NOTED REACTIVE AXILLARY LYMPH NODES EDEMA SUSPECTED PAIN PATHOLOGICAL TESTING LEFT BREAST CAPSULE FEATURES CONSISTENT BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA DESCRIPTION CAPSULE INCLUDED THREE ADJACENT SEPARATE HARD WHITE NODULES MEASURING 50 CM 55 CM 60 CM MAXIMUM DIAMETER TESTING ALK RESULTS PERFORMED PROVIDED PATHOLOGY TESTS ALCL CANNOT CONFIRMED CONTINUE CAPTURED LYMPHOMA|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4957654|55248980|N|1||EVENT LYMPHOMA ALCL PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4702205|15310134|D|1||HEALTH PROFESSIONAL REPORTED REGULATORY AGENCY VIA VOLUNTARY MW5039346 ALCL CASE REPORT ASSOCIATED BREAST CANCER RECONSTRUCTION PATIENT FOLLOW-UP REVEALS PATIENT HISTORY LEFT BREAST DUCTAL CARCINOMA SITU PRIOR BREAST IMPLANTS PATIENT PRESENTED SWELLING PAIN PRIMARY DIAGNOSIS ALCL DIAGNOSED RIGHT SIDE PERI IMPLANT FLUID 1 X 23 CM MASS MEDIANINFERIOR EDGE IMPLANT SEROMA NOTED SEVERE PATIENT TREATED CHEMOTHERAPY RIGHT SIDE DEVICE EXPLANTED PATHOLOGY RESULTS CONFIRM DIAGNOSIS READ BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IMMUNOSTAINS SHOW TUMOR CELLS POSITIVE CD30 CD2 CD4 NEGATIVE ER PR HER2 CYTOKERATIN S100 CD45 MPO CD3 CD20 ALK1|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|04/16/2015|||DA|N|R||0HP|FWM|1.0|12/05/2008|nan||1059645|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4600131|5470590|D|1||PHYSICIAN REPORTED REGULATORY AGENCY 2 SUICIDE ATTEMPTS FIBROMYALGIA RUPTURE ROTATOR CUFF LEFT B6 TWO PHLEBITIS DYSTHYROIDEA IRON DEFICIENCY ANEMIA GASTRITIS ESOPHAGITIS ARTHRITIS REQUIRING IMPLANTATION KNEE PROSTHESIS CLINICAL CONSEQUENCE ANAPLASTIC LARGE CELL LYMPHOMA ALCL ALK1 - CD30 LAGC SIDE UNKNOWN TREATMENT UNKNOWN|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|03/11/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4600131|12978182|N|1||DEVICE LABELING ADDRESSES ALCL ANAPLASTIC LARGE CELL LYMPHOMA ALCL - WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ANAPLASTIC LARGE CELL LYMPHOMA ALCL SCAR TISSUE FLUID ADJACENT IMPLANT ALCL BREAST CANCER - RARE TYPE NON-HODGKINS LYMPHOMA CANCER IMMUNE SYSTEM ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS PATIENTS DIAGNOSED SOUGHT MEDICAL TREATMENT IMPLANT RELATED SYMPTOMS PAIN LUMPS SWELLING ASYMMETRY DEVELOPED INITIAL SURGICAL SITES FULLY HEALED CASES REPORTED ALCL TYPICALLY DIAGNOSED YEARS IMPLANT SURGERY DEVICE LABELING ADDRESSES ARTHRITIS FIBROMYALGIA CONNECTIVE TISSUE DISEASES INCLUDE DISEASES LUPUS SCLERODERMA RHEUMATOID ARTHRITIS FIBROMYALGIA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|03/11/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5098529|26591653|N|1||DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL PATIENT TOLD PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGE IMPLANT SHAPE MAY SIGNS SYMPTOMATIC RUPTURE IMPLANT PATIENT SIGNS TOLD REPORT POSSIBLY MRI EVALUATION SCREEN RUPTURE LITERATURE REPORTS ALSO MADE ASSOCIATING SILICONE BREAST IMPLANTS VARIOUS RHEUMATOLOGICAL SIGNS SYMPTOMS FATIGUE EXHAUSTION JOINT PAIN SWELLING MUSCLE PAIN CRAMPING TINGLING NUMBNESS WEAKNESS SKIN RASHES|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/23/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||nan|||||||True
5098529|26591654|D|1||PATIENT REPORTED DIAGNOSED RARE FORM ANAPLASTIC LARGE CELL LYMPHOMA CANCER DOCTOR STATED DIRECT RESULT IMPLANTS PATIENT REPORTED LARGE TUMOUR MEASURING 5CM BREASTS STARTED COURSE CHEMOTHERAPY REDUCE ASAP SWELLING UNCOMFORTABLE SORE MAKES BREATHLESS SIDE SPECIFIED FILE RIGHT SIDE SEE MFR  9617229-2015-00388 LEFT SIDE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/23/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||nan|||||||True
4922455|14212221|N|1||BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/16/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL SALINE||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5049277|24825793|D|1||ALMOST NINE YEARS ALLERGAN TEXTURED SILICONE BREAST IMPLANTS DEVELOPED ANAPLASTIC LARGE CELL LYMPHOMA|INAMED 410 COHESIVE GEL||08/29/2015||||*|*||I|FTR|2.0||BREAST IMPLANT|||||||ALLERGAN|||||||True
5049277|24825793|D|1||ALMOST NINE YEARS ALLERGAN TEXTURED SILICONE BREAST IMPLANTS DEVELOPED ANAPLASTIC LARGE CELL LYMPHOMA|INAMED 410 COHESIVE GEL||08/29/2015||||*|*||I|FTR|1.0||BREAST IMPLANT|||||||ALLERGAN|||||||True
5049277|24825793|D|1||ALMOST NINE YEARS ALLERGAN TEXTURED SILICONE BREAST IMPLANTS DEVELOPED ANAPLASTIC LARGE CELL LYMPHOMA|INAMED 410 COHESIVE GEL||08/29/2015||||*|*||I|FTR|3.0||BREAST IMPLANT|||||||ALLERGAN|||||||True
5230911|31447415|D|1||VIA MW5055880 PATIENT REPORTED DEVICE REMOVAL DUE DEVELOPING ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGICAL MARKERS PROVIDED EVENT CAPTURED LYMPHOMA TIME SIDE UNKNOWN|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|11/17/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5230911|31447414|N|1||DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|11/17/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4553419|19634012|N|1||UNIQUE IDENTIFIER UDI  B4 DEVICE LABELING ADDRESSES ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALAL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL YU PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410470|02/25/2015|||DA|N|R||0HP|FTR|1.0|01/15/2011|nan||1210806|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5222818|31178939|N|1||B4 DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL PASS STUDY LEAST 1 REOPERATION PERFORMED 315 PATIENTS 365 10 YEARS TOTAL 424 REOPERATIONS PERFORMED PRIMARY REASON REOPERATION 10 YEARS AUGMENTATION PATIENTS IMPLANT DEFLATION 217 PERCENTAGE REOPERATIONS DUE LUMPMASSCYST INCREASED 85 293 REOPERATIONS 5 YEARS 139 424 REOPERATIONS 10 YEARS OCCURRENCE LUMPS MASSES CYSTS EXPECTED NATURALLY INCREASE PATIENTS AGE COULD EXPLANATION INCREASE POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY CAPSULAR CONTRACTURE Â¿ PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT DEFLATION ONE COMMON REASONS REOPERATION 237 PATIENTS R95 STUDY LEAST 1 REOPERATION PERFORMED 99 PATIENTS 42 TOTAL 125 REOPERATIONS 5 YEARS PRIMARY REASON REOPERATION 5 YEARS CAPSULAR CONTRACTURE 256 237 RECONSTRUCTION PATIENTS R95 62 PATIENTS 262 70 IMPLANTS REMOVED 5 YEARS 70 RECONSTRUCTION IMPLANTS REMOVED 5 YEARS 70 REPLACED COMMON REASON IMPLANT REMOVAL CAPSULAR CONTRACTURE 314 10 YEARS 104 IMPLANTS REMOVED 85 PATIENTS COMMON REASON IMPLANT REMOVAL IMPLANT LEAKAGEDEFLATION 327|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-410|11/13/2015||||N|R||0HP|FWM|1.0|10/09/2005|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||569053|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5222818|31178940|D|1||PHYSICIAN REPORTED VIA VOLUNTARY MW5055722 PATIENT CAME SKIN LESION CHEST BIOPSY LESION CAME BACK ALCL ANAPLASTIC LARGE CELL LYMPHOMA PHYSICIAN ADDITIONALLY NOTED RIGHT SIDE DEVICE RIGHT SIDE CAPSULE REMOVED FLUID SENT CYTOLOGY PHYSICIAN SPECIFIED RIGHT BREAST FILLED THICK RED COLOREDBROWN COLORED FLUID REPORT RIGHT SIDE FOLLOW-UP REVEALS PATHOLOGY INITIALLY ASSESSED ABDOMINAL LESION BIOPSY RESULTS LESION UPPER ABDOMEN - CD30 POSITIVE LYMPHOMA CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA LARGE CELLS ALSO NEGATIVE EBER ALK-1 IMPLANTS REMOVED PATHOLOGY INDICATED RIGHT BREAST CAPSULE DIAGNOSED ALCL ALK NEGATIVE PATHOLOGY REPORT ADDITIONALLY INDICATES SINGLE 15 CM NODULE IDENTIFIED LOCATED NEAR IDENTICAL LESION RIGHT BREAST CAPSULE NODULE TESTED POSITIVE CD30 NEGATIVE ALK ALSO NOTED IMPLANT RECEIVED MINIMAL AMOUNTS ATTACHED BLOOD CLOT TISSUE PHYSICIAN ADDITIONALLY REPORTED RIGHT SIDE GRADE IV CAPSULAR CONTRACTURE PHYSICIAN NOTED PATIENT REFUSED CHEMOTHERAPY RADIOTHERAPY|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-410|11/13/2015||||N|R||0HP|FWM|1.0|10/09/2005|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||569053|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4902572|55597680|D|1||REPORT NULL-TYPE ANAPLASTIC LARGE CELL LYMPHOMA ARISING SILICONE BREAST IMPLANT CAPSULE WRITTEN PLASTIC RECONSTRUCTIVE SURGERY JUNE 2011 VOL 127 NUMBER 6 REPORTS PATIENT PRESENTED PAINFUL RIGHT BREAST BAKER GRADE III CAPSULAR CONTRACTUREIMPLANT REMOVED SUBMUSCULAR POUCH EXPLORED DRAINAGE SEROUS-HEMATIC FLUID SURROUNDING RIGHT PROSTHESIS CAPSULECTOMY PERFORMED REMOVED FIBROUS TISSUE ANALYZED ALTERED ASPECT PATHOLOGY FINDINGS CONSISTENT DIAGNOSIS NULL-TYPE ANAPLASTIC LYMPHOMA KINASE-NEGATIVE NON-HODGKINS ANAPLASTIC LARGE CELL LYMPHOMA ALCL DEVICE REMOVED MANUFACTURER DEVICE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/08/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4902572|14225628|N|1||UNIQUE IDENTIFIER UDI  NA MEDWATCH SUBMITTED FDA 07082015 DEVICE LABELING POTENTIAL ADVERSE EVENT MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PTS IMPLANT HISTORY INCLUDES ALLERGANS MFRS BREAST IMPLANTS CONSIDER POSSIBLY ALCL PT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REP PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS PTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PTS PRIMARY AUGMENTATION RECONSTRUCTION PTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT DEFLATION ONE COMMON REASONS REOPERATION PTS ALSO ADVISED ADDL SURGERY MAY NEEDED CASES PAIN ANDOR FIRMNESS SEVERE SURGERY RANGES REMOVAL IMPLANT CAPSULE TISSUE REMOVAL POSSIBLE REPLACEMENT IMPLANT SURGERY MAY RESULT LOSS BREAST TISSUE CAPSULAR CONTRACTURE MAY HAPPEN ADDL SURGERIES CAPSULAR CONTRACTURE MAY INCREASE RISK DEFLATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/08/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
4902572|6067684|D|1||REPORT NULL-TYPE ANAPLASTIC LARGE CELL LYMPHOMA ARISING SILICONE BREAST IMPLANT CAPSULE WRITTEN PLASTIC RECONSTRUCTIVE SURGERY JUNE 2011 VOL 127 NUMBER 6 REPORTS PT PRESENTED PAINFUL RIGHT BREAST BAKER GRADE III CAPSULAR CONTRACTUREIMPLANT REMOVED SUBMUSCULAR POUCH EXPLORED DRAINAGE SEROUS-HEMATIC FLUID SURROUNDING RIGHT PROSTHESIS CAPSULECTOMY PERFORMED REMOVED FIBROUS TISSUE ANALYZED ALTERED ASPECT PATHOLOGY FINDINGS CONSISTENT DIAGNOSIS NULL-TYPE ANAPLASTIC LYMPHOMA KINASE-NEGATIVE NON-HODGKINS ANAPLASTIC LARGE CELL LYMPHOMA ALCL DEVICE REMOVED MFR DEVICE UNK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/08/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNK|||||||True
5138318|27896968|D|1||ALLERGAN REPRESENTATIVE REPORTED CASE ALCL RECEIVED PHYSICIAN PATIENT PRESENTED SEROMA DRAINED SEROMA PROCEEDED SURGERY COMPLETE CAPSULECTOMY SEND CAPSULE PATHOLOGY PATHOLOGY CONFERRED CD30+ SIDE UNSPECIFIED FOLLOW-UP HEALTH PROFESSIONAL FOUND EXPANDING RIGHT BREAST CATEGORIZED SIGNIFICANT SEROMA CAPSULAR CONTRACTURE BAKER GRADE DIFFICULT DETERMINE DUE TENSION CAUSED SEROMA DEVICE REMOVED INTRAOPERATIVELY NOTED MATERIAL INTRACAPSULE APPEARED OLD HEMATOMA PATIENT YET CHEMOTHERAPY RADIOTHERAPY IMMUNOHISTOCHEMISTRY MALIGNANT APPEARING TUMOR CELLS REVEALS CELLS NEGATIVE CK7 AE1AE3 CD68 CK19 CK20 ER CD20 EMA TUMOR CELLS POSITIVE CD3 CD30 CD45 IMMUNOHISTOCHEMISTRY SUPPORTS DIAGNOSIS ANAPLASTIC LARGE CELL LYMPHOMA CELL LYMPHOMA ALK- MARKER CONFIRMED EVENT CAPTURED LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX155-685|10/08/2015||||N|R||0HP|FTR|1.0|11/28/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1172190|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5138318|27896967|N|1||B4 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX155-685|10/08/2015||||N|R||0HP|FTR|1.0|11/28/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1172190|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286954|33227537|D|1||PHYSICIAN REPORTS PATIENT BREAST IMPLANT DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL RIGHT BREAST PATHOLOGICAL MARKERS PROVIDED CASE CAPTURED LYMPHOMA DIAGNOSTIC CONFIRMATION RECEIVED TREATMENT UNKNOWN|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM240|12/10/2015|||DA|N|R||0HP|FTR|1.0|06/17/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2131883|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5286954|33227536|N|1||DEVICE LABELING ANAPLASTIC LARGE CELL LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM240|12/10/2015|||DA|N|R||0HP|FTR|1.0|06/17/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2131883|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5098467|26589689|D|1||PATIENT REPORTED DIAGNOSED RARE FORM ANAPLASTIC LARGE CELL LYMPHOMA CANCER DOCTOR STATED DIRECT RESULT IMPLANTS PATIENT REPORTED LARGE TUMOUR MEASURING 5CM BREASTS STARTED COURSE CHEMOTHERAPY REDUCE ASAP SWELLING UNCOMFORTABLE SORE MAKES BREATHLESS SIDE SPECIFIED FILE LEFT SIDE SEE MFR  9617229-2015-00398 RIGHT SIDE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/23/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5098467|26589688|N|1||B4 BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL PATIENT TOLD PRESENCE LUMPS PERSISTENT PAIN SWELLING HARDENING CHANGE IMPLANT SHAPE MAY SIGNS SYMPTOMATIC RUPTURE IMPLANT PATIENT SIGNS TOLD REPORT POSSIBLY MRI EVALUATION SCREEN RUPTURE LITERATURE REPORTS ALSO MADE ASSOCIATING SILICONE BREAST IMPLANTS VARIOUS RHEUMATOLOGICAL SIGNS SYMPTOMS FATIGUE EXHAUSTION JOINT PAIN SWELLING MUSCLE PAIN CRAMPING TINGLING NUMBNESS WEAKNESS SKIN RASHES|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/23/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4974939|26960388|D|1||FOLLOW-UP PATHOLOGIST REVEALS PATIENTS INITIAL PRESENTATION OCCURRED LEFT BREAST BECAME SWOLLEN ALSO BECAME RATHER TIGHT SORE THIN LAYER FLUID AROUND LEFT IMPLANT IRRITATION FOUND LEFT SIDE DEVICE REMOVAL CAPSULE CAVITY ENTERED LEFT SIDE EMPTIED ESTIMATED APPROX 1 LITER SEROUS FLUID CAPSULE REMOVED THREE YEARS LATER SMALL ROUND DENSIFICATION SHOWN LEFT MAMMA DIAMETER APPROX 8 MM LEFT SIDE CAPSULE REMOVED CAPSULE RUPTURES CLEAR SERUM FLUID FLOWS PATHOLOGY TESTED TISSUE LEFT BREAST CYST LESION FOUND BREAST TISSUE WITHIN FIBROUS WALL RIM GRANULATION TISSUE PARTLY ORGANIZED SERUMHEMATOMA MATERIAL FOUND PATHOLOGY CONFIRMS MALIGNANT TUMOR CYSTIC NECROSIS POSITIVE CD30 NEGATIVE REACTION ALK PROTEIN CONFIRMS DIAGNOSIS ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY REPORT ALSO INDICATES SIGNS ANYWHERE TUMOR CELLS INFILTRATING SURROUND SOFT TISSUE FIBROUS CAPSULE PATHOLOGIST NOTED PATIENT RECEIVED 3 SERIES CHOP CHEMOTHERAPY REGIMEN CURRENTLY UNDERGOING RADIATION THERAPY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/04/2015|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4974939|14087432|N|1||DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTEDLY GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/04/2015|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4399502|19805106|D|1||ONE RARE CASES ANAPLASTIC LARGE CELL LYMPHOMA ALCL CAUSED BREAST IMPLANTS CAPSULECTOMY BREASTS SINCE RECONSTRUCTION USING DIFFERENT MAKETYPE PROSTHESIS SINCE FIRST DIAGNOSED 2009 ABLE OBTAIN INFORMATION DETERMINED CASES LIKE MINE RECOMMENDATIONS GIVEN PATIENTS TIME DISCOVERED FIRST COUSIN ALSO SUFFERED CONDITION ALSO CAUSED IMPLANTS ALSO TOLD CAUGHT EARLY ENOUGH REQUIRE TREATMENT REMOVAL HAPPENED BIRTH COUNTRY B6 PLASTIC SURGEON B6 B6 PERFORMED ORIGINAL BREAST AUGMENTATION 2006 RECENTLY STARTED RESEARCHING PREVIOUS CONDITION CANNOT FIND DETAILS CONTACT INFORMATION COUNTRY HOPING AMERICAN FDA MAY CURRENT INFORMATION GIVE|MOULDED TEARDROP BREAST IMPLANT||01/05/2015|||DA||*||0|FTR|1.0||MOULDED TEARDROP BREAST IMPLANT|||||||MENTOR|||||||True
4399502|19805106|D|1||ONE RARE CASES ANAPLASTIC LARGE CELL LYMPHOMA ALCL CAUSED BREAST IMPLANTS CAPSULECTOMY BREASTS SINCE RECONSTRUCTION USING DIFFERENT MAKETYPE PROSTHESIS SINCE FIRST DIAGNOSED 2009 ABLE OBTAIN INFORMATION DETERMINED CASES LIKE MINE RECOMMENDATIONS GIVEN PATIENTS TIME DISCOVERED FIRST COUSIN ALSO SUFFERED CONDITION ALSO CAUSED IMPLANTS ALSO TOLD CAUGHT EARLY ENOUGH REQUIRE TREATMENT REMOVAL HAPPENED BIRTH COUNTRY B6 PLASTIC SURGEON B6 B6 PERFORMED ORIGINAL BREAST AUGMENTATION 2006 RECENTLY STARTED RESEARCHING PREVIOUS CONDITION CANNOT FIND DETAILS CONTACT INFORMATION COUNTRY HOPING AMERICAN FDA MAY CURRENT INFORMATION GIVE|MOULDED TEARDROP BREAST IMPLANT||01/05/2015|||||*||0|FTR|2.0||MOULDED TEARDROP BREAST IMPLANT|||||||MENTOR|||||||True
4672656|13207851|N|1||B4 EVENT ANAPLASTIC LARGE CELL LYMPHOMA INITIALLY REPORTED VIA EASR B6 2010 ADVERSE EVENT TERM CODE CANCER UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER LYMPHOMA-ALCL DUE INCREASED SPECIFICITY SEROMA REPORTED TIME ALSO DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS BASED INFO REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MUFTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL USE CARE SUBSEQUENT PROCEDURES OPEN CAPSULOTOMY BREAST POCKET REVISION HEMATOMASEROMA ASPIRATION BIOPSYLUMPECTOMY AVOID DAMAGE IMPLANT SHELL VALVE POSTOPERATIVE EVACUATION HEMATOMA SEROMA MUST CONDUCTED CARE AVOID BREAST IMPLANT CONTAMINATION DAMAGE SHARP INSTRUMENTS USE MICROWAVE DIATHERMY PATIENTS BREAST IMPLANTS RECOMMENDED REPORTED CAUSE TISSUE NECROSIS SKIN EROSION EXTRUSION IMPLANT ALLERGAN TESTED VIVO EFFECTS RADIATION THERAPY PATIENTS BREAST IMPLANTS LITERATURE SUGGESTS RADIATION THERAPY MAY INCREASE LIKELIHOOD CAPSULAR CONTRACTURE NECROSIS IMPLANT EXTRUSION PATIENTS INFORMED DISSATISFACTION COSMETIC RESULTS RELATED THINGS SCAR DEFORMITY HYPERTROPHIC SCARRING CAPSULAR CONTRACTURE ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION INCORRECT SIZE IMPLANT PALPABILITYVISIBILITY MAY OCCUR CAREFUL SURGICAL PLANNING TECHNIQUE MINIMIZE PRECLUDE RISK RESULTS PRE-EXISTING ASYMMETRY MAY ENTIRELY CORRECTABLE REVISION SURGERY MAY INDICATED MAINTAIN PATIENT SATISFACTION CARRIES ADDITIONAL CONSIDERATIONS RISKS RECONSTRUCTION MAIN REASONS REOPERATION 5 10 YEARS IMPLANT MALPOSITION YEAR 5 RATE= 32 IMPLANT MALPOSITION YEAR 10 RATE= 38|STYLE 163 SALINE FILLED BREAST IMPLANT|163-530|04/08/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4672656|5689022|D|1||HEALTH PROFESSIONAL REPORTED LEFT SIDE DEVICE REMOVED DUE PTS REPORT SWOLLEN TIGHT FEELING HEALTH PROFESSIONAL NOTED YELLOW CLEAR FLUID DRAINED PATHOLOGY SHOWED CYTOLOGIC FEATURES CONSISTENT ATYPICAL CELLS UPON REMOVAL DEVICE NOTED UPSIDE LEFT BREAST CAPSULE MALIGNANT CELLS FOCALLY INFILTRATING CAPSULAR SURFACE ASSOCIATED NECROSIS PATHOLOGY RESULTS CONFIRM ANAPLASTIC LARGE CELL LYMPHOMA STRONG POSITIVE CD30+|STYLE 163 SALINE FILLED BREAST IMPLANT|163-530|04/08/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4732544|17584118|D|1||B6 UNDERWENT BILATERAL AESTHETIC BREAST AUGMENTATION 285CC TEXTURED ANATOMIC SALINE FILLED BREAST IMPLANTS MCGHAN RETRO-PECTORAL POSITION BIA PERIAREOLAR INCISION B6 1999 B6 2014 NOTED INCREASED SZE LEFT BREAST FIRM MASS MEDIALLY  ALSO LEFT BREAST ULTRASONIC-GUIDED NEEDLE BIOPSY BREAST MASS PROVED RETRO-PECTORAL LEFT AXILLARY LYMPH NODES DONE B6 2014 SHOWED ANAPLASTIC LARGE CELL LYMPHOMA ALK NEG BREAST NODES PETCT SHOWED BREAST MASS HIGHLY HYPERMETABOLIC ENLARGED HYPERMETABOLIC LEFT RIGHT AXILLARY NODES PATIENT RECEIVED CHEMOTHERAPY CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE ETOPOSIDE B6 2014 B6 2015 GOOD RESPONSE BREAST IMPLANT REMOVAL RECOMMENDED PATIENT SENT CONSIDERATION BONE MARROW TRANSPLANT|MCGHAN BREAST IMPLANT|27-468271|04/22/2015|||||||0|FWM|2.0||MCGHAN BREAST IMPLANT|||||||MCGHAN|||||STYLE 468||True
4732544|17584118|D|1||B6 UNDERWENT BILATERAL AESTHETIC BREAST AUGMENTATION 285CC TEXTURED ANATOMIC SALINE FILLED BREAST IMPLANTS MCGHAN RETRO-PECTORAL POSITION BIA PERIAREOLAR INCISION B6 1999 B6 2014 NOTED INCREASED SZE LEFT BREAST FIRM MASS MEDIALLY  ALSO LEFT BREAST ULTRASONIC-GUIDED NEEDLE BIOPSY BREAST MASS PROVED RETRO-PECTORAL LEFT AXILLARY LYMPH NODES DONE B6 2014 SHOWED ANAPLASTIC LARGE CELL LYMPHOMA ALK NEG BREAST NODES PETCT SHOWED BREAST MASS HIGHLY HYPERMETABOLIC ENLARGED HYPERMETABOLIC LEFT RIGHT AXILLARY NODES PATIENT RECEIVED CHEMOTHERAPY CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE ETOPOSIDE B6 2014 B6 2015 GOOD RESPONSE BREAST IMPLANT REMOVAL RECOMMENDED PATIENT SENT CONSIDERATION BONE MARROW TRANSPLANT|MCGHAN BREAST IMPLANT|27-468271|04/22/2015|||||||0|FWM|1.0||MCGHAN BREAST IMPLANT|||||||MCGHAN|||||STYLE 468||True
4720409|16988108|D|1||HEALTH PROFESSIONAL REPORTED LATE SEROMA - ASPIRATION POSITIVE ALCL SPECIFIED RIGHT SIDE CYTOLOGY CONFIRMS TUMOUR CELLS EXPRESS PAN LYMPHOID MARKER CD45 CD3 CD30 B CELLS EXPRESSING CD20 STAINING ALK1CONCLUSION MALIGNANT BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BIA-ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX130-450|04/21/2015|||DA|N|R||0HP|FTR|1.0|06/14/2015|nan||1850087|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4688919|13145475|N|1||EVENT ANAPLASTIC LARGE CELL LYMPHOMA INITIALLY REPORTED VIA EASR B6 2011 ADVERSE EVENT TERM CODE CANCER UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED LYMPHOMA - ALCL DUE INCREASED SPECIFICITY PATIENT IDENTIFIER B6 RELATES PATIENTS RECORD PREVIOUSLY EXISTING B6 DATABASE CURRENT DATABASE PATIENT IDENTIFIER PR B6 DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHY CHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS NATRELLE CORE STUDY CONTINUE EVALUATE LONG-TERM 10 YEARS SAFETY EFFECTIVENESS PRODUCTS ADDITION ALLERGAN INITIATED SEPARATE LARGE 10-YEAR POST-APPROVAL STUDY BREAST IMPLANT FOLLOW-UP STUDIES BIFS ADDRESS SPECIFIC ISSUES ALLERGANS CORE STUDY DESIGNED FULLY ANSWER WELL PROVIDE REAL-WORLD ASSESSMENT ENDPOINTS ENDPOINTS BIFS LARGE POST-APPROVAL STUDY INCLUDE LONG-TERM LOCAL COMPLICATIONS CONNECTIVE TISSUE DISEASE CTD CTD SIGNS SYMPTOMS NEUROLOGICAL DISEASE NEUROLOGICAL SIGNS SYMPTOMS OFFSPRING ISSUES REPRODUCTIVE ISSUES LACTATION ISSUES CANCER SUICIDE MAMMOGRAPHY ISSUES MRI COMPLIANCE RESULTS ALLERGAN UPDATE LABELING REGULAR BASIS RESULTS TWO STUDIES 1 PRIMARY AUGMENTATION PATIENT NEW DIAGNOSIS BREAST CANCER 7 YEARS CORE STUDY 13 BENIGN BREAST DISEASE RATE 1 MALIGNANT BREAST DISEASE RATE REVISION-AUGMENTATION PATIENTS 1 PATIENT NEW DIAGNOSIS BREAST CANCER 15 BENIGN BREAST DISEASE RATE 1 MALIGNANT BREAST DISEASE RATE 7 YEARS PRIMARY AUGMENTATION PATIENTS 1 REPORT THYROID CANCER 1 REPORT BRAIN CANCER REPORTS CANCERS RESPIRATORY CERVICALVULVAR REVISION-AUGMENTATION PATIENTS 8 PRIMARY RECONSTRUCTION PATIENTS 8 NEW REPORTS BREAST CANCER 7 YEARS CORE STUDY 17 BENIGN BREAST DISEASE RATE 10 MALIGNANT BREAST DISEASE RATE 7 YEARS REVISION RECONSTRUCTION PATIENTS REPORTS NEW DIAGNOSES REOCCURRENCE BREAST CANCER 7 BENIGN BREAST DISEASE RATE 7 YEARS REPORTS CANCERS BRAIN RESPIRATORY CERVICALVULVAR PRIMARY RECONSTRUCTION REVISION-RECONSTRUCTION PATIENTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/13/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4730396|17824636|N|1||EVENT ANAPLASTIC LARGE CELL LYMPHOMA INITIALLY REPORTED VIA EASR JULY 28 2010 ADVERSE EVENT TERM CODE CANCER UPDATE SAFETY DATABASE REPORTED EVENT NOTES TERM CODE CHANGED CANCER LYMPHOMA - ALCL DUE INCREASED SPECIFICITY B6|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/24/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|LA AURORA DE HEREDIA|||CS|ALLERGAN|||||||True
5092043|26351217|N|1||DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/21/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4739847|20018445|D|1||PHYSICIAN REPORTS LEFT SIDE DEVICE REMOVAL REPLACEMENT PT HISTORY BREAST CANCER DUE SEROMA CONFIRMED HISTOLOGY ALCL ANAPLASTIC LARGE CELL LYMPHOMA ALCL CONFIRMED TEST RESULTS NEITHER PROVIDED REPORTED EVENT CAPTURED LYMPHOMA TEST RESULTS RECEIVED|UK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|04/29/2015|||DA|N|R||0HP|FWM|1.0||nan|||||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4541872|16628904|D|1||PT B6 FEMALE HISTORY DCIS LEFT BREAST DIAGNOSED 1989 UNDERWENT LUMPECTOMY RADIATION THERAPY FOUND RECURRENCE 2006 TIME UNDERWENT LEFT MASTECTOMY SENTINEL LYMPH NODE BIOPSY 2006 RECONSTRUCTION B6 2007 UNDERWENT DELAYED PLACEMENT MENTOR TEXTURED SILTEXT MEDIUM HEIGHT TISSUE EXPANDER REFERENCE 3584-6215 LOT 5725412 SERIAL NUMBER B4 650CC VOLUME INTRAOPERATIVE FILL 180CC SALINE LATISSIMUS DORSI FLAP LEFT SIDE UNDERWENT TISSUE EXPANSION SUBSEQUENTLY B6 2007 UNDERWENT EXCHANGE TISSUE EXPANDER PERMANENT SILICONE TEXTURED MENTOR CPG IMPLANT CONCURRENTLY UNDERWENT RIGHT MASTOPEXY AUGMENTATION SYMMETRY PTS RECORDS DR B6 REVIEWED PT MENTOR CPG 323 SILICONE GEL IMPLANT 685 CC LEFT REF 334-1452G MENTOR CPG 323 GEL IMPLANT SIZE 350CC RIGHT REF 350-3501BC B6 2014 NOTICED LEFT BREAST SUDDENLY 1-2 WEEKS LARGER RIGHT FLUID COLLECTION FOUND PHYSICAL EXAM UNDERWENT ASPIRATION FLUID COLLECTION TOTALED 400 CUBIC CENTIMETERS CLEAR YELLOW OUTPUT SENT PATHOLOGY DEMONSTRATED CD30 POSITIVE ALK NEGATIVE ANAPLASTIC LARGE-CELL LYMPHOMA ALCL CONSISTENT BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 2014 UNDERWENT BILATERAL BREAST EXPLANTATION WELL BILATERAL TOTAL CAPSULECTOMIES EXTENSIVE CAPSULECTOMY LEFT SIDE MARGINS NEGATIVE PER PTS REPORT SUSPICIOUS LYMPHADENOPATHY DONE B6 ALSO PTS BREAST RECONSTRUCTION MASS ALCL LOCATED WITHIN IMPLANT CAPSULE PTS SURGICAL ONCOLOGIST DR B6 PT SEEN LYMPHOMA SERVICE PLASTIC SURGERY B4 SURVEILLANCE RECONSTRUCTION|CPG MEMORY SHAPE GEL BREAST IMPLANT|334-1452G|02/19/2015|||DA|N|R||0HP|FTR|1.0||BREAST IMPLANT||5719721|||IRVING|US|MENTOR||TX|||||True
6177062|62452555|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL SEROMA BREAST LUMPS ERYTHEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6177062|62452556|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 OLD PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED MASS SEROMA ERYTHEMATOUS SKIN ERUPTION  TREATMENT REPORTED IMPLANT REMOVAL CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6145512|61450146|D|1||PHYSICIAN REPORTED CLOUDY YELLOW FLUID BREAST PROSTHESIS DIAGNOSIS ANAPLASTIC LARGE CELL LYMPHOMA CYTOLOGICAL MARKERS CD30+ ALK- CONFIRMED EVENT CAPTURED LYMPHOMA DEVICE EXPLANTED MEDWATCH RIGHT SIDE DEVICE SEE MANUFACTURER REPORT  9617229-2016-00173 LEFT SIDE REPORT|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5691027|46273890|N|1||MEDWATCH SENT FDA 06012016 EVENTS SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE RETURNED THEREFORE UNAVAILABLE ANALYSIS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410215|06/01/2016|||DA|N|R||0HP|FTR|1.0|06/02/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1620541|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6177002|62447627|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA Â¿DISRUPTED IMPLANTÂ¿ TREATMENT REPORTED IMPLANT REMOVAL CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP FOUND Â¿NO EVIDENCE DISEASEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6177002|62447626|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5488699|39950188|N|1||MEDWATCH SUBMITTED 03092016 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION BEN IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|03/09/2016|||DA|N|R||0HP|FWM|1.0|04/12/2008|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||621428|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5597717|43315362|N|1||MEDWATCH SUBMITTED FDA 04222016 B4  DEVICE RETURNED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLY CAUSE EVENT DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|07/12/2001|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||530498|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5597737|43319693|N|1||MEDWATCH SUBMITTED FDA 04222016 B4 DEVICE RETURNED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLY CAUSE EVENT DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|168-360|04/22/2016|||DA|N|R||0HP|FWM|1.0|01/20/2002|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||533743|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6037732|57779753|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/18/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5922918|53782148|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING PATIENT INFORMATION DEVICE INFORMATION SIDE EXPERIENCING POSSIBLE ALCL PATHOLOGY REPORT DEVICE RETURN REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|09/01/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5922918|53782149|D|1||HEALTHCARE PROFESSIONAL REPORTED PATIENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL EXPLANT SURGERY OCCURRED 3 WEEKS AGO PATHOLOGICAL MARKERS RECEIVED CONFIRMING ALCL EVENT CAPTURED LYMPHOMA MARKERS RECEIVED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|09/01/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5708570|46882993|N|1||MEDWATCH SENT FDA 06092016 RESPONSE FDA REPORT NUMBER MW5061580 B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE SERIALLOT NUMBER PATIENT INFORMATION PROVIDED DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-400|06/09/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5596175|43273718|D|1||HEALTH PROFESSIONAL REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE III-IV EXPLANT SURGERY CAPSULE OPENED PHYSICIAN LOCATED 5ML BROWN FLOCCULENT MATERIAL PERIPROSTHETIC SPACE LOOKED LIKE OLD BLOOD LIQUID SURGERY FOUND MASS CAPSULE PALPABLE OUTSIDE PHYSICIAN ALSO STATED REMOVING IMPLANT NOTICED TUMOR GOING PATIENTS RIB CAGE MASS DEEMED MALIGNANT SENT PATHOLOGY PATHOLOGY REPORTED STATES LEFT BREAST CAPSULE - PATCHY INFILTRATE ANAPLASTIC LARGE CELL LYMPHOMA ALK-NEGATIVE WITHIN BACKGROUND FIBROSIS INFLAMMATION SECOND SET IMMUNOPEROXIDASE STAINS PERFORMED SHOWING TUMOR CELLS POSITIVE CD30 NEGATIVE EMA ALK-1 CD3 CLINICAL HISTORY NOTES PERSONAL HISTORY BREAST CANCER ACQUIRED ABSENCE BREAST CONTRACTURE PAIN TREATMENT INCLUDED SURGICAL MANAGEMENT CHEMOTHERAPY RADIOTHERAPY|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-500|04/21/2016|||DA|N|R||0HP|FTR|1.0|01/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1204889|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5596175|43273717|N|1||B4 DEVICE RETURNED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLY CAUSE EVENT DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NONHODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-500|04/21/2016|||DA|N|R||0HP|FTR|1.0|01/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1204889|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5596175|47926535|D|1||HEALTH PROFESSIONAL REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE III-IV EXPLANT SURGERY CAPSULE OPENED PHYSICIAN LOCATED 5ML BROWN FLOCCULENT MATERIAL PERIPROSTHETIC SPACE LOOKED LIKE OLD BLOOD LIQUID SURGERY FOUND MASS CAPSULE PALPABLE OUTSIDEÂ¿ PHYSICIAN ALSO STATED REMOVING IMPLANT NOTICED TUMOR GOING PATIENTS RIB CAGE MASS DEEMED MALIGNANT SENT PATHOLOGY PATHOLOGY REPORTED STATES Â¿LEFT BREAST CAPSULE Â¿ PATCHY INFILTRATE ANAPLASTIC LARGE CELL LYMPHOMA ALK-NEGATIVE WITHIN BACKGROUND FIBROSIS INFLAMMATIONÂ¿A SECOND SET IMMUNOPEROXIDASE STAINS PERFORMED SHOWING TUMOR CELLS POSITIVE CD30Â¿NEGATIVE EMA ALK-1 CD3Â¿ CLINICAL HISTORY NOTES Â¿PERSONAL HISTORY BREAST CANCER ACQUIRED ABSENCE BREAST CONTRACTURE PAINÂ¿ TREATMENT INCLUDED SURGICAL MANAGEMENT CHEMOTHERAPY RADIOTHERAPY|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-500|04/21/2016|||DA|N|R||0HP|FTR|1.0|01/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1204889|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6011867|56822654|D|1||ALLERGANÂ¿S LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ ARTICLEÂ¿S PURPOSE CAPTURE REPORTED BIA-ALCL AUSTRALIA NEW ZEALAND STUDY ASSOCIATION RISK DIFFERENT IMPLANT SURFACES INCIDENCE BIA-ALCL TOTAL 46 PATIENTS IDENTIFIED 2007 AUGUST 2016 FIVE WOMEN MULTIPLE IMPLANTS REMAINING 41 SINGLE IMPLANT HISTORY TOTAL 56 IMPLANT PAIRS ARTICLE STATES Â¿ALL PATIENTS EXPOSED TEXTURED IMPLANTS POINT IMPLANT HISTORYÂ¿ ARTICLE CLARIFIES Â¿THERE TOTAL 46 IMPLANTS PLACED AUSTRALIA 8 IMPLANTS PLACED NEW ZEALAND TWO PATIENTS IMPLANT PLACED OUTSIDE AUSTRALIA NEW ZEALAND 1 MEXICO 1 THAILANDÂ¿ MANUFACTURER COULD SPECIFIED ARTICLE STATES Â¿BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED 571 IMPLANTS SERIESÂ¿ ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011867|56822653|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENT LYMPHOMA ALCL PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5670826|58278251|D|1||PHYSICIAN REPORTED TUMOUR CELLS EXPRESS CD3 CD30 CD15 P63 FOCAL WEAK NEGATIVE PAX5 CD20 ALK EBV EBER DIAGNOSIS ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANTS EVENT ALCL CONFIRMED TIME PHYSICIAN ADDITIONALLY REPORTED SMALL POST-BIOPSY HEMATOMA OBSERVED PROBABLE THROMBOSIS ADJACENT VESSEL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MM125-320|05/20/2016|||DA|N|R||0HP|FTR|1.0|02/03/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2073435|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5670826|45647377|D|1||PHYSICIAN REPORTED APPROXIMATELY FIVE YEARS IMPLANTATION PATIENT CONSULTED DOCTOR DISCOVERING SELF-EXAM TEN DAYS EARLIER INFRACLAVICULAR C11 LUMPS PATIENTS LEFT BREAST LEFT AXILLARY ADENOPATHY ULTRASOUND-GUIDED BAG ACCORDING BI-RADS ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA ALCL CD30 RESULTS PROVIDED REPORT ALCL YET CONFIRMED CURRENTLY CAPTURED LYMPHOMA DEVICE EXPLANTED PATIENT STUDIED CHEMOTHERAPY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MM125-320|05/20/2016|||DA|N|R||0HP|FTR|1.0|02/03/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2073435|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6146400|61491852|N|1||B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA NECROSIS PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA ARTICLE CITATION Â¿CLASSICAL HODGKIN LYMPHOMA ARISING ADJACENT BREAST IMPLANTÂ¿ CIARA RYAN MB MRCSI FRCPATH1 YASSER GED MB1 FIONA QUINN PHD1 JAN WALKER BSC1 JOHN KENNEDY MB FRCPI1 CHARLES GILLHAM MB MRCP FRCR1 STEFANIA PITTALUGA MD PHD2 RONAN MCDERMOTT MB MRCPI FRCR FFRRCSI1 ELISABETH VANDENBERGHE MB PHD MRCPI MRCPATH1 CLIONA GRANT MB MRCPI1 RICHARD FLAVIN MD PHD FRCPATH1 INTERNATIONAL JOURNAL SURGICAL PATHOLOGY 2016 VOL 245 448Â¿455|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/05/2016|||DA|*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6146400|66166179|D|1||FOLLOW-UP PHYSICIAN REVEALED PATIENT ANAPLASTIC LARGE CELL LYMPHOMA HODGKIN LYMPHOMA FAILED ESTABLISH DIRECT CAUSATION LINK IMPLANT EVENT LYMPHOMA CONSIDERED DEVICE RELATED EVENTS LUMPNODULE PRURITUS CANCER BREAST NECROSIS CONSIDERED DEVICE RELATED SECONDARY EVENT LYMPHOMA EVENT LATE SEROMA REMAINS MDR REPORTABLE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/05/2016|||DA|*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5880065|52274646|N|1||MEDWATCH SENT FDA 08162016 EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT FOLLOW PERFORMED DETERMINE DEVICE MANUFACTURER SERIAL NUMBER LOT NUMBER IMPLANT DATE PATIENT NAME PATIENT DATE BIRTH PATHOLOGICAL TESTING RESULTS EXPLANT DATE DEVICE RELATIONSHIP REPORTED EVENT DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/16/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|UNK|||||||True
5936530|54204592|N|1||MEDWATCH SENT FDA 09082016 EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING SERIAL NUMBER DATE IMPLANTEXPLANT IMPLANTING PHYSICIAN PATIENT INFORMATION RETURN PATHOLOGICAL MARKERS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/08/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176674|62457390|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA MASS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176674|62457391|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED MASS SEROMA TREATMENT REPORTED IMPLANT REMOVAL CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6142978|61395222|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL DEATH PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6142978|62721838|D|1||ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTS B6 PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN CHART ADDITIONALLY PROVIDES PATIENT EXPERIENCED RIGHT SIDE MASS TREATMENT REPORTED IMPLANT REMOVAL CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP REVEALED PATIENT DIED LYMPHOMA PROGRESSION REPORT INITIALLY SENT REPRESENT TWO PATIENTS DUE DISCOVERY IDENTIFYING INFORMATION SUPPLEMENTAL REPORT REPRESENT B6 PATIENT DEVICE MFR  9617229-2016-00227 SENT REPRESENT PATIENT PREVIOUSLY REPRESENTED INITIAL REPORT MFR  9617229-2016-00195|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6142978|61395223|D|1||LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTED Â¿19 I-ALCLSÂ¿ CASES ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ ARTICLE REPORTED CASES Â¿INFILTRATIVE I-ALCLÂ¿ SURVIVAL RATE 525 ARTICLE REPORTS CASES RESULTED DEATH TWO LYMPHOMA PROGRESSION RECORD REPRESENTS CASES INFILTRATIVE I-ALCL RESULTED DEATH LYMPHOMA PROGRESSION ARTICLE REPORTS HISTOPATHOLOGY REPORTS MALIGNANT CELLS CD30-POSITIVE ALK NEGATIVE REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ WAY KNOWING TREATMENT USED TWO CASES MANUFACTURER DEVICES UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6153182|61700301|D|1||JOURNAL ARTICLE Â¿AXILLARY LYMPHADENOPATHY OUTSTANDING PRESENTATION BREAST IMPLANT-ASSOCIATED ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ REPORTS Â¿WE REPORT CASE PATIENT PRESENTING AXILLARY LYMPHADENOPATHY 8 YEARS BREAST PROSTHESES IMPLANTATION CLINICAL EXAMINATION ULTRASOUND MAGNETIC RESONANCE IMAGING DETECTED MAMMARY LESIONS LYMPH NODE SHOWED INTRASINUSOIDAL INFILTRATION LARGE PLEOMORPHIC CELLS EXPRESSING CD30 LACKING ALK-IMMUNOREACTIVITY TUMOR STAGING NEGATIVE CELLS IDENTICAL FEATURES FOUND IPSILATERAL PERIPROSTHETIC CAPSULE PATIENT TREATED CHOP RADIOTHERAPY PATIENT ALIVE WITHOUT EVIDENCE DISEASE 30-MONTH FOLLOW-UPÂ¿ FINE-NEEDLE ASPIRATION CYTOLOGY TAKEN AXILLARY LYMPH NODE CD30+  ALK- CONFIRMED DEVICE REMOVAL CAPSULECTOMY PERFORMED MANUFACTURER DEVICE UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5940718|69962842|N|1||EVENTS INFLAMMATION LUMPNODULE LYMPHOMA ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CASES PATIENTS PRESENTED MASSES ADJACENT BREAST IMPLANT PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/09/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5940718|54394902|N|1||MEDWATCH SENT FDA 09092016 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/09/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6199283|63133500|D|1||PHYSICIAN REPORTED ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT REQUIRED CYTOLOGICAL MARKERS DIAGNOSIS RECEIVED EVENT CAPTURED TERM CODE LYMPHOMA DEVICE EXPLANTED|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM130-360|12/22/2016|||DA|N|R||0HP|FTR|1.0|11/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||352966|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6153188|61710211|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ 137 6 1659-1669 HONGHUA HU PHD KHALID JOHANI AHMAD ALMATROUDI KAREN VICKERY PHD BVSC BRUCE VAN NATTA MD MARSHALL E KADIN MD GARRY BRODY MD MARK CLEMENS MD CHAN YOON CHEAH MD STEPHEN LADE MD PREETI AVINASH JOSHI MDPHD H MILES PRINCE MDPHD ANAND K DEVA BSCMED MBBS MS PUBLISHED JUNE 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5659740|45309562|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE SWELLING WOULD COME GO VARYING TIMES ADDITION FIRMNESS SIGNIFICANT SUPERIOR POLE FULLNESS CAPSULAR CONTRACTURE BAKER GRADE IV CONFIRMED UPON EXPLANT CAPSULECTOMY PATHOLOGY NOTED RIGHT BREAST CAPSULE CAPSULECTOMY BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA SEE COMMENT COMMENT NOTES LYMPHOMA CELLS APPEAR PRIMARILY CONFINED INNER SURFACE RIGHT BREAST CAPSULE DESCRIBED EFFUSION-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ALCLÂ¿ GROSS EXAMINATION NOTES Â¿PREVIOUSLY OPENED BREAST CAPSULE CONTAINS 45 CC TURBID TAN-YELLOW FLUIDÂ¿ MICROSCOPIC EXAMINATION NOTES Â¿THE LARGE ATYPICAL CELLS STAIN POSITIVELY CD30Â¿THESE CELLS NEGATIVE ALKÂ¿|STYLE 168 SALINE FILLED BREAST IMPLANT|UNK STYLE 168|05/17/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5659740|45309561|N|1||MEDWATCH SENT FDA 05172016 B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE RETURNED SERIAL NUMBER AVAILABLE DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|UNK STYLE 168|05/17/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5894468|52721867|D|1||COMPANY REPRESENTATIVE REPORTED BEHALF HEALTH PROFESSIONAL LATE SEROMA TESTED POSITIVE CD30 OPERATIVE REPORT REFERENCES SURGERY B6 2008 PATIENT BILATERAL NEOSUBMUSCULAR POCKET REPOSITIONING EXISTING BREAST IMPLANTS OPERATIVE REPORT ADDITIONALLY NOTES BOTTOMING BREAST IMPLANT BREAST ASYMMETRY CHEST WALL DEFORMITY CONSTRICTED BREASTÂ¿ ADDITION Â¿THE BREAST IMPLANT WIPED ANTIBIOTIC LAP PAD REINSERTED POCKETÂ¿ B6 2015 PATIENT NOTICED BREAST IMPLANTS ASYMMETRIC EVALUATED PLASTIC SURGEON SUSPECTED CAPSULAR CONTRACTION PHYSICIAN NOTES CLARIFY Â¿ON PHYSICAL EXAMINATION LEFT BREAST ALMOST TWICE SIZE RIGHT BREAST EDEMA LEFT BREAST SKIN ULTRASOUND LATER CONFIRMED LEFT SIDE RUPTURE FLUID SURROUNDING IMPLANT LEFT BREAST LATER BECAME ENGORGED DEVELOPED SEROMA ASPIRATED B6 2016 FOUND POSITIVE CD30 ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY DATED B6 2016 STATES Â¿LYMPHOID CELLS POSITIVE CD3 CD30Â¿THE FINDINGS SUGGEST POSSIBLE BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ EXAM DATED B6 2016 STATES Â¿DIAGNOSIS ALCL BREAST PALPABLE LEFT BREAST MASSÂ¿ PATIENT SURGERY B6 2016 REPLACEMENT TIME DEVICE AVAILABLE RETURN ALLERGAN B6 2016 PATIENT EVIDENCE ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-354|08/22/2016|||DA|N|R||0HP|FTR|1.0|01/13/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1393696|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5894468|52721866|N|1||B4 EVENTS LYMPHOMA ALCL SEROMA LATE EDEMA VISIBILITYPALPABILITY PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE REOPERATION IMPLANT REMOVAL ASYMMETRY IMPLANT MISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY HEMATOMASEROMA BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-354|08/22/2016|||DA|N|R||0HP|FTR|1.0|01/13/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1393696|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5894468|54359677|D|1||COMPANY REPRESENTATIVE REPORTED BEHALF HEALTH PROFESSIONAL LATE SEROMA TESTED POSITIVE CD30 OPERATIVE REPORT REFERENCES SURGERY B6 2008 PATIENT BILATERAL NEOSUBMUSCULAR POCKET REPOSITIONING EXISTING BREAST IMPLANTS OPERATIVE REPORT ADDITIONALLY NOTES BOTTOMING BREAST IMPLANT BREAST ASYMMETRY CHEST WALL DEFORMITY CONSTRICTED BREASTÂ¿ ADDITION Â¿THE BREAST IMPLANT WIPED ANTIBIOTIC LAP PAD REINSERTED POCKETÂ¿ B6 2015 PATIENT NOTICED BREAST IMPLANTS ASYMMETRIC EVALUATED PLASTIC SURGEON SUSPECTED CAPSULAR CONTRACTION PHYSICIAN NOTES CLARIFY Â¿ON PHYSICAL EXAMINATION LEFT BREAST ALMOST TWICE SIZE RIGHT BREAST EDEMA LEFT BREAST SKIN ULTRASOUND LATER CONFIRMED LEFT SIDE RUPTURE FLUID SURROUNDING IMPLANT LEFT BREAST LATER BECAME ENGORGED DEVELOPED SEROMA ASPIRATED B6 2016 FOUND POSITIVE CD30 ANAPLASTIC LARGE CELL LYMPHOMA PATHOLOGY DATED B6 2016 STATES Â¿LYMPHOID CELLS POSITIVE CD3 CD30Â¿THE FINDINGS SUGGEST POSSIBLE BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ EXAM DATED B6 2016 STATES Â¿DIAGNOSIS ALCL BREAST PALPABLE LEFT BREAST MASSÂ¿ PATIENT SURGERY 06132016 REPLACEMENT TIME DEVICE AVAILABLE RETURN ALLERGAN B6 2016 PATIENT EVIDENCE ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-354|08/22/2016|||DA|N|R||0HP|FTR|1.0|01/13/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1393696|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5935521|54162317|N|1||MEDWATCH SENT FDA 09082016 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|09/08/2016|||DA|N|R||0HP|FWM|1.0|05/05/2011|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1440846|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5904549|58060034|D|1||PHYSICIAN REPORTED RIGHT BREAST SWOLLEN FIRM SENSITIVE DEEP PALPATION PHYSICIAN ALSO STATED ANAPLASTIC LARGE CELL LYMPHOMA FOUND PERI PROSTHETIC FLUID FIBRINOID DEPOSITS WITHIN PERIPROSTHETIC CAPSULE RIGHT BREAST PHYSICIAN ALSO STATED PT UNDERWENT BILATERAL TOTAL CAPSULECTOMY IMPLANT REMOVAL YEAR PT DISEASE FREE CT PET SCANS INCLUDING RECENT SCAN SHOW SIGNS LYMPHOMA EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
5904549|53036937|D|1||PHYSICIAN REPORTED RIGHT BREAST SWOLLEN FIRM SENSITIVE DEEP PALPATION PHYSICIAN ALSO STATED ANAPLASTIC LARGE CELL LYMPHOMA FOUND PERI PROSTHETIC FLUID FIBRINOID DEPOSITS WITHIN PERIPROSTHETIC CAPSULE RIGHT BREAST PHYSICIAN ALSO STATED PT UNDERWENT BILATERAL TOTAL CAPSULECTOMY IMPLANT REMOVAL YEAR PT DISEASE FREE CT PET SCANS INCLUDING RECENT SCAN SHOW SIGNS LYMPHOMA EVENT CAPTURED LYMPHOMA PATHOLOGICAL MARKERS CONFIRM ALCL RECEIVED|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
5991152|58278327|D|1||GOVERNING BODY REPORTED RIGHT SIDE Â¿CLINICAL SIGNS SIGNS MRI ULTRASOUND ENLARGEMENT LYMPH NODES ANAPLASTIC LARGE CELL LYMPHOMA ALK- SPECIFIED DISCOVERING ANAPLASTIC LYMPHOMA AXILLARY LYMPHADENOPATHY ALCL DIAGNOSIS RECEIVED MAY 2016 TREATMENT INCLUDES EXPLANTATION BREAST PROSTHESIS CAPSULECTOMY PERFORMED ANATOMOPATHOLOGIC RESULT MATERIAL KEPT PATIENT RECEIVE SPECIFIC TREATMENT CHEMOTHERAPY APPROVAL COLLEGIAL DECISION MULTIDISCIPLINARY MEETING|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF135-420|09/30/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2334015|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5991152|56059751|N|1||MEDWATCH SENT FDA 09302016 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE HISTORY REVIEW DHR SUMMARY REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED THREE DEVICES SCRAPPED ASSEMBLY PROCESS RELATED REPORTED EVENT  ADDITION DHR SHELL RUNS NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF135-420|09/30/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2334015|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5991152|56059752|D|1||GOVERNING BODY REPORTED RIGHT SIDE CLINICAL SIGNS SIGNS MRI ULTRASOUND ENLARGEMENT LYMPH NODES ANAPLASTIC LARGE CELL LYMPHOMA ALK- SPECIFIED DISCOVERING ANAPLASTIC LYMPHOMA AXILLARY LYMPHADENOPATHY ALCL DIAGNOSIS RECEIVED B6 2016 TREATMENT INCLUDES EXPLANTATION BREAST PROSTHESIS CAPSULECTOMY PERFORMED ANATOMOPATHOLOGIC RESULT MATERIAL KEPT PATIENT RECEIVE SPECIFIC TREATMENT CHEMOTHERAPY APPROVAL COLLEGIAL DECISION MULTIDISCIPLINARY MEETING|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF135-420|09/30/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2334015|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5991152|59996591|D|1||GOVERNING BODY ADDITIONALLY REPORTED RIGHT SIDE CAPSULAR PAIN RIGHT SIDE LYMPH NODE TUMOR SYNDROME PRURITUS SINE MATERIAL AXILLARY GANGLIONS ANAPLASTIC LARGE CELL LYMPHOMA CD30+ ALK -|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF135-420|09/30/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2334015|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191866|64757804|N|1||EVENTS ALCL LYMPHOMA CAPSULAR CONTRACTURE SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVALHEMATOMASEROMA BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWINGSEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT RUPTURE ONE COMMON REASONS REOPERATION|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191866|62906212|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6191882|62905244|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF145-490|12/20/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5719833|47208525|D|1||PATIENT REPORTED SEROMA RIGHT BREAST PARTIAL CAPSULECTOMY  CAPSULOTOMY EXCHANGE PERFORMED SURGICAL LOG REPORTS 600 CC SEROUS FLUID PRESENT RIGHT SEROLOGY PENDING PATHOLOGY + ALCL PETCT SCAN STATES FAINT ACTIVITY AFFILIATED RIGHT AXILLARY NODES RELATIVELY LESS CONCERN POTENTIALLY INFLAMMATORYREACTIVE CYTOLOGY REPORT STATES RIGHT BREAST FLUID HIGHLY ATYPICAL LYMPHOCYTES PRESENT CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE COMMENT HIGHLY ATYPICAL LYMPHOCYTES DEMONSTRATES STAINING CD30 NEGATIVE ALK-1 IMMUNOHISTOCHEMISTRY PROFILE CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/13/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2594775|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5719833|47208524|N|1||MEDWATCH SENT FDA 06132016 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS KNOWN DEVICE RETURNED PATIENT DECLINED PERMISSION CONTACT HEALTH PROFESSIONAL TIME DEVICE HISTORY RECORD REPORTS REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUNS NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/13/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2594775|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6145514|61451048|D|1||PHYSICIAN REPORTED CLOUDY YELLOW FLUID BREAST PROSTHESIS DIAGNOSIS ANAPLASTIC LARGE CELL LYMPHOMA CYTOLOGICAL MARKERS CD30+ ALK- CONFIRMED EVENT CAPTURED LYMPHOMA DEVICE EXPLANTED MEDWATCH LEFT SIDE DEVICE SEE MANUFACTURER REPORT B4 RIGHT SIDE REPORT|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5531532|44806115|D|1||HEALTH PROFESSIONAL REPORTED LEFT SIDE SWELLING SEROMA LYMPHOMA CONFIRMED CYTOLOGY LYMPHOMA IDENTIFIED ANAPLASTIC LARGE CELL LYMPHOMA FOLLOW-UP FINDINGS NOTED PATIENT WELL RECENTLY NOTED SWELLING LEFT BREAST IMAGING STUDY SHOWED LARGE SEROMA COLLECTION AROUND IMPLANT ASPIRATED CYTOLOGY SHOWED ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE NOTED MRI SHOW SPREAD TUMOR BEYOND CAPSULE SEROMA DRAINED CYTOLOGY REPORT STATED IMMUNOHISTOCHEMICAL STAINS PERFORMED CELL BLOCK DEMONSTRATE DIFFUSE STRONG EXPRESSION CD30 MAY CELLS EXPRESSING CD3 EPITHELIAL MEMBRANE ANTIGEN EMA CELLS EXPRESSING PAN-CYTOKERATIN ALK1 PATHOLOGY REPORT INCLUDES MICROSCOPIC DESCRIPTION STATES SECTIONS PART LEFT BREAST CAPSULE SHOW DIFFUSE INFLAMMATORY INFILTRATE COMPRISED PREDOMINANTLY LYMPHOCYTES PLASMA CELLS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-550|03/29/2016||04/13/2016|DA|R|Y||0HP|FTR|1.0|02/20/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1235003|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5531532|46702393|D|1||HEALTH PROFESSIONAL REPORTED LEFT SIDE SWELLING SEROMA LYMPHOMA CONFIRMED CYTOLOGY LYMPHOMA IDENTIFIED ANAPLASTIC LARGE CELL LYMPHOMA FOLLOW-UP FINDINGS NOTED PATIENT WELL RECENTLY NOTED SWELLING LEFT BREAST IMAGING STUDY SHOWED LARGE SEROMA COLLECTION AROUND IMPLANT ASPIRATED CYTOLOGY SHOWED ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE NOTED MRI SHOW SPREAD TUMOR BEYOND CAPSULE SEROMA DRAINED CYTOLOGY REPORT STATED IMMUNOHISTOCHEMICAL STAINS PERFORMED CELL BLOCK DEMONSTRATE DIFFUSE STRONG EXPRESSION CD30 MAY CELLS EXPRESSING CD3 EPITHELIAL MEMBRANE ANTIGEN EMA CELLS EXPRESSING PAN-CYTOKERATIN ALK1 PATHOLOGY REPORT INCLUDES MICROSCOPIC DESCRIPTION STATES SECTIONS PART LEFT BREAST CAPSULE SHOW DIFFUSE INFLAMMATORY INFILTRATE COMPRISED PREDOMINANTLY LYMPHOCYTES PLASMA CELLS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-550|03/29/2016||04/13/2016|DA|R|Y||0HP|FTR|1.0|02/20/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1235003|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5531532|41335750|D|1||HEALTH PROFESSIONAL REPORTED LEFT SIDE SWELLING SEROMA LYMPHOMA CONFIRMED CYTOLOGY  LYMPHOMA IDENTIFIED ANAPLASTIC LARGE CELL LYMPHOMA FOLLOW-UP FINDINGS NOTED Â¿PATIENT WELL RECENTLY NOTED SWELLING LEFT BREAST IMAGING STUDY SHOWED LARGE SEROMA COLLECTION AROUND IMPLANT ASPIRATED CYTOLOGY SHOWED ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVEÂ¿IT NOTED MRI SHOW SPREAD TUMOR BEYOND CAPSULEÂ¿ SEROMA DRAINED CYTOLOGY REPORT STATED Â¿IMMUNOHISTOCHEMICAL STAINS PERFORMED CELL BLOCK DEMONSTRATE DIFFUSE STRONG EXPRESSION CD30 MAY CELLS EXPRESSING CD3 EPITHELIAL MEMBRANE ANTIGEN EMA CELLS EXPRESSING PAN-CYTOKERATIN ALK1Â¿ PATHOLOGY REPORT INCLUDES MICROSCOPIC DESCRIPTION STATES Â¿SECTIONS PART LEFT BREAST CAPSULE SHOW DIFFUSE INFLAMMATORY INFILTRATE COMPRISED PREDOMINANTLY LYMPHOCYTES PLASMA CELLS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-550|03/29/2016||04/13/2016|DA|R|Y||0HP|FTR|1.0|02/20/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1235003|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5531532|41335749|N|1||DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|120-550|03/29/2016||04/13/2016|DA|R|Y||0HP|FTR|1.0|02/20/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1235003|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6177211|62456167|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL SEROMA LUMP ERYTHEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6177211|62456168|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 OLD PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN CHART ADDITIONALLY PROVIDES PATIENT EXPERIENCED LEFT MASS SEROMA Â¿DISRUPTED IMPLANTÂ¿ ARTICLE ADDITIONALLY REPORTS ERYTHEMATOUS SKIN ERUPTION CASE TREATMENT REPORTED CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE EXPLANT REPORTED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5551762|42003099|D|1||PT SILICONE BREAST IMPLANTS PLACED ORIGINALLY APPROX 15 YEARS AGO SP MULTIPLE REVISIONS DIAGNOSED B6 2016 BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ORIGINAL IMPLANTS NATRELLE 20-400ML B6 2015 LEFT BREAST IMPLANT REMOVED ALLODERM ALLERGAN 2400 IMPLANT INSERTED|NATRELLE 20 - 400ML||04/04/2016||||N|*||I|FTR|1.0||BREAST IMPLANT|||||||nan|||||||True
5708519|46870798|D|1||AUTHORS REPORTED CASE ONE PATIENT FOLLOWING JOURNAL ARTICLE BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT LITERATURE REVIEW AUTHORS REPORTED  PATIENT PRESENTED PAIN FIRMNESS PATIENTS RIGHT BREAST SEVERAL WEEKS PATIENT UNDERGONE BREAST AUGMENTATION SALINE IMPLANTS 16 YEARS PRIOR PRESENTATION ROUTINE LABORATORY WORK REVEALED ABNORMALITIES PATIENT REFERRED PATIENTS PRIMARY CARE PHYSICIAN MRI RIGHT BREAST MRI DEMONSTRATED LARGE FLUID COLLECTION SURROUNDING RIGHT BREAST IMPLANT ASSOCIATED SIGNIFICANT ENHANCEMENT SUSPICIOUS MASS LESION AXILLARY ADENOPATHY IMPLANT INTACT ULTRASOUND PERFORMED DEMONSTRATED SIMPLE FLUID COLLECTION SURROUNDING IMPLANT MASS IDENTIFIED ULTRASOUND-GUIDED FLUID ASPIRATION PERFORMED YIELDED APPROXIMATELY 20 CUBIC CENTIMETERS YELLOW SEROUS FLUID PATHOLOGY DEMONSTRATED SEROMA-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA RIGHT BREAST ANAPLASTIC LYMPHOMA KINASE ALK GENE TESTING NEGATIVE PATIENT UNDERWENT PETCT REVEALED METASTATIC DISEASE PATIENT TAKEN SURGERY IMPLANTS REMOVED PATIENT RECEIVE NEOADJUVANT ADJUVANT CHEMOTHERAPY RADIATION THERAPY PATIENT DISEASE-FREE EVIDENCE DISEASE RECURRENCE THREE YEARS CD30 RESULTS PROVIDED THEREFORE REPORTED CASE ALCL CONSIDERED SUSPECTED CASE CAPTURED LYMPHOMA MANUFACTURER DEVICE UNKNOWN|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5708519|46870797|N|1||MEDWATCH SENT FDA 06092016 FULL CITATION ARTICLE LETTER H ROP B EDISON N ET AL MARCH 26 2016 BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT LITERATURE REVIEW  CUREUS 83 E546 DOI 107759CUREUS546 REQUEST INFORMATION REGARDING EVENT DATES PRODUCT INFORMATION PRODUCT RETURN PATIENT DETAILS MADE ALLERGAN RECEIVED RESPONSE CORRESPONDING AUTHOR ADDITIONAL ATTEMPTS MADE B4 EVENTS SEROMA FIRMNESS ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTER EVENT ASKED RETURN PRODUCT ANALYSIS ALLERGAN RECEIVED PRODUCT TIME THEREFORE ANALYSIS TESTING DONE DEVICE QUESTION MANUFACTURED ALLERGAN FOLLOWING DEVICE LABELING WOULD APPLY PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5788476|49361321|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT IMPLANT DATE DEVICE RETURN STATUS KNOWN TIME FOLLOW-UP CONDUCTED DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5620649|49979256|D|1||EXPLANTING PHYSICIAN REPORTED PATIENT TREATED LATE SEROMA ANAPLASTIC LARGE CELL LYMPHOMA ALCL CONTRALATERAL SIDE FINE NEEDLE ASPIRATION BIOPSY CONTRALATERAL SIDE REVEALED FOLLOWING ADDITIONAL DIAGNOSIS CYTOLOGIC FINDINGS COMPATIBLE LYMPH NODE INVOLVEMENT LYMPHOPROLIFERATIVE PROCESS B4-B6 PROBABLY HODGKINS LYMPHOMA HODGKINS LYMPHOMA SYSTEMIC DISEASE SIDE-SPECIFIC EVENT DIAGNOSTIC TESTING REVEALED NON SIDE-SPECIFIC EVENTS GOITER LUNG PARENCHYMA MODERATE PARASEPTAL CENTRILOBULAR EMPHYSEMA MIDDLE UPPER FIELDS LAMINAR ATELECTASIS APPROXIMATELY ONE MONTH LEFT SIDE ALCL DIAGNOSIS PATIENTS RIGHT SIDE DEVICE REMOVED PHYSICIAN NOTED SURGERY OBSERVED CLINICAL WORSENING PATIENT RESPIRATORY FAILURE SECONDARY LEFT PLEURAL EFFUSION RESULTING ADMISSION ICU THORACIC DRAINAGE RECURRENT CHEST TUBE DRAINAGE REQUIRED 3 OCCASIONS PATIENTS FIRST STAY ICU PATIENT GOES FIRST FLOOR RECEIVES FIRST CYCLE CHEMOTHERAPY SHOWING GRADE IV NEUTROPENIA DIARRHOEA SECOND CHEMOTHERAPY PATIENT SHOWS MARKED CLINICAL DETERIORATION SUSPICIOUS TUMOUR LYSIS SYNDROME METABOLIC ACIDOSIS RENAL FAILURE RESULTS SECOND ADMISSION ICU PATIENT DIED APPROXIMATELY FIVE WEEKS IMPLANT REMOVAL MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00035 LEFT SIDE|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|04/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||396184|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5620649|44064473|D|1||EXPLANTING PHYSICIAN REPORTED PATIENT TREATED LATE SEROMA ANAPLASTIC LARGE CELL LYMPHOMA ALCL CONTRALATERAL SIDE FINE NEEDLE ASPIRATION BIOPSY CONTRALATERAL SIDE REVEALED FOLLOWING ADDITIONAL DIAGNOSIS CYTOLOGIC FINDINGS COMPATIBLE LYMPH NODE INVOLVEMENT LYMPHOPROLIFERATIVE PROCESS CD30-POSITIVE PROBABLY HODGKINS LYMPHOMA HODGKINS LYMPHOMA SYSTEMIC DISEASE SIDE-SPECIFIC EVENT DIAGNOSTIC TESTING REVEALED NON SIDE-SPECIFIC EVENTS GOITER Â¿LUNG PARENCHYMA MODERATE PARASEPTAL CENTRILOLOBULAR EMPHYSEMA MIDDLE UPPER FIELDSÂ¿ Â¿LAMINAR ATELECTASISÂ¿ APPROXIMATELY ONE MONTH LEFT SIDE ALCL DIAGNOSIS PATIENTS RIGHT SIDE DEVICE REMOVED PHYSICIAN NOTED SURGERY OBSERVED CLINICAL WORSENING PATIENT RESPIRATORY FAILURE SECONDARY LEFT PLEURAL EFFUSION RESULTING ADMISSION ICU THORACIC DRAINAGE RECURRENT CHEST TUBE DRAINAGE REQUIRED 3 OCCASIONS PATIENTS FIRST STAY ICU PATIENT GOES FIRST FLOOR RECEIVES FIRST CYCLE CHEMOTHERAPY SHOWING GRADE IV NEUTROPENIA DIARRHOEA SECOND CHEMOTHERAPY PATIENT SHOWS MARKED CLINICAL DETERIORATION SUSPICIOUS TUMOUR LYSIS SYNDROME METABOLIC ACIDOSIS RENAL FAILURE RESULTS SECOND ADMISSION ICU PATIENT DIED APPROXIMATELY FIVE WEEKS IMPLANT REMOVAL MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00035 LEFT SIDE|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|04/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||396184|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176804|62446183|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA TREATMENT REPORTED IMPLANT REMOVAL FOLLOW-UP FOUND EVIDENCE DISEASE MEDWATCH LEFT SIDE MFR 9617229-2016-00241 REPRESENTS RIGHT SIDE DEVICE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176804|62446182|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6064624|58710791|N|1||EVENTS LYMPHOMA SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX140-520|10/28/2016|||DA|*|*||0HP|FTR|1.0|01/29/2014|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1699897|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6135580|61143723|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-700|11/30/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6148888|61547076|D|1||REVIEWED JOURNAL ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT LI-FRAUMENI SYNDROMEÂ¿ Â¿WE REPORT UNIQUE CASE BIA-ALCL ARISING PATIENT LIÂ¿FRAUMENI SYNDROME GERMLINE MUTATIONS TP53 CASE NOTABLE SHORT INTERVAL 3 YEARS PLACEMENT IMPLANTS DEVELOPMENT ALCL CAPSULECTOMY IMPLANT REMOVAL PATIENT RECURRENCE BIA-ALCL CLINICAL FOLLOW-UP 7 YEARSÂ¿ ARTICLE STATES Â¿THE PATIENT NOTED ASYMMETRIC SWELLING RIGHT BREAST FINE NEEDLE ASPIRATION BREAST SEROMA PERFORMED LEADING DIAGNOSIS BIAALCLÂ¿ SAMPLE POSITIVE CD30 NEGATIVE ALK ARTICLE ALSO STATES SUBSEQUENT YEARS PATIENT DIAGNOSED ADRENOCORTICAL CARCINOMASUBSEQUENTLY DEVELOPED METASTATIC ADRENOCORTICAL CARCINOMA LIVER LUNG MANUFACTURER DEVICE UNKNOWN MEDWATCH RIGHT SIDE DEVICE SEE MANUFACTURER REPORT  9617229-2016-00207 LEFT SIDE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/06/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6148888|61547075|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT LI-FRAUMENI SYNDROMEÂ¿ YI-SHAN LEE ARMANDO FILIE DIANE ARTHUR ANTONIO FOJO ELAINE JAFFE PUBLISHED HISTOPATHOLOGY 67 923Â¿935 2015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA CANCER LYMPHOMA-ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/06/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5820703|50386638|N|1||MEDWATCH SENT FDA 07252016 B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT FOLLOW PERFORMED OBTAIN DEVICE MANUFACTURER SERIAL NUMBER LOT NUMBER IMPLANT EXPLANT DATE IMPLANTINGEXPLANTING PHYSICIAN PATIENT NAME PATIENT DATE BIRTH DEVICE RETURN STATUS DEVICE RELATIONSHIP REPORTED EVENTS DEVICE HISTORY RECORD UNAVAILABLE DEVICE INFORMATION UNKNOWN DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410520|07/25/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5820703|50386639|D|1||FOLLOWING CASE RECEIVED ARTICLE TITLED SKIN INVOLVEMENT FIRST MANIFESTATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ARTICLE STATES PRESENT NEW CASE BREAST IMPLANT-ASSOCIATED ALCL CUTANEOUS LESIONS MIMICKING CUTANEOUS METASTASES POORLY DIFFERENTIATED BREAST ADENOCARCINOMA DETAILS INCLUDE SEVERAL CUTANEOUS NODULES 2 MONTHSÂ¿ DURATION RIGHT BREASTÂ¿RADIOGRAPHIC FOLLOW-UP REVEALED RIGHT SUPRACLAVICULAR MASS MULTIPLE ENLARGED LYMPH NODES PATIENT UNDERWENT CORE NEEDLE BIOPSY MASS REVEALED EXTENSIVE NECROSIS PATIENT TREATED CHEMOTHERAPY RADIATION THERAPY IMPROVEMENTS NOTED SECOND ROUND CHEMOTHERAPY PRESCRIBED DISEASE PROGRESSED Â¿WITH PROGRESSIVE HARDENING RIGHT BREAST APPEARANCE SEVERAL CUTANEOUS LESIONSTHERE ALSO SEVERAL POORLY CIRCUMSCRIBED ERYTHEMATOUS INDURATED PAPULESÂ¿THE PATIENT REPORTED MODERATE PAINÂ¿THE CT SCAN SHOWED LARGE AMOUNT PERI-IMPLANT FLUIDÂ¿ TESTED CELLS Â¿WERE CD15 CD30 POSITIVE ALK-1 NEGATIVEÂ¿ PATIENT DIAGNOSED ALCL ASSOCIATED BREAST IMPLANT CAPSULE Â¿PATIENT STARTED CHOP THERAPY BREAST IMPLANT REMOVED PATIENT PRESENTED FEBRILE NEUTROPENIA TREATMENT FINALLY PATIENT DIED SEPTIC SHOCKÂ¿ AUTOPSY REQUESTED FAMILY REFUSED MANUFACTURER DEVICE UNKNOWN MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00093 LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410520|07/25/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5820703|55107988|D|1||FOLLOWING CASE RECEIVED ARTICLE TITLED SKIN INVOLVEMENT FIRST MANIFESTATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ARTICLE STATES PRESENT NEW CASE BREAST IMPLANT-ASSOCIATED ALCL CUTANEOUS LESIONS MIMICKING CUTANEOUS METASTASES POORLY DIFFERENTIATED BREAST ADENOCARCINOMA DETAILS INCLUDE SEVERAL CUTANEOUS NODULES 2 MONTHSÂ¿ DURATION RIGHT BREASTÂ¿RADIOGRAPHIC FOLLOW-UP REVEALED RIGHT SUPRACLAVICULAR MASS MULTIPLE ENLARGED LYMPH NODES PATIENT UNDERWENT CORE NEEDLE BIOPSY MASS REVEALED EXTENSIVE NECROSIS PATIENT TREATED CHEMOTHERAPY RADIATION THERAPY IMPROVEMENTS NOTED SECOND ROUND CHEMOTHERAPY PRESCRIBED DISEASE PROGRESSED Â¿WITH PROGRESSIVE HARDENING RIGHT BREAST APPEARANCE SEVERAL CUTANEOUS LESIONSTHERE ALSO SEVERAL POORLY CIRCUMSCRIBED ERYTHEMATOUS INDURATED PAPULESÂ¿THE PATIENT REPORTED MODERATE PAINÂ¿THE CT SCAN SHOWED LARGE AMOUNT PERI-IMPLANT FLUIDÂ¿  TESTED CELLS Â¿WERE CD15 CD30 POSITIVE ALK-1 NEGATIVEÂ¿ PATIENT DIAGNOSED ALCL ASSOCIATED BREAST IMPLANT CAPSULE Â¿PATIENT STARTED CHOP THERAPY BREAST IMPLANT REMOVED PATIENT PRESENTED FEBRILE NEUTROPENIA TREATMENT FINALLY PATIENT DIED SEPTIC SHOCKÂ¿ AUTOPSY REQUESTED FAMILY REFUSED MANUFACTURER DEVICE UNKNOWN MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00093 LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MX-410520|07/25/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6148913|61548012|D|1||REVIEWED JOURNAL ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT LI-FRAUMENI SYNDROMEÂ¿ ARTICLE STATES SUBSEQUENT YEARS PATIENT DIAGNOSED ADRENOCORTICAL CARCINOMASUBSEQUENTLY DEVELOPED METASTATIC ADRENOCORTICAL CARCINOMA LIVER LUNG MEDWATCH LEFT SIDE DEVICE SEE MANUFACTURER REPORT  9617229-2016-00190 RIGHT SIDE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/06/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6148913|61548011|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT LI-FRAUMENI SYNDROMEÂ¿ YI-SHAN LEE ARMANDO FILIE DIANE ARTHUR ANTONIO FOJO ELAINE JAFFE PUBLISHED HISTOPATHOLOGY 67 923Â¿935 2015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE CANCER PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/06/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6176705|62451143|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA DISRUPTED IMPLANT TREATMENT REPORTED IMPLANT REMOVAL RADIOTHERAPY B6 FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176730|62445769|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176730|62445770|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 YEAR-OLD PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA TREATMENT REPORTED IMPLANT REMOVAL FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176886|62453117|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 OLD PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED MASS SEROMA DISRUPTED IMPLANT TREATMENT REPORTED IMPLANT REMOVAL CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176886|62453116|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA SEROMA MASS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6146425|61492492|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA ARTICLE CITATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT LITERATURE REVIEW LETTER HALEY ROP BAIYWO EDISON MICHELE N TURNER PATRICIA CUREUS 2016 VOL 8 3 PP E546 ELECTRONIC PUBLICATION DATE 26 MAR 2016 JOURNAL CODE 101596737 B4|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/05/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6146425|61492493|D|1||JOURNAL ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT LITERATURE REVIEWÂ¿ ABSTRACT STATES Â¿PATIENT PRESENTED SEVERAL WEEKS PAIN FIRMNESS PATIENT RIGHT BREAST MRI ULTRASOUND DEMONSTRATED PERI-IMPLANT FLUID COLLECTION ULTRASOUND-GUIDED ASPIRATION REVEALED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT TREATED IMPLANT REMOVAL ALONE REMISSION 3 YEARSÂ¿ PATHOLOGICAL MARKERS CONFIRM ALCL YET RECEIVED THEREFORE EVENT REPORTED LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/05/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6176855|62446706|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6176855|62446707|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED LEFT SIDE TEXTURED SALINE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA TREATMENT REPORTED IMPLANT REMOVAL FOLLOW-UP FOUND EVIDENCE DISEASE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6176798|62453768|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176798|62453769|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA TREATMENT REPORTED IMPLANT REMOVAL FOLLOW-UP FOUND EVIDENCE DISEASE MEDWATCH RIGHT SIDE MFR 9617229-2016-00240 REPRESENTS LEFT SIDE DEVICE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6153200|61697778|N|1||EVENT LYMPHOMA ALCL PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL Â¿COMPLETE SURGICAL EXCISION ESSENTIAL MANAGEMENT PATIENTS BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ MARK W CLEMENS L JEFFREY MEDEIROS CHARLES E BUTLER KELLY K HUNT MICHELLE FANALE STEVEN HORWITZ DENNIS WEISENBURGER JUN LIU ELIZABETH MORGAN RASHMI KANAGAL-SHAMANNA VINITA PARKASH JING NING ALIYAH R SOHANI JUDITH FERRY NEHA MEHTA-SHAH AHMED DOGAN HUI LIU NORA THORMANN ARIANNA DI NAPOLI STEPHEN LADE JORGE PICCOLINI RUBEN REYES TRAVIS WILLIAMS COLLEEN MCCARTHY SUMMER E HANSON LORETTA J NASTOUPIL RAKESH GAUR YASUHIRO OKI KEN H YOUNG ROBERTO N MIRANDA JOURNAL CLINICAL ONCOLOGY VOLUME 34 NUMBER 2 JANUARY 10 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6011951|56916914|D|1||ALLERGANS LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGY TABLE 4 PRESENTATION BIA-ALCL N=46 ARTICLE REPORTS FOLLOWING 2 CASES SEROMA CAPSULAR CONTRACTURE CONTRALATERAL RECORD CREATED CAPTURE 2 EVENTS CAPSULAR CONTRACTURE CONTRALATERAL EVENT SEROMA CAPTURED MDR  9617229-2016-00142 ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS MANUFACTURER COULD SPECIFIED ARTICLE STATES BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED 571 IMPLANTS SERIES ARTICLE STATES PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011951|56916913|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENT CAPSULAR CONTRACTURE PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT RUPTURE ONE COMMON REASONS REOPERATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5864951|51736729|N|1||MEDWATCH SENT FDA 08102016 B4 CONCOMITANT MEDICAL PRODUCTS FOLIC ACID D3 VITAMIN CALCIUM CARBONATE OMEGA 3 PAST MEDICAL HISTORY HYDROXYCHLOROQUINE EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL CHANGES BREAST SENSATION HEMATOMASEROMA LYMPHADENOPATHY|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|N-27-120181|08/10/2016|||DA|N|R||0HP|FTR|1.0|02/20/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2243522|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5864951|51736730|D|1||ENGLISH PRODUCT FIELD NOTE PFN RECEIVED VIA EMAIL REPORTS LEFT SIDE PATIENT ALLERGAN PROSTHESIS DIAGNOSED ALCL ANAPLASTIC LARGE CELL LYMPHOMA ADENOPATHY AXILLARY ENCAPSULATION INFLAMMATORY PROCESS SUPERIOR INTERIOR INTRACAPSULAR LIQUID PATHOLOGIC DIAGNOSTIC NON-HODGKIN LYMPHOMA ALK NEGATIVE ANAPLASTIC LYMPHOMA ALK NEGATIVE CD 30+ ASSOCIATED BREAST PROSTHESIS CLINICAL STATUS II E  PATIENT MEDICAL HISTORY PRIMARY SJOGREN SYNDROME B6 2015 MRI FOUND BIGGER VOLUME LEFT BREAST EDEMA SUBCUTANEOUS LAYER PERIPROSTHETIC LIQUID ALSO NOTED PATIENT PRESENTED PAIN RELATED DEVICE ONE WEEK MRI B6 2015 NOTED CAPSULAR CONTRACTURE B6 2015 MRI DETECTED MASS SUPERIOR AREA LEFT BREAST BIOPSY INJURY CAME NEGATIVE B6 2016 PATIENT PALPATED LEFT AXILLARY ADENOPATHY B6 2016 CONSULTATION NOTED SIGNALS RUPTURE SMALL MASS SUPERIOR LEFT PROSTHESIS CONSULTATION HEALTHCARE PROFESSIONAL BIOPSY PERFORMED CONFIRMED LYMPHOMA ANAPLASTIC CELLS ALK - PERIPROSTHETIC LIQUID ALSO NOTED EXPLANT DATE PROVIDED B6 2016 IMPLANT REPLACED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|N-27-120181|08/10/2016|||DA|N|R||0HP|FTR|1.0|02/20/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2243522|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5864951|63818637|D|1||ENGLISH PRODUCT FIELD NOTE PFN RECEIVED VIA EMAIL REPORTS Â¿LEFT SIDE PATIENT ALLERGAN PROSTHESIS DIAGNOSED ALCL ANAPLASTIC LARGE CELL LYMPHOMA ADENOPATHY AXILLARY ENCAPSULATION INFLAMMATORY PROCESS SUPERIOR INTERIOR INTRACAPSULAR LIQUID PATHOLOGIC DIAGNOSTIC NON-HODGKIN LYMPHOMA ALK NEGATIVE ANAPLASTIC LYMPHOMA ALK NEGATIVE CD 30+ ASSOCIATED BREAST PROSTHESIS CLINICAL STATUS II EÂ¿ PATIENT MEDICAL HISTORY PRIMARY SJOGREN SYNDROME B6 2015 MRI FOUND BIGGER VOLUME LEFT BREAST EDEMA SUBCUTANEOUS LAYER PERIPROSTHETIC LIQUID ALSO NOTED PATIENT PRESENTED PAIN RELATED DEVICE ONE WEEK MRI B6 2015 NOTED CAPSULAR CONTRACTURE B6 2015 MRI DETECTED MASS SUPERIOR AREA LEFT BREAST BIOPSY INJURY CAME NEGATIVE B6 2016 PATIENT PALPATED LEFT AXILLARY ADENOPATHY B6 2016 CONSULTATION NOTED SIGNALS RUPTURE SMALL MASS SUPERIOR LEFT PROSTHESIS CONSULTATION HEALTHCARE PROFESSIONAL BIOPSY PERFORMED CONFIRMED LYMPHOMA ANAPLASTIC CELLS ALK - PERIPROSTHETIC LIQUID ALSO NOTED EXPLANT DATE PROVIDED B6 2016 IMPLANT REPLACED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|N-27-120181|08/10/2016|||DA|N|R||0HP|FTR|1.0|02/20/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2243522|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5864951|60014363|D|1||B4 PRODUCT FIELD NOTE PFN RECEIVED VIA EMAIL REPORTS LEFT SIDE PATIENT ALLERGAN PROSTHESIS DIAGNOSED ALCL ANAPLASTIC LARGE CELL LYMPHOMA ADENOPATHY AXILLARY ENCAPSULATION INFLAMMATORY PROCESS SUPERIOR INTERIOR INTRACAPSULAR LIQUID PATHOLOGIC DIAGNOSTIC NON-HODGKIN LYMPHOMA ALK NEGATIVE ANAPLASTIC LYMPHOMA ALK NEGATIVE CD 30+ ASSOCIATED BREAST PROSTHESIS CLINICAL STATUS II E  PATIENT MEDICAL HISTORY PRIMARY SJOGREN SYNDROME B6 2015 MRI FOUND BIGGER VOLUME LEFT BREAST EDEMA SUBCUTANEOUS LAYER PERIPROSTHESTIC LIQUID ALSO NOTED PATIENT PRESENTED PAIN RELATED DEVICE ONE WEEK MRI B6 2015 NOTED CAPSULAR CONTRACTURE B6 2015 MRI DETECTED MASS SUPERIOR AREA LEFT BREAST BIOPSY INJURY CAME NEGATIVE B6 2016 PATIENT PALPATED LEFT AXILLARY ADENOPATHY B6 2016 CONSULTATION NOTED SIGNALS RUPTURE SMALL MASS SUPERIOR LEFT PROSTHESIS CONSULTATION HEALTHCARE PROFESSIONAL BIOPSY PERFORMED CONFIRMED LYMPHOMA ANAPLASTIC CELLS ALK - PERIPROSTHESTIC LIQUID ALSO NOTED EXPLANT DATE PROVIDED B6 2016 IMPLANT REPLACED|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|N-27-120181|08/10/2016|||DA|N|R||0HP|FTR|1.0|02/20/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2243522|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6037704|57781486|N|1||EVENTS SEROMA LYMPHOMA ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY REVIEW DHR SUMMARY REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR WORK ORDER B4 INDICATES REPROCESS PRIMARY PACKAGING OPERATION REPORTED DEVICE REPROCESSED HOWEVER REVIEW REPROCESS WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MAY ASSOCIATED REPORTED DEVICE EVENT DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUN NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL HEMATOMASEROMA|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSX525|10/18/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2433989|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5343961|35063341|N|1||B4 DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|153-630|01/05/2016||03/17/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||339918|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5488680|46690345|D|1||HEALTH PROFESSIONAL ADDITIONALLY PROVIDED CT CHEST PELVIS REPORT Â¿CLINICAL NOTES SHORTNESS BREATH RECENT DIAGNOSIS BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ FINDINGS NOTES Â¿LUNGS SATISFACTORY MEDIASTINAL STRUCTURE NORMAL LYMPHADENOPATHYÂ¿|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|03/09/2016|||DA|N|R||0HP|FTR|1.0|02/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||276452|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5488680|39947738|D|1||PATIENT REPORTED DIAGNOSED BREAST IMPLANT ASSOCIATED ALCL PATIENT SOUGHT CONSULT EXPERIENCING LOT SWELLING IMPLANT REMOVED PATHOLOGY RESULTS CONFIRMED ALCL FOLLOW-UP PROVIDED INDICATED RIGHT BREAST CYTOPATHOLOGY REPORT STATES FINE NEEDLE ASPIRATION RIGHT BREAST Â¿ 5 ML CLOUDY ORANGE FLUID Â¿ BREAST ASPIRATE IMPLANT CAPSULE FOLLOWED Â¿POSITIVE ANTIBODIES CD30 STRONGÂ¿ Â¿NEGATIVE ANTIBODIES ALK1 CONCLUSIONS REPORTED Â¿THIS IMMUNOPHENOTYPE TYPICAL SEEN BREAST-IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ ADDITIONALLY PHYSICIAN NOTES RECEIVED DOCUMENTED PRIOR 4 X 7 MM SIMPLE CYST 1100 OÂ¿CLOCK RIGHT BREAST HISTOPATHOLOGY REPORT NOTED CAPSULE FOREIGN BODY GRANULOMATOUS LYMPHOID REACTION|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|03/09/2016|||DA|N|R||0HP|FTR|1.0|02/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||276452|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5488680|41343420|D|1||PATIENT REPORTED DIAGNOSED BREAST IMPLANT ASSOCIATED ALCL PATIENT SOUGHT CONSULT EXPERIENCING LOT SWELLING IMPLANT REMOVED PATHOLOGY RESULTS CONFIRMED ALCL FOLLOW-UP PROVIDED INDICATED RIGHT BREAST CYTOPATHOLOGY REPORT STATES FINE NEEDLE ASPIRATION RIGHT BREAST - 5 ML CLOUDY ORANGE FLUID - BREAST ASPIRATE IMPLANT CAPSULE FOLLOWED - POSITIVE ANTIBODIES CD30 STRONG- - NEGATIVE ANTIBODIES ALK1 CONCLUSIONS REPORTED IMMUNOPHENOTYPE TYPICAL SEEN BREAST-IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ADDITIONALLY PHYSICIAN NOTES RECEIVED DOCUMENTED PRIOR 4 X 7 MM SIMPLE CYST 1100 OCLOCK RIGHT BREAST HISTOPATHOLOGY REPORT NOTED CAPSULE FOREIGN BODY GRANULOMATOUS LYMPHOID REACTION|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|03/09/2016|||DA|N|R||0HP|FTR|1.0|02/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||276452|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5844861|51109569|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT FOLLOW CONDUCTED DETERMINE FOLLOWING INFORMATION SERIAL NUMBER LOT NUMBER IMPLANT DATE PATIENT NAME PATIENT DATE BIRTH PATHOLOGICAL TESTING RESULTS DETERMINATION SURGERY SCHEDULED DEVICE RELATIONSHIP REPORTED EVENTS DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/03/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5607727|43625364|D|1||PHYSICIAN REPORTS PATIENT BIA-ALCL BREAST IMPLANT ASSOCIATED - ANAPLASTIC LARGE CELL LYMPHOMA DEVICE EXPLANTED PATHOLOGICAL MARKERS PROVIDED CASE CAPTURED LYMPHOMA SIDE UNKNOWN|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410420|04/26/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6158856|62125553|D|1||ALLERGAN PRODUCT SURVEILLANCE RECEIVED LITERATURE ARTICLE Â¿COMPREHENSIVE IMMUNOPHENOTYPIC ANALYSIS 64 CASES BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA SHOWS ACTIVATED CYTOTOXIC SILENT T-CELL RECEPTOR PATTERNÂ¿ 13NOV2016 ARTICLE REPORTS Â¿64 CASESÂ¿ ARTICLE CONTINUES STATE Â¿WE REVIEWED WORLD LITERATURE CASES BI-ALCL ACCRUED CASES IMMUNOPHENOTYPIC DATA DERIVED USING IMMUNOHISTOCHEMICAL FLOW CYTOMETRY METHODS USED LEAST 5 FOLLOWING 13 MARKERS REPORTED CD3 CD4 CD8 CD30 CD43 CD45 EMATIA-1 GRANZYME-B ALK-1 TCR-Â¿Â¿ TCR-GÂ¿ EBER SITU HYBRIDIZATION LESS 5 MARKERS REPORTED CONTACTED CORRESPONDING AUTHORS AVAILABLE MATERIAL ADDITIONAL STUDIES INCLUDED DATAÂ¿ Â¿CD30 POSITIVE N=64 CASES WHEREAS ALK EBER NEGATIVE TESTED CASES N=56 N=25 RESPECTIVELY CD3 POSITIVE 15 62 24 CASES CD4 4361 70 CD8 657 11 CD43 37 46 80 CD45 2949 59 EMA 2542 60 TIA-1 2846 61 GRANZYME-B 28 47 60 TCR Â¿Â¿ 5 24 21 TCR GÂ¿ 1 23 4 THUS TCR SILENT 1824 75 CASESÂ¿ RECORD CREATED CAPTURE 8 CASES LYMPHOMA TESTING ALK|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6158856|62125552|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED AUTHOR RESPONDED REFUSED PROVIDE INFORMATION DEVICE LABELING ADDRESSES PUBLISHED STUDIES INDICATE BREAST CANCER COMMON WOMEN IMPLANTS WITHOUT IMPLANTS LARGE LONG-TERM FOLLOW-UP FOUND SIGNIFICANT INCREASES RISK RATES WIDE VARIETY CANCERS INCLUDING STOMACH CANCER LEUKEMIA LYMPHOMA Â¿COMPREHENSIVE IMMUNOPHENOTYPIC ANALYSIS 64 CASES BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA SHOWS ACTIVATED CYTOTOXIC SILENT T-CELL RECEPTOR PATTERNÂ¿ ANA CLAUDIA FROTA LOPES L JEFFREY MEDEIROS MARK W CLEMENS MING CHAI HUI LIU ARIANNA DI NAPOLI STEPHEN LADE MITUAL AMIN KEN H YOUNG ROBERTO MIRANDA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5672723|45694208|D|1||PHYSICIAN REPORTS PATIENT DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL RIGHT BREAST CONCERNS DIAGNOSE ALCL CD30+ ALK- FOLLOWING IDENTIFICATION PERIPROSTHETIC SEROMA BREAST IMPLANT IMPLANTED 10 YEAR AGO CAPSULECTOMY PERFORMED DEVICE EXPLANTED|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|05/23/2016||||N|R||0HP|FTR|1.0|09/19/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1139476|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5994929|56333880|D|1||COMPLAINT LITERATURE SOURCE REPORTED B6 YEAR-OLD WOMAN MASTECTOMY AXILLARY DISSECTION 2004 LYMPH NODE-FREE LOBULAR CARCINOMA RIGHT BREAST COMPLETE REMISSION 11 YEARS UNDERWENT RECONSTRUCTIVE SURGERY BILATERAL ALLERGAN IMPLANTS 2005 REPLACED MENTOR IMPLANTS 2008 MODERATELY-LARGE LEFT PERI-PROSTHETIC EFFUSION SEEN MRI 2012 CONTAINED NON-ATYPICAL LYMPHOCYTES MACROPHAGES PROTEINACEOUS BACKGROUND CYTOLOGICALLY INTERPRETED SEROMA TWO SEROMAS RIGHT BREAST 2013 SPONTANEOUSLY REGRESSED WITHOUT EVACUATION B6 2015 COMPLAINED PAIN SWELLING RIGHT BREAST LARGE PERI-IMPLANT EFFUSION SUSPICIOUS INFLAMMATORY PROCESS ULTRASOUND COMPLETELY DRAINED FNA RECOVERING 85 CC CLOUDY YELLOW FLUID BILATERAL IMPLANTS REMOVED CURRENTLY UNDERGOING WAIT-AND-SEE STRATEGY ALIVE WITHOUT DISEASE 8 MONTHS LYMPHOMA DIAGNOSIS TITLE CASE BIOFILM PRIMARY INITIATOR BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA PURPOSE STUDY PRESENT FIRST PUBLISHED REPORT BILATERAL ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED CYTOLOGY SUSPECT DEVICE MENTOR IMPLANT HOWEVER CATALOG LOT NUMBER UNKNOWN CONTACT B6 AGE STUDY AVERAGE B6 DOS UNK SURGEON UNK DEVICE INFO UNK|nan|UNKNOWN|10/03/2016||||N|R||0HP|FTR|1.0||BREAST IMPLANT|||3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||UNK||True
6153064|61697996|N|1||ARTICLE CITATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT UNDIAGNOSED FORM MANAGEMENT RECONSTRUCTION ALCL ALHAMAD GUERID EH EL FAKIR P BIRON C TOURASSE E DELAY PUBLISHED 062016 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6153064|61697997|D|1||JOURNAL ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA CASE REPORT UNDIAGNOSED FORM MANAGEMENT RECONSTRUCTION ALCLÂ¿ ABSTRACT STATES Â¿THIS ARTICLE REPORTS CASE PATIENT PROGRESSIVE SWELLING RIGHT BREAST AESTHETIC BREAST IMPLANTS DIAGNOSTIC DELAYED FIRST SURGEON FAMILIAR DISEASE PERFORMED IMPLANT REMOVAL COMPLETE CAPSULECTOMY PATHOLOGIC REPORT CONFIRMS DIAGNOSTIC ONE YEAR NORMAL ULTRASOUND EVALUATION RECONSTRUCTED BREAST LIPOMODELING MASTOPEXYÂ¿ MANUFACTURER DEVICE SPECIFIED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6153076|61697270|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION HEMATOMASEROMA BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ 137 6 1659-1669 HONGHUA HU PHD KHALID JOHANI AHMAD ALMATROUDI KAREN VICKERY PHD BVSC BRUCE VAN NATTA MD MARSHALL E KADIN MD GARRY BRODY MD MARK CLEMENS MD CHAN YOON CHEAH MD STEPHEN LADE MD PREETI AVINASH JOSHI MDPHD H MILES PRINCE MDPHD ANAND K DEVA BSCMED MBBS MS PUBLISHED JUNE 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5793065|49492129|N|1||MEDWATCH SENT FDA 07132016 B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT SERIAL NUMBER AVAILABLE TIME KNOWN DEVICE RETURNED REQUEST INFORMATION PERFORMED DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL DEVICE HISTORY RECORD REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT ORACLE VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUNS NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6143087|61396767|D|1||ABSTRACT LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTED Â¿19 I-ALCLSÂ¿ CASES ONE TWO CLINICAL PRESENTATIONS REPORTED Â¿TUMOR MASSÂ¿ 2 PATIENTS EXPERIENCED ALCL MASS RECORD REPRESENTS 2 CASES ALCL PRESENTED TUMOR MASS HISTOPATHOLOGY REPORTS MALIGNANT CELLS CD30-POSITIVE ALK NEGATIVE ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ CURRENTLY WAY DETERMINE TREATMENTS USED 11 CASES MANUFACTURER DEVICES UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/02/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6143087|62805862|D|1||ABSTRACT LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ B6-YEAR-OLD PATIENT IMPLANTED UNKNOWN IMPLANT DEVICE MANUFACTURER UNKNOWN PATIENT DIAGNOSED ALCL CHART ADDITIONALLY PROVIDES PATIENT EXPERIENCED LEFT SIDE MASS UNKNOWN IMPLANT REMOVED TREATMENT REPORTED ADRIAMYCINE BLEOMYCINE VINBLASTINE DACARBAZINE ABVD RADIOTHERAPY 30GY FOLLOW-UP FOUND EVIDENCE DISEASE REPORT INITIALLY SENT REPRESENT TWO PATIENTS DUE DISCOVERY IDENTIFYING INFORMATION SUPPLEMENTAL REPORT REPRESENT B6 YEAR-OLD PATIENT DEVICE MFR  9617229-2016-00195 SENT REPRESENT PATIENT PREVIOUSLY REPRESENTED INITIAL REPORT MFR  9617229-2016-00196|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/02/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6143087|61396766|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL LUMPNODULE PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/02/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6177272|62460335|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED TEXTURED SALINE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED RIGHT SEROMA Â¿DISRUPTED IMPLANTÂ¿ TREATMENT REPORTED IMPLANT REMOVAL Â¿CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP FOUND Â¿NO EVIDENCE DISEASEÂ¿|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6177272|62460334|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5924670|53824368|D|1||PT PLEASANT B6 YRS OLD FEMALE HISTORY BILATERAL BREAST IMPLANTS 2007 DEVELOPED RIGHT BREAST SWELLING FIRMNESS TENDERNESS SUDDENLY B6 2016 EMAIL INVALID B6 2016 PREVIOUS HISTORY CONTRACTURE LEFT BREAST THOUGHT SYMPTOMS SIMILAR SOUGHT CARE DR B6 UNDERWENT IMPLANT REMOVAL CAPSULECTOMY SURGICAL UNCOMPLICATED PATHOLOGY RESULTED ANAPLASTIC LARGE CELL LYMPHOMA BREAST|BREAST IMPLANTS, STYLE 115||08/31/2016||||N|*||I|FWM|1.0||BREAST IMPLANT||1382362|||||MCGHAN|||||||True
5697584|46502156|D|1||FOLLOWING JOURNAL ARTICLE REVIEWED Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORT 2 CASES REVIEW LITERATUREÂ¿ AUTHORS REPORTED PATIENT Â¿PRESENTED 6-WEEK HISTORY RIGHT BREAST SWELLINGÂ¿ Â¿NINE YEARS EARLIER PATIENT UNDERGONE BILATERAL SUBMUSCULAR BREAST AUGMENTATION 510-CC TEXTURED SALINE BIOCELL IMPLANTS ALLERGAN B64 PATIENTS MEDICAL HISTORY REVEALED RECENT DIAGNOSIS CELIAC DISEASE CONFIRMED DUODENAL BIOPSY CLINICAL EXAMINATION SHOWED SWELLING ERYTHEMA RIGHT BREAST PERCUTANEOUS FLUID ASPIRATION PRODUCED 200 ML CLEAR YELLOW FLUID FLOW CYTOMETRIC IMMUNOPHENOTYPING ASPIRATE DEMONSTRATED PHENOTYPICALLY ABERRANT POPULATION LARGE CELLS EXPRESSED CD2 CD5 CD4 CD30 FAILED EXPRESS CD3 CD7 RESULTS IMMUNOHISTOCHEMICAL STAINING HEMATOXYLIN EOSIN NEGATIVE ANAPLASTIC LYMPHOMA KINASE 1 ALK-L DIAGNOSIS ALKÂ¿ ALCL RESULTS POSITRON EMISSION TOMOGRAPHY SCAN BONE MARROW ASPIRATE BIOPSY DETERMINED NEGATIVE DISEASE PATIENTS LEVEL LACTATE DEHYDROGENASE NORMAL TREATMENT INCLUDED BILATERAL TOTAL CAPSULECTOMY IMPLANT REMOVAL WITHOUT IMPLANT REPLACEMENT APPROXIMATELY SIX MONTHS PRESENTING SYMPTOMS HEALTH PROFESSIONAL REMOVAL IMPLANTS CAPSULES SENT FLOW CYTOMETRY CYTOGENETIC ANALYSIS IMMUNOHISTOCHEMICAL STAINING SHOW UNIQUE CELL POPULATIONS EVIDENCE SILICONE CAPSULE THROUGHOUT 20 MONTHS REGULAR FOLLOW-UP SINCE IMPLANT REMOVAL CAPSULECTOMY PATIENT SYSTEMIC EVIDENCE DISEASEÂ¿ REPORT REPRESENTS RIGHT SIDE SEE MFR REPORT  9617229-2016-00066 LEFT SIDE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5697584|46502155|N|1||B4 CORRESPONDING AUTHOR DECLINED PROVIDE ALLERGAN INFORMATION REGARDING EVENT PRODUCT PRODUCT RETURN PATIENT DETAILS EVENTS FLUID COLLECTION Â¿RECENT HISTORY CELIAC DISEASEÂ¿ ERYTHEMA ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176870|62452744|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA TREATMENT REPORTED IMPLANT REMOVAL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176870|62452743|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011928|56911407|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011928|56911408|D|1||ALLERGANÂ¿S LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALANDÂ¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ TABLE 4 Â¿PRESENTATION BIA-ALCL N=46Â¿ ARTICLE REPORTS FOLLOWING 2 CASES Â¿SEROMA CAPSULAR CONTRACTURE CONTRALATERALÂ¿ RECORD CREATED CAPTURE 2 SEROMAS CONTRALATERAL EVENT CAPSULAR CONTRACTURE CAPTURED MDR  9617229-2016-00146 ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5665954|45480789|D|1||2 BREAST IMPLANTS IMPLANTED B6 2008 SINCE FINE REMAINED INTACT YESTERDAY B6 2016 PT DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL CAUSED 2 IMPLANTS SCHEDULED MEET DOCTOR TODAY PLAN EXPLANTING DEVICES|MEMORY GEL BREAST IMPLANT||05/18/2016||||*|*||0LP|FTR|2.0||MEMORY GEL BREAST IMPLANT|||3041 SKYWAY CIRCLE NORTH||IRVINE|US|MENTOR|75038|TX|75038||||True
5665954|45480789|D|1||2 BREAST IMPLANTS IMPLANTED B6 2008 SINCE FINE REMAINED INTACT YESTERDAY B6 2016 PT DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL CAUSED 2 IMPLANTS SCHEDULED MEET DOCTOR TODAY PLAN EXPLANTING DEVICES|MEMORY GEL BREAST IMPLANT||05/18/2016||||*|*||0LP|FTR|1.0||MEMORY GEL BREAST IMPLANT||5746123|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||||True
6139164|61260978|N|1||ARTICLE CITATION Â¿MARKED EOSINOPHILIA INITIAL PRESENTATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ NICOLA OROFINO FRANCESCA GUIDOTTI DANIELE CATTANEO MARIARITA SCIUMÃ UMBERTO GIANELLI AGOSTINO CORTELEZZI  ALESSANDRA LURLO PUBLISHED LEUKEMIA  LYMPHOMA PUBLISHED ELECTRONICALLY 17MAR2016 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA LYMPHOMA-ALCL PRURITUS EOSINOPHILIA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/01/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6139164|61260979|D|1||JOURNAL ARTICLE MARKED EOSINOPHILIA INITIAL PRESENTATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORTS DESCRIBE CASE BI-ALCL PATIENT PRESENTED HYPEREOSINOPHILIA DIFFUSE PRURITUS PATIENT PRESENTED DISCOMFORT MODERATE PAIN LEFT BREAST DIAGNOSIS CHRONIC SEROMA MADE LEUKEMIA  LYMPHOMA 5711 2712-2715 DEVICE REMOVED REPLACED TEXTURED IMPLANT ALLERGAN PATIENTS SYMPTOMS PERSISTED REPLACEMENT IMPLANT ALSO REMOVED ARTICLE STATES CHRONIC SEROMA CONTINUED TRU-CUT BIOPSY CARRIED THREE YEARS LATER REVEALED CHRONIC INFLAMMATIONÂ¿ ARTICLE GOES STATE HISTOLOGICAL EXAMINATION PSEUDO-CAPSULE SHOWED DIFFUSE INFILTRATION LARGE CELLS IRREGULAR ANAPLASTIC Â¿EMBRYO-LIKEÂ¿ NUCLEI ABUNDANT EOSINOPHILIC GRANULAR CYTOPLASM MALIGNANT POPULATION TESTED CD30+ ALK-1 EXPRESSION BONE MARROW BIOPSY PERFORMED STAGING PURPOSES ALSO NEGATIVE DIAGNOSIS BI-ALCL MADE FILE REPRESENTS DEVICE REMOVED PREVIOUS ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/01/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6196606|63054804|D|1||JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT NEW CASE REPORTS B62015 PATIENTÂ¿CONSULTS PALPABLE NODULES RIGHT BREAST 2 MONTHS PATIENT BREAST IMPLANTS SINCE 2011 MAMMOGRAPHY ULTRASOUND MAGNETIC RESONANCE NEUROGRAPHY ANOTHER INSTITUTION LED CONCLUSION PROBABLE COMPLICATION RIGHT BREAST IMPLANT ARTICLE GOES STATE PATIENT REEVALUATED CENTER NEW MX ULTRASOUND ADDITION IDENTIFY IPSILATERAL ADENOPATHIES CAPSULAR NODULE AXILLARY LYMPH NODE RESECTEDÂ¿ IMPLANT CAPSULE REMOVED ARTICLE ADDITIONALLY STATES Â¿THE CAPSULE 15 CM THICK HARD YELLOWISH NODULESÂ¿ Â¿THE PATIENT 4 CHOP CYCLES SEVEN MONTHS LATER PATIENT CONDITION OPTIMALÂ¿|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/21/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6196606|63054803|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS CANNOT OBTAINED TIME CONTACTFOLLOW INFORMATION PROVIDED FOUND DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS ARTICLE CITATION ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT NEW CASE ALVARO IBARRA MARCELA JACARD SOLEDAD TORRES PATRICIA FARDELLA MD AMERICAN SOCIETY CLINICAL PATHOLOGY 2016146S1-S26|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/21/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6144474|61423058|N|1||ARTICLE CITATION Â¿WHOLE EXOME SEQUENCING REVEALS ACTIVATING JAK1 STAT3 MUTATIONS BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA PIERS BLOMBERY ELLA R THOMPSON KATE JONES GISELA MIR ARNAU STEPHEN LADE JOHN F MARKHAM JASON LI ANAND DEVA RICKY W JOHNSTONE AMIT KHOT H MILES PRINCE DAVID WESTERMAN PUBLISHED HAEMATOLOGICA ELECTRONICALLY PUBLISHED SEPTEMBER 2016 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA LYMPHOMA-ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/05/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6144474|61423059|D|1||REVIEWED JOURNAL ARTICLE Â¿WHOLE EXOME SEQUENCING REVEALS ACTIVATING JAK1 STAT3 MUTATIONS BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ JOURNAL HAEMATOLOGICA SEPTEMBER 2016 101 E387-E390 ARTICLE STATES PATIENT Â¿PRESENTED THREE MONTH HISTORY BREAST SWELLING APPROXIMATELY SEVEN YEARS INSERTION ANATOMIC SALT-LOSS TEXTURED SILICONE- FILLED BREAST IMPLANTS FLUID ASPIRATED LEFT BREAST SHOWED LARGE ATYPICAL CELLS CD2Â¿ CD3Â¿ CD4+ CD5+ CD7Â¿ CD8Â¿ CD30+ ALKÂ¿ IMMUNOHISTOCHEMISTRY HISTOLOGICAL EXAMINATION SHOWED DISEASE CONFINED EFFUSION EVIDENCE INFILTRATION PSEUDOCAPSULE PATIENT UNDERWENT REMOVAL IMPLANT LOCAL SYSTEMIC THERAPY REMAINS CLINICALLY WELL EVIDENCE RECURRENCE SIX MONTHS FOLLOW-UPÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/05/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176830|62457611|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 -YEAR-OLD PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA TREATMENT REPORTED IMPLANT REMOVAL FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176830|62457610|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5803927|49896516|N|1||EVENTS CAPSULAR CONTRACTURE NIPPLE SENSATION INCREASEDECREASE SEROMA DEFLATION PREVIOUSLY REPORTED VIA ASR B6 2016 ADDITION LAB ANALYSIS RESULTS DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-560|07/19/2016||09/25/2015||R|Y||0HP|FWM|1.0|06/26/2006|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||578468|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6153092|61703506|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ 137 6 1659-1669 HONGHUA HU PHD KHALID JOHANI AHMAD ALMATROUDI KAREN VICKERY PHD BVSC BRUCE VAN NATTA MD MARSHALL E KADIN MD GARRY BRODY MD MARK CLEMENS MD CHAN YOON CHEAH MD STEPHEN LADE MD PREETI AVINASH JOSHI MDPHD H MILES PRINCE MDPHD ANAND K DEVA BSCMED MBBS MS PUBLISHED JUNE 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6167285|62187250|D|1||ABSTRACT LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTS Â¿19 I-ALCLSÂ¿ CASES ARTICLE ADDITIONALLY STATES Â¿FIVE PATIENTS PRESENTED ERYTHEMATOUS SKIN ERUPTIONÂ¿ RECORD CREATED CAPTURE 5 CASES ALCL Â¿ERYTHEMATOUS SKIN ERUPTIONÂ¿ ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ CURRENTLY WAY DETERMINE TREATMENTS USED 65 CASES MANUFACTURER DEVICES UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6167285|62187249|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL ERYTHEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6167285|62735770|D|1||ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTS B6 PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED LEFT SEROMA Â¿DISRUPTED IMPLANTÂ¿ TREATMENT REPORTED IMPLANT REMOVAL FOLLOW-UP REVEALED EVIDENCE DISEASE REPORT INITIALLY SENT REPRESENT FIVE PATIENTS DUE DISCOVERY IDENTIFYING INFORMATION SUPPLEMENTAL REPORT REPRESENT B6 PATIENT MFR 9617229-2016-00227 9617229-2016-00196 9617229-2016-00244 9617229-2016-00204 SENT REPRESENT PATIENTS PREVIOUSLY REPRESENTED INITIAL REPORT MFR 9617229-2016-00206|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6157808|62108428|D|1||LITERATURE ARTICLE Â¿COMPREHENSIVE IMMUNOPHENOTYPIC ANALYSIS 64 CASES BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA SHOWS ACTIVATED CYTOTOXIC SILENT T-CELL RECEPTOR PATTERNÂ¿ REPORTS Â¿64 CASESÂ¿ ARTICLE CONTINUES STATE Â¿WE REVIEWED WORLD LITERATURE CASES BI-ALCL ACCRUED CASES IMMUNOPHENOTYPIC DATA DERIVED USING IMMUNOHISTOCHEMICAL FLOW CYTOMETRY METHODS USED LEAST 5 FOLLOWING 13 MARKERS REPORTED CD3 CD4 CD8 CD30 CD43 CD45 EMATIA-1 GRANZYME-B ALK-1 TCR-Â¿Â¿ TCR-GÂ¿ EBER SITU HYBRIDIZATION LESS 5 MARKERS REPORTED CONTACTED CORRESPONDING AUTHORS AVAILABLE MATERIAL ADDITIONAL STUDIES INCLUDED DATAÂ¿ Â¿CD30 POSITIVE N=64 CASES WHEREAS ALK EBER NEGATIVE TESTED CASES N=56 N=25 RESPECTIVELY CD3 POSITIVE 15 62 24 CASES CD4 4361 70 CD8 657 11 CD43 37 46 80 CD45 2949 59 EMA 2542 60 TIA-1 2846 61 GRANZYME-B 28 47 60 TCR Â¿Â¿ 5 24 21 TCR GÂ¿ 1 23 4 THUS TCR SILENT 1824 75 CASESÂ¿ CYTOLOGICAL MARKERS ALK- CD30+ REPORTED RECORD CREATED CAPTURE 56 CASES BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6157808|62108427|N|1||EVENT LYMPHOMA ALCL PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED AUTHOR RESPONDED REFUSED PROVIDE INFORMATION DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL Â¿COMPREHENSIVE IMMUNOPHENOTYPIC ANALYSIS 64 CASES BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA SHOWS ACTIVATED CYTOTOXIC SILENT T-CELL RECEPTOR PATTERNÂ¿ ANA CLAUDIA FROTA LOPES L JEFFREY MEDEIROS MARK W CLEMENS MING CHAI HUI LIU ARIANNA DI NAPOLI STEPHEN LADE MITUAL AMIN KEN H YOUNG ROBERTO MIRANDA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5612275|43806327|D|1||DIAGNOSED ALCL SILICONE BREAST IMPLANTS PLACED LEFT BREAST GREW APPROX 50 LARGER PAIN FINE NEEDLE ASPIRATION STRAW COLORED FLUID TWO WEEKS GIVEN DIAGNOSIS ALCL ANAPLASTIC LARGE CELL LYMPHOMA MET LYMPHOMA SPECIALIST BREAST SURGEON B6 2016 B6 2016 UNDERWENT CAPSULECTOMY LEFT BREAST BILATERAL REMOVAL BREAST IMPLANTS PET SCAN REVEALED SYSTEMIC MIGRATION LYMPHOMA|SILICONE BREAST IMPLANTS||04/25/2016||||N|*||I|FTR|1.0||SILICONE BREAST IMPLANTS|||||||nan|||||||True
6143032|61396907|D|1||ABSTRACT LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTED Â¿19 I-ALCLSÂ¿ CASES ONE TWO CLINICAL PRESENTATIONS REPORTED Â¿EFFUSIONÂ¿ ELEVEN PATIENTS EXPERIENCED ALCL EFFUSION RECORD REPRESENTS 11 CASES ALCL PRESENTED EFFUSION HISTOPATHOLOGY REPORTS MALIGNANT CELLS CD30-POSITIVE ALK NEGATIVE ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ CURRENTLY WAY DETERMINE TREATMENTS USED 11 CASES MANUFACTURER DEVICES UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6143032|62822269|D|1||ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTS B6 -YEAR-OLD PATIENT IMPLANTED LEFT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN CHART ADDITIONALLY PROVIDES PATIENT EXPERIENCED LEFT SIDE SEROMA TREATMENT REPORTED IMPLANT REMOVAL CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP FOUND EVIDENCE DISEASE REPORT INITIALLY SENT REPRESENT ELEVEN PATIENTS DUE DISCOVERY IDENTIFYING INFORMATION SUPPLEMENTAL REPORT REPRESENT B6 -YEAR-OLD PATIENT DEVICE MFR 9617229-2016-00234 9617229-2016-00235 9617229-2016-00206 9617229-2016-00236 9617229-2016-00240 9617229-2016-00241 9617229-2016-00239 9617229-2016-00238 9617229-2016-00242 9617229-2016-00245 9617229-2016-00243 SENT REPRESENT PATIENTS PREVIOUSLY REPRESENTED INITIAL REPORT MFR  9617229-2016-00197|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6143032|61396906|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL LATE SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011805|56820798|D|1||ALLERGANÂ¿S LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ TABLE 5 Â¿TNM STAGING PATIENTS ANZ COHORTÂ¿ ARTICLE REPORTS ADDITIONAL THREE OCCURRENCES DEATH APPROX 2 CASES Â¿DEATH  MASS EXTENDING BEYOND CAPSULEÂ¿ ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS MANUFACTURER COULD SPECIFIED ARTICLE STATES Â¿BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED 571 IMPLANTS SERIES ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011805|56820797|N|1||ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5697586|46503421|N|1||MEDWATCH SENT FDA 06032016 LITERATURE CITATION HART ALEXANDRA LECHOWICZ MARY JO PETERS KENDALL K HOLDEN JEANNINE CARLSON GRANT W Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORT 2 CASES REVIEW LITERATUREÂ¿ AESTHETIC SURGERY JOURNAL 2014 VOL 346 884-894 FIRST PUBLISHED ONLINE 01AUG2014 CORRESPONDING AUTHOR DECLINED PROVIDE ALLERGAN INFORMATION REGARDING EVENT PRODUCT PRODUCT RETURN PATIENT DETAILS EVENTS FLUID COLLECTION Â¿RECENT HISTORY CELIAC DISEASEÂ¿ PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5697586|46503422|D|1||FOLLOWING JOURNAL ARTICLE REVIEWED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORT 2 CASES REVIEW LITERATURE AUTHORS REPORTED PATIENTS MEDICAL HISTORY REVEALED RECENT DIAGNOSIS CELIAC DISEASE CONFIRMED DUODENAL BIOPSY AUTHORS ADDITIONALLY NOTED MRI BREASTS SHOWED POSTERIOR FLUID COLLECTIONS BILATERALLY DEVICE REMOVED TOTAL CAPSULECTOMY PERFORMED AUTHORS NOTE EVIDENCE SILICONE CAPSULE SIDE CAPSULE SPECIFIED REPORT REPRESENTS LEFT SIDE SEE MFR REPORT  9617229-2016-00063 RIGHT SIDE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6011770|56819840|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011770|56819841|D|1||ALLERGANS LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND - HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGY TABLE 4 PRESENTATION BIA-ALCL N=46 ARTICLE REPORTS FOLLOWING 1 CASE MASS METASTATIC DISEASE AXILLA TABLE 4 DEATH  MASS METASTATIC DISEASE ONE LYMPH NODE AXILLA TABLE 5 MANUFACTURER COULD SPECIFIED ARTICLE STATES BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED 571 IMPLANTS SERIES ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS ARTICLE STATES PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6153118|61701316|N|1||EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION PATIENTS ADVISED CAPSULAR CONTRACTURE MAY COMMON FOLLOWING INFECTION HEMATOMA SEROMA CHANCE HAPPENING MAY INCREASE TIME CAPSULAR CONTRACTURE OCCURS COMMONLY REVISION PATIENTS PRIMARY AUGMENTATION RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE ALSO RISK FACTOR IMPLANT DEFLATION ONE COMMON REASONS REOPERATION PATIENTS ALSO ADVISED ADDITIONAL SURGERY MAY NEEDED CASES PAIN ANDOR FIRMNESS SEVERE SURGERY RANGES REMOVAL IMPLANT CAPSULE TISSUE REMOVAL POSSIBLE REPLACEMENT IMPLANT SURGERY MAY RESULT LOSS BREAST TISSUE CAPSULAR CONTRACTURE MAY HAPPEN ADDITIONAL SURGERIES CAPSULAR CONTRACTURE MAY INCREASE RISK DEFLATION B4|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6167248|62147367|D|1||ABSTRACT LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTS Â¿19 I-ALCLSÂ¿ CASES ONE CLINICAL PRESENTATIONS REPORTED Â¿MASS + SEROMAÂ¿ 6 PATIENTS EXPERIENCED  ALCL Â¿MASS + SEROMAÂ¿ RECORD CREATED CAPTURE 6 CASES ALCL Â¿MASS + SEROMAÂ¿ ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿  REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT  IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ CURRENTLY WAY DETERMINE TREATMENTS USED 6 CASES MANUFACTURER DEVICES UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6167248|62147366|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL LATE SEROMA LUMPNODULE PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6167248|62810641|D|1||ALLERGAN PRODUCT SURVEILLANCE RECEIVED LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMES ARTICLE REPORTS B6 YEAR-OLD PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN TREATMENT REPORTED IMPLANT REMOVAL FOLLOW-UP REVEALED EVIDENCE DISEASE REPORT INITIALLY SENT REPRESENT SIX PATIENTS DUE DISCOVERY IDENTIFYING INFORMATION SUPPLEMENTAL REPORT REPRESENT B6 YEAR-OLD PATIENT DEVICE MFR  9617229-2016-00237 9617229-2016-00227 9617229-2016-00246 9617229-2016-00244 9617229-2016-00204 SENT REPRESENT PATIENTS PREVIOUSLY REPRESENTED INITIAL REPORT MFR  9617229-2016-00205|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011872|56922006|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011872|56922007|D|1||ALLERGANÂ¿S LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ TABLE 4 Â¿PRESENTATION BIA-ALCL N=46Â¿ ARTICLE REPORTS FOLLOWING 5 CASES Â¿MASS ONLYÂ¿ TWO RECORDS CAPTURED EVENTS LYMPHOMA-ALCL MASS  IDENTIFIED PREVIOUSLY REPORTED RECORD CREATED CAPTURE REMAINING 3 5 CASES NOTED ARTICLE LYMPHOMA-ALCL MASS MANUFACTURER COULD SPECIFIED ARTICLE STATES Â¿BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED 571 IMPLANTS SERIESÂ¿ ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011849|56929012|D|1||ALLERGANS LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 - HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGY TABLE 4 PRESENTATION BIA-ALCL N=46 ARTICLE REPORTS FOLLOWING 35 CASES SEROMA SPECIFIED ARTICLE UNILATERAL LATE SEROMA EIGHTEEN RECORDS CAPTURED EVENTS LYMPHOMA-ALCL SEROMA  IDENTIFIED PREVIOUSLY REPORTED RECORD CREATED CAPTURE REMAINING 17 35 CASES NOTED ARTICLE LYMPHOMA-ALCL SEROMA MANUFACTURER COULD SPECIFIED ARTICLE STATES BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED B4 IMPLANTS SERIES ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS ARTICLE STATES PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011849|56929011|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA B6 Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME HEMATOMASEROMA|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5834667|50817904|D|1||ACCORDING INFORMATION PROVIDED PATIENT DIAGNOSED ANAPLASTIC LARGE CELL LYMPHOMA ALCL LEFT PROSTHESIS ASSOCIATED COMPLAINT RETURNED MENTOR ADDITIONAL INFORMATION ANDOR DEVICE BECOME AVAILABLE PE COMPLAINT REEVALUATED TIME BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ACCORDING FDA INCIDENCE ALCL PATIENTS BREAST IMPLANTS SMALL FRACTION 5-10 MILLION WOMEN RECEIVED BREAST IMPLANTS WORLDWIDE INVESTIGATION DEVICE HISTORY RECORD REVEALED IRREGULARITIES REVIEW NC SYSTEM COMPLAINT DATABASE REVEALED COMPLAINTS ASSOCIATED LOT 6438477 MAIN SYMPTOMS ALCL WOMEN BREAST IMPLANTS LATE ONSET PERSISTENT SWELLING PAIN VICINITY IMPLANT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL MENTOR CONCURS FDAS POSITION RISK ALCL APPEARS SMALL FDA BELIEVES TOTALITY EVIDENCE CONTINUES SUPPORT REASONABLE ASSURANCE FDA-APPROVED BREAST IMPLANTS SAFE EFFECTIVE USED LABELED ANAPLASTIC LARGE CELL LYMPHOMA ALCL KNOWN COMPLICATION ASSOCIATED DEVICES REFERENCED IFU|MEMORY GEL SILTEX ROUND MODERATE PLUS PROFILE MAMMARY PROSTHESIS|3544751|07/29/2016|||DA|N|R||I|FTR|1.0||BREAST IMPLANT||6438477|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||||True
5695364|46431599|D|1||HEALTH PROFESSIONAL REPORTED PATIENT SUFFERED SIZE INCREASE RECONSTRUCTED RIGHT BREAST APPROXIMATELY THREE YEARS FOUR MONTHS IMPLANTATION SIZE INCREASE COMPATIBLE SEROMA CONSERVATIVE TREATMENT INITIATED CONSISTING ANTIBIOTIC THERAPY CORTICOSTEROIDS PATIENT ADVISED REST RIGHT ARM PUNCTURED TWICE PERFORM HISTOLOGICAL ANALYSIS GERMINAL CELL RESULTS DETERMINED ATYPICAL CELLS REASON DEVICE EXPLANTED COMPLETE CAPSULECTOMY MADE PATIENT PATHOLOGY REPORT CAPSULE POSITIVE ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA ALCL ASSOCIATED BREAST IMPLANTS CD30 RESULTS PROVIDED CASE CURRENTLY SUSPECTED-ALCL CAPTURED LYMPHOMA PATIENTS CONDITION PROGRESSED FAVOURABLY|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX135-445|06/02/2016||||N|R||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2070807|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5440576|38326420|D|1||ALCL CASE REPORT REPORT CASE B6 WOMAN PREVIOUS HISTORY SMOKING MULTIPLE BREAST AUGMENTATION SURGERIES IMPLANTS FIRST ONE 20 YEARS AGO 15 YEARS AGO LAST 3 YEARS AGO B6 2012 DENIED HISTORY ALLERGIC REACTION TRANSFUSION MEDICAL PROBLEMS TAKING ASPIRIN 81MG MOMENT EVENT ADMITTED HOSPITAL B6 2016 5 MONTH HISTORY PROGRESSIVE SWELLING RIGHT ARM ALSO ERYTHEMATOUS RASH ARM EXTENDING CHEST RIGHT BREAST SKIN INDURATED FIRM LUMP RIGHT EXTERNAL QUADRANT RIGHT BREAST PAIN ARM DIDNT FEVER ORDERED MRI ARM INVOLVING BREAST SHOWED FASCIAL HYPERINTENSITY SWELLING SOFT TISSUE ADDITIONALLY PERFORMED ROUTINE LABORATORIES SHOWED HYPERLEUKOCYTOSIS 38000 SEVERE EOSINOPHILIA 26000 HAEMOGLOBIN PLATELETS NORMAL HS-CRP 292 PROCALCITONIN NEGATIVE LDH 393 BETA-2 MICROGLOBULIN 2000 KIDNEY LIVER FUNCTION TEST UNREMARKABLE PERFORMED PET SCAN SHOWED HYPERMETABOLISM PREVIOUS DESCRIBED SWOLLEN AREA ENLARGEMENT HYPERMETABOLISM PERIHEPATIC LYMPH NODES THEREFORE BIOPSY ARM PERFORMED PATHOLOGIC SPECIMEN INCLUDED SKIN SOFT TISSUE FASCIA MUSCLE PATHOLOGY RESULT CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA CD4+ CD30+ EMA+ ALT- SURGICAL REMOVAL BREAST IMPLANTS CARRIED PATHOLOGY LAB CONFIRMED AROUND IMPLANTS CAPSULE RIGHT BREAST EXTENDED INFILTRATION NEOPLASTIC CELLS CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA IMMUNOHISTOCHEMISTRY PROFILE INTERESTINGLY NEOPLASTIC CELLS SURROUNDED EOSINOPHIL-RICH INFLAMMATORY INFILTRATE LEFT IMPLANT DIDNT NEOPLASTIC CELLS IMPLANTS ALLERGAN MODEL MHP VOLUME 130 CUBIC CENTIMETERS ROUND FILLED COHESIVE SILICONE CURRENTLY PT SYSTEMIC CHEMOTHERAPY CYCLOPHOSPHAMIDE DOXORUBICIN ETOPOSIDE VINCRISTINE PREDNISONE|ALLERGAN SILICONE BREAST IMPLANT||02/11/2016||||*|*||0HP|FTR|1.0||ALLERGAN SILICONE BREAST IMPLANT||||||US|ALLERGAN|||||MHP||True
5440576|38326420|D|1||ALCL CASE REPORT REPORT CASE B6 WOMAN PREVIOUS HISTORY SMOKING MULTIPLE BREAST AUGMENTATION SURGERIES IMPLANTS FIRST ONE 20 YEARS AGO 15 YEARS AGO LAST 3 YEARS AGO B6 2012 DENIED HISTORY ALLERGIC REACTION TRANSFUSION MEDICAL PROBLEMS TAKING ASPIRIN 81MG MOMENT EVENT ADMITTED HOSPITAL B6 2016 5 MONTH HISTORY PROGRESSIVE SWELLING RIGHT ARM ALSO ERYTHEMATOUS RASH ARM EXTENDING CHEST RIGHT BREAST SKIN INDURATED FIRM LUMP RIGHT EXTERNAL QUADRANT RIGHT BREAST PAIN ARM DIDNT FEVER ORDERED MRI ARM INVOLVING BREAST SHOWED FASCIAL HYPERINTENSITY SWELLING SOFT TISSUE ADDITIONALLY PERFORMED ROUTINE LABORATORIES SHOWED HYPERLEUKOCYTOSIS 38000 SEVERE EOSINOPHILIA 26000 HAEMOGLOBIN PLATELETS NORMAL HS-CRP 292 PROCALCITONIN NEGATIVE LDH 393 BETA-2 MICROGLOBULIN 2000 KIDNEY LIVER FUNCTION TEST UNREMARKABLE PERFORMED PET SCAN SHOWED HYPERMETABOLISM PREVIOUS DESCRIBED SWOLLEN AREA ENLARGEMENT HYPERMETABOLISM PERIHEPATIC LYMPH NODES THEREFORE BIOPSY ARM PERFORMED PATHOLOGIC SPECIMEN INCLUDED SKIN SOFT TISSUE FASCIA MUSCLE PATHOLOGY RESULT CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA CD4+ CD30+ EMA+ ALT- SURGICAL REMOVAL BREAST IMPLANTS CARRIED PATHOLOGY LAB CONFIRMED AROUND IMPLANTS CAPSULE RIGHT BREAST EXTENDED INFILTRATION NEOPLASTIC CELLS CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA IMMUNOHISTOCHEMISTRY PROFILE INTERESTINGLY NEOPLASTIC CELLS SURROUNDED EOSINOPHIL-RICH INFLAMMATORY INFILTRATE LEFT IMPLANT DIDNT NEOPLASTIC CELLS IMPLANTS ALLERGAN MODEL MHP VOLUME 130 CUBIC CENTIMETERS ROUND FILLED COHESIVE SILICONE CURRENTLY PT SYSTEMIC CHEMOTHERAPY CYCLOPHOSPHAMIDE DOXORUBICIN ETOPOSIDE VINCRISTINE PREDNISONE|ALLERGAN SILICONE BREAST IMPLANT||02/11/2016||||*|*||0HP|FTR|2.0||ALLERGAN SILICONE BREAST IMPLANT||||||US|ALLERGAN|||||MHP||True
5759530|48466890|D|1||PATIENT REPORTED LEFT BREAST CAPSULAR CONTRACTURE SEROMA TOTAL CAPSULECTOMY LEFT BREAST EXCHANGE PERFORMED SURGICAL LOG REPORTS 200 CC SEROUS FLUID PRESENT LEFT SEROLOGY + ALCL PATHOLOGY + ALCL CYTOLOGY REPORT DATED B6 2016 STATES LEFT BREAST FLUID HIGHLY ATYPICAL LYMPHOCYTES PRESENT CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE COMMENT MORPHOLOGY HIGHLY ATYPICAL CELLS SEEN SPECIMEN B SIMILAR SPECIMEN CELLS DEMONSTRATE STAINING CD30 OVERALL FEATURES CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/29/2016|||DA|N|R||0HP|FTR|1.0|08/30/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180804|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5759530|48466889|N|1||MEDWATCH SENT FDA 06292016 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT KNOWN DEVICE RETURNED PATIENT DECLINED PERMISSION CONTACT DOCTOR INFORMATION TIME DEVICE LABELING ADDRESSES POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/29/2016|||DA|N|R||0HP|FTR|1.0|08/30/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180804|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5759530|50477356|D|1||PATIENT REPORTED LEFT BREAST CAPSULAR CONTRACTURE SEROMA TOTAL CAPSULECTOMY LEFT BREAST EXCHANGE PERFORMED SURGICAL LOG REPORTS 200 CC SEROUS FLUID PRESENT LEFT SEROLOGY + ALCL PATHOLOGY + ALCL CYTOLOGY REPORT DATED B6 2016 STATES 62213FT BREAST FLUID HIGHLY ATYPICAL LYMPHOCYTES PRESENT CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE COMMENT MORPHOLOGY HIGHLY ATYPICAL CELLS SEEN SPECIMEN B SIMILAR SPECIMEN CELLS DEMONSTRATE STAINING CD30 OVERALL FEATURES CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE62282|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-469|06/29/2016|||DA|N|R||0HP|FTR|1.0|08/30/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180804|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176648|62440610|D|1||LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ ARTICLE REPORTED CASES Â¿INFILTRATIVE I-ALCLÂ¿ SURVIVAL RATE 525 B6 PATIENT IMPLANTED TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN CHART ADDITIONALLY PROVIDES PATIENT EXPERIENCED LEFT SEROMA MASS ARTICLE ADDITIONALLY STATES PATIENT 11 Â¿PRESENTED ERYTHEMATOUS SKIN ERUPTION TREATMENT REPORTED IMPLANT REMOVAL CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE PREDNISONE 6 CURES CHOP CHOP-LIKE FOLLOW-UP REVEALED PATIENT DIED LYMPHOMA PROGRESSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176648|62440609|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS DEATH LYMPHOMA ALCL SEROMA LUMP ERYTHEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5901883|52941730|N|1||B4 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING DEVICE INFORMATION REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES BREAST SENSATION SEROMA NECROSIS LYMPHADENOPATHY |UNK SALINE IMPLANT|UNK SALINE IMPLANT|08/24/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6106949|60072475|N|1||EVENTS LYMPHOMA SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS CURRENTLY UNKNOWN EXPLANTED DEVICE RETURNED REPORTER CONFIRMED DEVICE SENT PATHOLOGY ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY RECORD DHR REVIEW REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT B4 VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUN NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANS MANUFACTURERS BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL IMPLANT PALPABILITYVISIBILITY HEMATOMASEROMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF125-375|11/16/2016||||*|*||0HP|FTR|1.0|11/08/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1359584|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6141438|61344363|D|1||REPORTED EVENTS Â¿ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ Â¿LATE SEROMAÂ¿ OCCURRING MCGHAN STYLE 153 LUMEN DEVICE FOUND WITHIN JOURNAL ARTICLE Â¿LONG-TERM OUTCOMES MCGHAN STYLE 153 DUAL-LUMEN BREAST IMPLANT IMPLICATIONS FUTURE IMPLANT DESIGNÂ¿ JOURNAL PLASTIC RECONSTRUCTIVE AESTHETIC SURGERY 69 02 JUL 2016 PP 1211-1217 ARTICLE STATES Â¿ONE CASE 075 ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSED DEVELOPMENT LATE SEROMA TEN YEARS POST-OPERATIVELYÂ¿ INFORMATION PROVIDED PATHOLOGICAL MARKERS CONFIRMING ALCL RECEIVED EVENT CAPTURED LYMPHOMA AFFECTED SIDE SPECIFIED|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|12/02/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6141438|61344362|N|1||ARTICLE CITATION LONG-TERM OUTCOMES MCGHAN STYLE 153 DUAL-LUMEN BREAST IMPLANT IMPLICATIONS FUTURE IMPLANT DESIGNÂ¿ DC HAMMOND WP SCHMITT PUBLISHED J PLAST RECONSTR AESTHET SURG ELECTRONICALLY PUBLISHED 07022016 INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME EVENTS LYMPHOMA SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING POTENTIAL ADVERSE EVENTS MAY OCCUR SILICONE GEL-FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES NIPPLE BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL - ATTACHMENT ARTICLE - LONG-TERM OUTCOMESPDF|STYLE 153 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 153|12/02/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5962723|55115726|N|1||MEDWATCH SENT FDA 09202016 ALLERGAN INITIATED INVESTIGATION LATE REPORT B4 ARTICLE CITATION FIRST CASE REPORT MEXICO LATIN AMERICA ANAPLASTIC LARGE CELL LYMPHOMA PATIENT MAMMARY IMPLANTS TORRES-RIVERO CESAR RAMOS-GALLARDO GUILLERMO NAMBO-LUCIO DE JESÃS VAQUERO-PÃREZ MAR CIR PLÃST IBEROLATINOAM-VOL 42 Â¿ 2 APRIL Â¿ MAY Â¿ JUNE 2016  P 175-180 REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING SERIAL NUMBER LOT NUMBER IMPLANTEXPLANT DATE IMPLANTINGEXPLANTING PHYSICIAN PATIENT DATE BIRTH DEVICE RETURN STATUS DEVICE RELATIONSHIP REPORTED EVENTS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL PAIN VARYING INTENSITY LENGTH TIME MAY OCCUR PERSIST FOLLOWING BREAST IMPLANT SURGERY PATIENTS ADVISED CONTACT SURGEON SIGNIFICANT PAIN PAIN PERSISTS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/20/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5962723|55115727|D|1||FOLLOWING JOURNAL ARTICLE REVIEWED Â¿FIRST CASE REPORT MEXICO LATIN AMERICA ANAPLASTIC LARGE CELL LYMPHOMA PATIENT MAMMARY IMPLANTS AUTHORS REPORT KNOWLEDGE PRESENT FIRST CASE REPORTED PLASTIC SURGEON MEXICO LATIN AMERICA PATIENT HISTORY BREAST AUGMENTATION UNILATERAL ASYMMETRY DUE LATE SEROMA 2 UNSUCCESSFUL PUNCTURES REMOVAL BREAST IMPLANT CAPSULECTOMY SCHEDULED DIAGNOSIS ALCL CONFIRMED PERIPROSTHETIC FLUID DEVICE DETAILS SPECIFIED PLACEMENT 290 CC TEXTURED COHESIVE GEL ANATOMICAL IMPLANTS MCGHAN MEDICAL CORPORATION B6 ADDITIONAL EVENT DETAILS INCLUDE YEAR PROCEDURE PATIENT PRESENTED DISCOMFORTS EDEMA RIGHT BREAST CEASED NONSTEROIDAL ANTI-INFLAMMATORY DRUGS DOSE 120 MG DAY 7 DAYS LATER PROGRESS SATISFACTORY 2015 5 YEARS SYMPTOMS 6 FOLLOWING INTERVENTION PATIENT PRESENTED DISCOMFORTS EDEMA RIGHT BREAST IMAGING STUDIES PERFORMED PATIENT MAGNETIC RESONANCE MR DOCUMENTING PRESENCE ABUNDANT PERIPROSTHETIC FLUID AFFECTED BREASTÂ¿ Â¿THE SAMPLE SENT CYTOLOGICAL STUDY INFORMED CHRONIC MASTITIS GRANOMALOTOUS REACTION NEGATIVE CULTURE HOWEVER GRADUAL INCREASE BREAST CONTINUED FOLLOWING MONTHS 2 NEW PUNCTURES PERFORMED UNSUCCESSFULLY SECOND PUNCTURE FLUID SENT MALIGNANCY STUDY SUSPECTED POSSIBLE DUCTAL CARCINOMAÂ¿ Â¿THE PATIENT ASSESSED ULTRASOUND ASSISTED IMAGING STUDIES MR WITHOUT FINDING ANOMALIES MAMMARY PARENCHYMA REASON OPTED WITHDRAWAL IMPLANT CAPSULECTOMY EXAMINATION BREAST TISSUE TRANSOPERATIVE BIOPSYÂ¿ PATIENT REJECTED TREATMENT CURRENTLY ASYMPTOMATIC|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/20/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5846890|51223996|D|1||ACCORDING INFORMATION PROVIDED PATIENT EXPERIENCED RIGHT RUPTURE ALONG ANAPLASTIC LARGE CELL LYMPHOMA ALCL BASED RESULTS LABORATORY EVALUATION PE IDENTIFIED THREE RENTS SHELL DEVICE FIRST RENT MEASURED APPROXIMATELY 3CM LENGTH TWO ADDITIONAL RENTS MEASURED APPROXIMATELY  1CM SHELL DEVICE AREAS SHELL WEAR ALSO OBSERVED SHELL ALTHOUGH ROOT CAUSE RENTS COULD DETERMINED SHELL WEAR SUGGEST IN-VIVO FOLDING CREASING DEVICE ANOMALIES OBSERVED BREAST IMPLANTS LIFETIME DEVICES RUPTURE OCCUR TIME IMPLANTATION RUPTURE KNOWN COMPLICATION ASSOCIATED DEVICES REFERENCED PIDS BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINS LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ACCORDING FDA INCIDENCE ALCL PATIENTS BREAST IMPLANTS SMALL FRACTION 5-10 MILLION WOMEN RECEIVED BREAST IMPLANTS WORLDWIDE INVESTIGATION DEVICE HISTORY RECORD REVEALED IRREGULARITIES REVIEW NC SYSTEM COMPLAINT DATABASE REVEALED COMPLAINTS TYPE ASSOCIATED LOT 5746123 MAIN SYMPTOMS ALCL WOMEN BREAST IMPLANTS LATE ONSET PERSISTENT SWELLING PAIN VICINITY IMPLANT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL MENTOR CONCURS FDAS POSITION RISK ALCL APPEARS SMALL FDA BELIEVES TOTALITY EVIDENCE CONTINUES SUPPORT REASONABLE ASSURANCE FDA-APPROVED BREAST IMPLANTS SAFE EFFECTIVE USED LABELED ANAPLASTIC LARGE CELL LYMPHOMA ALCL KNOWN COMPLICATION ASSOCIATED DEVICES REFERENCED PIDS|MEMORY GEL SILTEX ROUND MODERATE PLUS PROFILE MAMMARY PROSTHESIS|354-4507|08/04/2016||06/28/2016||R|Y||0HP|FTR|1.0||BREAST IMPLANT||5746123|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR|75038|TX|75038||||True
5896122|52746118|N|1||MEDWATCH SENT FDA 08232016 EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING DEVICE SERIAL NUMBER IMPLANTEXPLANT DATE IMPLANTINGEXPLANTING PHYSICIAN PATIENT NAME PATIENT DATE BIRTH DEVICE RETURN STATUS PATHOLOGICAL MARKERS DEVICE RELATIONSHIP REPORTED EVENT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/23/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6051104|58191673|D|1||ANAPLASTIC LARGE CELL LYMPHOMA RELATED BREAST IMPLANT ELEVEN YEARS HISTORY BREAST RECONSTRUCTION SALINE TEXTURED IMPLANT DEVELOPED SEROMA LAST YEAR|BREAST IMPLANT||10/21/2016||||N|*||I|FWM|1.0||BREAST IMPLANT|||UNK||UNK||UNK|||||||True
6011835|56821577|D|1||ALLERGANÂ¿S LITERATURE REVIEW RECENT JOURNAL ARTICLES RECEIVED FOLLOWING ARTICLE MEDICAL SAFETY Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ TABLE 5 Â¿TNM STAGING PATIENTS ANZ COHORTÂ¿ ARTICLE REPORTS ADDITIONAL THREE OCCURRENCES DEATH ONE CASE Â¿DEATH  MASS METASTATIC DISEASE MULTIPLE LYMPH NODESÂ¿ MANUFACTURER COULD SPECIFIED ARTICLE STATES Â¿BIOCELL ALLERGANINAMEDMCGHAN ACCOUNTED 571 IMPLANTS SERIES ARTICLE PROVIDE IMPLANTING EXPLANTING PHYSICIAN INFORMATION DEVICE SERIAL LOT INFORMATION SIDES ALCL DIAGNOSIS ARTICLE STATES Â¿ALL PATIENTS UNDERWENT TOTAL CAPSULECTOMY REMOVAL IMPLANTS DISEASED NON-DISEASED SIDE TUMORS CD30 POSITIVE ALK NEGATIVEÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6011835|56821576|N|1||MEDWATCH SENT FDA 10072016 ARTICLE CITATION Â¿BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA AUSTRALIA NEW ZEALAND Â¿ HIGHER RISK MACROTEXTURED IMPLANTS SUPPORTS BACTERIAL ETIOLOGYÂ¿ LOCH-WILKINSON KJ BEATH RJW KNIGHT WLF WESSELS MAGNUSSON PAPADOPOULOS CONNELL J LOFTS LOCKE HOPPER R COOTER K VICKERY PA JOSHI HM PRINCE  AK DEVA EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL -|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|10/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176965|62446268|D|1||ARTICLE Â¿Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿Â¿ REPORTED PATIENT DIAGNOSED ALCL ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ UNKNOWN TYPE CASE ARTICLE REPORTS B6 PATIENT IMPLANTED RIGHT SIDE TEXTURED SILICONE IMPLANT DEVICE MANUFACTURER UNKNOWN ARTICLE ADDITIONALLY PROVIDES PATIENT EXPERIENCED SEROMA DISRUPTED IMPLANT TREATMENT REPORTED IMPLANT REMOVAL DEXAMETHASONE HIGH-DOSE ARACYTINE OXALIPLATIN DHAOX FOLLOW-UP FOUND EVIDENCE DISEASE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176965|62446267|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6153187|61697755|N|1||B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR BREAST IMPLANT SURGERY INCLUDE REOPERATION IMPLANT REMOVAL INFECTION HEMATOMASEROMA BACTERIAL BIOFILM INFECTION DETECTED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ 137 6 1659-1669 HONGHUA HU PHD KHALID JOHANI AHMAD ALMATROUDI KAREN VICKERY PHD BVSC BRUCE VAN NATTA MD MARSHALL E KADIN MD GARRY BRODY MD MARK CLEMENS MD CHAN YOON CHEAH MD STEPHEN LADE MD PREETI AVINASH JOSHI MDPHD H MILES PRINCE MDPHD ANAND K DEVA BSCMED MBBS MS PUBLISHED JUNE 2016|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5350320|35251015|D|1||ALCL CASE REPORT B6 WOMAN UNDERWENT BREAST IMPLANTATION 8-9 YEARS AGO CENTRAL ASIA AUGMENTATION 2011 FIRST NOTICED SWELLING PAIN AROUND B6 2015 RIGHT BREAST FOUND FLUID COLLECTION B6 ED REFERRED B6 WORKUP MAMMOGRAPHY B6 2015 BIRADS 2 SHOWING FLUID COLLECTIONS NOTED US B6 FLUID ANALYSIS ASPIRATION B6 2015 SHOWED BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA|SILICONE BREAST IMPLANT||01/04/2016||||Y|*||0HP|FTR|1.0||SILICONE BREAST IMPLANT|||||||nan|||||||True
5912356|53436714|N|1||RESPONSE FDA REPORT NUMBER B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING PHYSICIAN INFORMATION PERMISSION CONTACT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|08/29/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5697379|46493992|N|1||MEDWATCH SENT FDA 06032016 LITERATURE CITATION HART ALEXANDRA LECHOWICZ MARY JO PETERS KENDALL K HOLDEN JEANNINE CARLSON GRANT W Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORT 2 CASES REVIEW LITERATUREÂ¿ AESTHETIC SURGERY JOURNAL 2014 VOL 346 884-894 FIRST PUBLISHED ONLINE 01AUG2014 CORRESPONDING AUTHOR DECLINED PROVIDE ALLERGAN INFORMATION REGARDING EVENT PRODUCT PRODUCT RETURN PATIENT DETAILS EVENTS SEROMA ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE LABELING BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL POTENTIAL ADVERSE EVENTS MAY OCCUR SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES NIPPLE BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS LYMPHADENOPATHY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5697379|46493993|D|1||FOLLOWING JOURNAL ARTICLE REVIEWED Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORT 2 CASES REVIEW LITERATUREÂ¿ AUTHORS REPORTED PATIENT UNDERGONE BILATERAL BREAST AUGMENTATION 16 YEARS EARLIER 425-CC TEXTURED ROUND SALINE IMPLANTS PLACED SUBGLANDULARLY MANUFACTURER IMPLANTS KNOWN PATIENT PRESENTED ACUTE ENLARGEMENT RIGHT BREAST ULTRASONOGRAPHY SHOWED FLUID COLLECTION AROUND RIGHT INTACT BREAST IMPLANT ULTRASOUND-GUIDED FLUID ASPIRATION SHOWED CD30+ ALKÂ¿ ALCL CELLS POSITIVE CD45 CD5 CD4 FAILED EXPRESS CD34 CD20 CD68 CD10 PATIENT UNDERWENT BILATERAL CAPSULECTOMIES IMPLANT REMOVAL APPROXIMATELY TWO MONTHS PRESENTATION IMMEDIATELY REMOVAL IMPLANTS CAPSULES EXAMINED MALIGNANCY FLOW CYTOMETRY CYTOGENETIC ANALYSIS IMMUNOHISTOCHEMICAL STAINING FAILED IDENTIFY UNIQUE CELL POPULATIONS PATIENT RECEIVE ADDITIONAL TREATMENT FREE DISEASE PATIENTS 15-MONTH FOLLOW-UP VISIT PATIENT CONTINUES MONITORED CLOSELY CHRONIC PAIN AFFECTED BREASTÂ¿|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5725674|47409581|N|1||MEDWATCH SENT FDA 06152016 B4 EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE SERIAL LOT NUMBER AVAILABLE EXACT IMPLANT DATE COULD SPECIFIED DEVICE RETURNED DEVICE LABELING ADDRESSES BASED INFORMATION REPORTED FDA FOUND MEDICAL LITERATURE POSSIBLE ASSOCIATION IDENTIFIED BREAST IMPLANTS RARE DEVELOPMENT ANAPLASTIC LARGE CELL LYMPHOMA ALCL TYPE NON-HODGKINÂ¿S LYMPHOMA WOMEN BREAST IMPLANTS MAY SMALL INCREASED RISK DEVELOPING ALCL FLUID SCAR CAPSULE ADJACENT IMPLANT ALCL REPORTED GLOBALLY PATIENTS IMPLANT HISTORY INCLUDES ALLERGANÂ¿S MANUFACTURERSÂ¿ BREAST IMPLANTS CONSIDER POSSIBILITY ALCL PATIENT LATE ONSET PERSISTENT PERI-IMPLANT SEROMA CASES PATIENTS PRESENTED CAPSULAR CONTRACTURE MASSES ADJACENT BREAST IMPLANT TESTING ALCL COLLECT FRESH SEROMA FLUID REPRESENTATIVE PORTIONS CAPSULE SEND PATHOLOGY TESTS RULE ALCL PATIENT DIAGNOSED PERI-IMPLANT ALCL DEVELOP INDIVIDUALIZED TREATMENT PLAN COORDINATION MULTI-DISCIPLINARY CARE TEAM SMALL NUMBER CASES WORLDWIDE DEFINED CONSENSUS TREATMENT REGIMEN PERI-IMPLANT ALCL|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/15/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5725674|47409582|D|1||VOLUNTARY MEDWATCH 5061844 REPORTED ALCL BREAST IMPLANT ASSOCIATED SIDE UNSPECIFIED DEVICE DESCRIPTION PROVIDED MCGHAN TEXTURED BREAST IMPLANT SALINE FOLLOW-UP HEALTH PROFESSIONAL REPORTS Â¿AUGMENTATION MCGHAN TEXTURED SALINE IMPLANT 360 CC IMPLANTED SUB MUSCULARÂ¿ ULTRASOUND FOUND Â¿CONTIGUOUS MEDIAL ASPECT PATIENTÂ¿S LEFT BREAST IMPLANT APPEARS ELLIPTICAL FLUID COLLECTIONÂ¿AREAS DENSE SHADOWING SEEN WITHIN TWELVE OÂ¿CLOCK RAY LEFT BREAST CORRESPOND PREVIOUSLY IDENTIFIED BENIGN APPEARING CALCIFICATIONS WITHIN REGION LEFT BREASTÂ¿ PHYSICIAN REFERRAL NOTE DESCRIBES Â¿BREAST MASSÂ¿ PHYSICIAN BELIEVES Â¿INFLAMMATORY RESPONSE BREAST IMPLANT LEFT BREASTÂ¿ ULTRASOUND LEFT BREAST STATES Â¿PALPABLE LUMP LEFT BREAST SWELLINGITCHING ALONG SURGICAL SCARÂ¿ FINDINGS STATE Â¿SMALL BENIGN OIL CYSTS IMAGED 1100 1200 POSITIONS LEFT BREAST BENIGN FLUID PERIPHERY IMPLANTÂ¿ OPERATIVE REPORT STATES Â¿PATIENT PRESENTED OFFICE SWELLING DISCOMFORT LEFT BREAST PATIENT DIAGNOSED LEFT BREAST SEROMA SENT CULTURE CYTOLOGY NEGATIVEÂ¿ DEVICE REMOVED REPLACED PATIENT Â¿CAPSULECTOMY BIOPSYÂ¿ ADDITION CHEMOTHERAPY ADDITIONAL OPERATIVE REPORT FOLLOWING PRIOR DEVICE REMOVAL DETAILS REMOVAL Â¿LEFT BREAST MASS CHEST WALL MASSÂ¿ DESCRIBED Â¿VERY LARGE 3 CM HARD FAIRLY WELL CIRCUMSCRIBEDÂ¿ SURGICAL PATHOLOGY REPORT NOTES Â¿LARGE CELLS POSITIVE CD30Â¿NEGATIVE ALK1Â¿ DIAGNOSIS PROVIDED Â¿BREAST IMPLANT Â¿ ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ ALCL DIAGNOSIS OCCURRED APPROXIMATELY 5 MONTHS EXPLANT SURGERY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/15/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5821949|50447305|D|1||B6 WOMAN BREAST IMPLANTS ADMITTED DEPARTMENT DUE SUDDEN UNILATERAL RIGHT BREAST ENLARGEMENT DISCOMFORT BREAST AUGMENTATION DONE 11 YEARS PREVIOUSLY SUBGLANDULAR PLACEMENT ALLERGAN TEXTURIZED PROSTHESES INFRAMAMMARY APPROACH BREAST AUGMENTATION DONE ELSEWHERE DESPITE EFFORTS GET INFO IMPLANT PLASTIC SURGEON IMPLANTED DEVICE SERIAL NUMBER PRODUCT CODE PT INFO ULTRASOUND MAMMOGRAPHY IMAGES DONE 4 MONTHS EARLIER NORMAL WOMAN DENIED HISTORY BREAST TRAUMA PRODROMAL ILLNESS PAIN PURULENT DRAINAGE LOCAL SIGN INFECTION NIGHT SWEATS WEIGHT LOSS POOR APPETITE FEVER PHYSICAL EXAMINATION BREAST ASYMMETRY OBVIOUS RIGHT BREAST SWOLLEN FIRM SENSITIVE DEEP PALPATION LEFT BREAST NORMAL SIGN LOCAL INFECTION OBSERVED B6 2015 ANAPLASTIC LARGE CELL LYMPHOMA FOUND PERIPROSTHETIC FLUID FIBRINOID DEPOSITS WITHIN PERIPROSTHETIC CAPSULE RIGHT BREAST LEFT BREAST WITHOUT CLINICAL LAB IMAGING HISTOPATHOLOGICAL EVIDENCE DISEASE B6 2015 PT UNDERWENT BILATERAL TOTAL CAPSULECTOMY IMPLANT REMOVAL YEAR PT DISEASE FREE CT PET SCANS INCLUDING RECENT SCAN SHOW SIGNS LYMPHOMA|ALLERGAN SILICONE TEXTURED BREAST IMPLANT||07/24/2016||||Y|*||0HP|FTR|1.0||ALLERGAN SILICONE TEXTURED BREAST IMPLANT|||||||ALLERGAN|||||||True
